neurology.peersalleyconferences.com
Open in
urlscan Pro
172.67.139.138
Public Scan
Submitted URL: http://tracking.researchproceedings.com/tracking/click?d=a0VoK3fpiBJxoZusPHik6VjLtOeKXe89Cl22z15nntCn0Nu1fE51gD0GM9-5O7n0rcYT6ETYYcCBCmN...
Effective URL: https://neurology.peersalleyconferences.com/
Submission: On October 15 via api from FR — Scanned from FR
Effective URL: https://neurology.peersalleyconferences.com/
Submission: On October 15 via api from FR — Scanned from FR
Form analysis 0 forms found in the DOM
Text Content
* Conference
* Tracks
* Workshops
* Submit Abstract
* Book Your Seat
* Media Partners
* Code of Conduct
* Terms & Conditions
* Testimonials
* 2023
* 2022
* 2021
* our experts
* Academic Speakers
* Business Speakers
* Student Sphere
* Best Poster Session
* Young Investigator Forum
* E-Posters
* Program
* Program (In detail)
* Program-at-a-glance
* Sponsors
* Hotel & Travel
* Add.Features
* Start Ups
* Careers
CONFERENCE
* Tracks
* Submit Abstract
* Register Now
* Poster Guidelines
* E-posters
* Terms & Conditions
OUR EXPERTS
* Academic Speakers
* Business Speakers
* Best Poster Session
* Young Investigators Forum
* Workshops
GENERAL INFO
* Careers
* Latest News
* Start Ups
* Program (In Detail)
* Program at a Glance
* Sponsors
* Hotel & Travel
* Register
* Abstract
GET IN TOUCH
+1 778-244-7702
NEURCONCLAVE@NEUROLOGISTSMEET.COM
*
*
*
*
*
QUICK LINKS
Organizing Committee Abstract Submission Register Now Scientific Program Call
Back Request
* 250days
* 16hours
* 24mins
* 43seco
6TH GLOBAL CONCLAVE ON NEUROLOGY AND NEUROLOGICAL DISORDERS
June 23-24, 2025 Berlin | Germany
WHY SHOULD YOU ATTEND NEURO CONCLAVE 2025?
1
PRESENTATION
Primary goal of attending an international conference is to present a paper to
the experts and influencers. It gives you a platform to exchange your
interest-related thoughts, paving the way for possible future collaborations.
2
CONNECT
Use this platform to build connections with an elite group of wise men and women
to enhance your intellect. Young entrepreneurs, this is a great platform to
connect with your peers.
3
EXCEL
Knowledge is Power. Knowledge teaches skills. Skills define excellence. Use this
platform to become cognizant of your interest area to achieve excellence in your
domain.
4
PUBLICATION
Attending a conference give you opportunity to get your abstract or paper
published in conference proceedings
5
COLLABORATION AND FRIENDSHIP
Meet and greet a myriad of industry professionals and academia experts with
common interest. Every meal will be an opportunity to meet and interact with
fellow researchers, attendees and experts.
6
REINVENT SKILLS IN PROFESSIONAL DEVELOPMENT WORKSHOPS
Expand your professional competency and learn useful tips and tricks of your
industry in our skill-building workshops.
7
LEARN ABOUT THE LATEST DEVELOPMENTS
Explore insights on recent advancements, new equipment, new techniques, and
unpublished data, learn from thought-leaders and get to network with a great
line up of speakers.
8
CAPITALIZE ON YOUR TIME BY VISITING THE EXHIBITS
Our exhibits floor offers the attendees with a dynamic display of the latest
products with cutting-edge technology.
9
GET EXCEPTIONAL VALUE FOR YOUR REGISTRATION FEE
Investing in you is the best investment. Peers Alley conferences give the
patrons with a feeling of the serendipity of real learning, skill development in
strategic workshops, networking and start-up opportunities, thus, is value for
money.
10
TRAVELING
Attending the conference gives you much needed break from your regular duties.
It also allows you to explore new cities, culture and meet new people. You will
feel energized and rejuvenated to return to the university and continue with the
job after attending the conference.
EVENT SUMMARY
Conferences are vital forum for academic researchers and business leaders. "It
involves multiple presentations, interactive breakout sessions, hands-on product
demonstrations and unrivalled networking opportunities".
We have invited some of the world's most sought-after keynote speakers, experts,
brand ambassadors, and industry leaders to share their thoughts and ideas with
our conference guests.
Register Now
Keynote Forum
Mini-Plenary Sessions
Distinguished Speakers Forum
Student Forum
Poster Sessions
Young Researchers Forum
Educational Workshops
Research Workshop
Corporate Workshop
Mini- Symposia
Highlights Of The Day Sessions
Meet The Professor
Educational Sessions
Training Programs
about
NEURO CONCLAVE 2025 CONFERENCE
Theme: Advancing Neurological Care: Innovations in Early Detection and Treatment
for Nervous System Disorders
Neurology & Neurological Disorders Proceedings
about NEURO Conclave 2025 conference
NEURO Conclave 2025 Conference
WELCOME MESSAGE
‹›
Meet our first list of distinguished speakers
We're adding more every week
SPEAKER LINE-UP
HASSAN M HESHMATI
Endocrinology Metabolism Consulting, LLC, USA
BEVERLY JEAN BRYANT
American Academy of Child and Adolescent Psychiatry, USA
VAL LANTZ-GEFROH
Sanford Institute for Empathy and Compassion Center for Compassionate
Communication, USA
KENNETH B STOREY
Carleton University, Canada
View More
SCIENTIFIC SESSIONS
* * Neurology
* Neurosurgery
* Neuroscience
* Neuropsychiatry
* Pain Disorder and Management
* Central Nervous System
* Pediatric Neurology
* Neuro-Oncology and Brain Tumors
* Neurophysiology
* Neuroimmunology
* Neuropathology
* Neuroimaging
* Neurodegenerative disease and Neurodegeneration
* Neurological Disorders
* Sleep Disorder
* Stroke
* Movement Disorders
* Parkinsons Disease
* Epilepsy
* Multiple Sclerosis
* Alzheimers Disease and Dementia
* Neuromuscular Disease
* Case Studies and Clinical Trials
* * Novel Treatment Strategies
* Speech Disorders
* Demyelinating Disorders
* Cerebrovascular Disorders
* Autoimmune and Inflammatory Disorders
* Neuropathy
* Headache and Facial Pain
* Diagnosis and Screening of Neurological Disorders
* Neuropharmacology and Neurochemistry
* Stem Cells and Neuroregeneration
* Cognitive Neuroscience
* Motor System Disorders
* Behavioral Neurology
* Computational Neuroscience
* Neurogenetics
* Spinal Neurosurgery
* Pediatric Neurosurgery
* Stereotactic and Functional Neurosurgery
* Neurovascular Surgery
* Intraoperative Neurophysiology
* Peripheral Nerve Surgery
* Robotics in Neurosurgery
* Latest advancement in Brain Surgery
Submit Abstract
* * Skull Base Surgery
* Trauma and Critical Care
* Child Psychology
* Social Cognitive Neuroscience
* Neurophysics
* Neuroradiology
* Neurorobotics
* Advanced Imaging Techniques
* Personalized Medicine
* Neuroinformatics
* Gene Therapy
* Neural Interface and Brain-Computer Interface BCI
* Neurorehabilitation
* Regenerative Medicine and Stem Cell Therapy
* Telemedicine in Neurology
* Nano-Neuroscience
* Neurosurgical Innovations
* Neuroethics
* Precision Psychiatry
* Neuromodulation and New Therapeutic Approaches
* Microbiome and Neurological Health
* Neurological Implications of COVID-19
CONFERENCE HIGHLIGHTS
* Topics Scientific Sessions
* Market Insights
* day1
* day2
NEUROLOGY
Neurology is a field in medicine which deals with the study of the Nervous
system and treatment of the respective disorders. The concerned areas of
Neurology are the central nervous system (CNS), peripheral nervous system (PNS),
brain, blood vessels, and spinal cord. Neurology is concerned to diagnose and
treat the disorders of these parts of humans. The nervous system is considered a
complex system that regulates body activities. Neurology count on the scientific
study of the nervous system, Neuroscience.
A physician who practices Neurology or doctor specialized in Neurology is called
Neurologists. They are trained to interpret or investigate and treat the
disorders related to the network of nerve cells and fibers or neurological
disorders. Neurologists start with a medical history and then with the
neurological examination which encompasses the evaluation of cranial nerves,
sensation, cognitive function, motor strength, reflexes, coordination, and
movement. They treat disorders like:
1. Headache disorders
2. Seizure disorders
3. Speech and Language disorders
4. Movement disorders
5. Neurodegenerative disorders
6. Cerebrovascular diseases
Neurology is connected to Psychiatry and Oncology. Even there is a very thin
line between Neurology and Psychiatry. The discipline of neurology is widening
day by day because of the advancements of Neuroscience and other Medical
specialties, which is helping to tackle the neurological disorders and other
diseases.
Sub-tracks:
* Neurochemistry
* Neuromuscular Medicine
* Neurocritical Care
* Neuro-Oncology
* Child Neurology
* Intervention Neurology
* Geriatric Neurology
* Stroke
* Neurological infections
Market Analysis: The global neurology market is expected to increase at a
compound annual growth rate (CAGR) of 3.5 percent from $33.3 billion in 2019 to
$39.4 billion in 2024. A recent WHO survey suggested that various neurological
disorders collectively accounts for more than 12% of global deaths on average,
and it is predicted that the number of death occurred due to neurological
diseases will rise from 95 million in 2015 to approximately 103 million in 2030.
In 2010, the global cost associated with neurological diseases was estimated to
be US$ 2.5 trillion, and it is expected to be over US$ 6 trillion in 2030. High
impacting elements such as ongoing neuro mapping research, government
initiatives based on neuro science, and algorithms used in the neuro science
sectors are driving the market growth.
Tags
Brain Cancer Conferences Headache Conferences Neurology Conferences Spinal
Disorders Conferences Parkinson Disease Conferences Neurology Conferences 2025
Europe Neurology Conferences 2025 Dementia Conferences Neurology Conferences
2025 USA Neurodegenerative Disorders Conferences Psychiatry Conferences Child
Psychology Conferences Neurosurgery Conferences 2025 Neurology Conferences
Europe Psychology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROSCIENCE
Neuroscience is to address and research the function and structure of the nerve
cells and fibers which comprises to form of the nervous system. It is a
multifaceted and rapidly growing field of biology that looks into the function
and structure of the brain and nervous system.
Neuroscience is a sphere where we study the combination of psychology and
biology to the extent to understand the physical connection, psychological
changes and study of neurological conditions with the brain, that how the brain
perceives these changes and connections.
The sphere of Neuroscience encompasses cellular and molecular biology,
development, evolution, biochemistry, physiology, anatomy and medical specialty
of the nervous system, computational neuroscience, behavioral neuroscience, and
cognitive neuroscience.
Neuroscience works closely with the field of engineering, linguistics,
mathematics, medicine, psychology, physiology, computer science, and chemistry.
Neuroscientists are the researchers who specialize in this branch of biology,
Neuroscience, which deals with molecular, biochemistry, physiology and anatomy
of the nervous system. They do their research by carrying out and framing the
experiments to understand the function of the nervous system and its structure,
especially associated with behavior and learning.
Neuroscience and its scope has been expanded exponentially, a consequence of new
research being done in this field, from molecular and cellular studies of
neurons and to do diagnostic imaging and imaging of brain responses to various
changes. Neuroscience is contributing a lot to Neurology, Neurosurgery,
Psychiatry and other Neuro-related disciplines.
Sub-tracks:
* Behavioral neuroscience
* Clinical neuroscience
* Computational neuroscience
* Cognitive neuroscience
* Developmental neuroscience
* Neuroimaging
Market Analysis: The study of the nervous system is linked to neuroscience.
Neuroscience is diverse in terms of research fields and study subjects. The
global neuroscience market is expected to reach $36.27 billion by 2024, with a
compound annual growth rate (CAGR) of 3.49 percent from 2019 to 2024. Several
government and healthcare industry efforts are expected to have an impact on
overall market growth. The increased prevalence of neurological illnesses is
also having an impact on the industry. In 2016, the global neuroscience market
was worth USD 28.42 billion, and it is predicted to increase at a CAGR of 3.1
percent over the next five years. High-impact factors such as ongoing brain
mapping research and investigation projects, government-led neuroscience
efforts, and technological advancements in neuroscience-related tools and
algorithms are likely to boost market expansion.
Tags
Stroke Conferences Psychology Conferences Neurology Conferences 2024 Asia
Clinical Neurology Conferences Sleep Disorders Conferences Neurology Conferences
2025 Child Psychology Conferences Neurology Conferences 2024 Japan Neurology
Conferences 2024 Alzheimer's Disease Conferences Neurology Conferences Europe
Neurology Conferences 2025 USA Parkinson Disease Conferences Neurology
Conferences Dementia Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROPSYCHIATRY
Neuropsychiatry is an integral part of medicine and science which deals with
mental disorders related to the nervous system. Neuropsychiatry is to study
neurology and psychiatry in an integrated form. Neuropsychiatry is growing far
from other fields of psychiatry and it is also interconnected with behavioral
neurology and neuropsychology.
Neuropsychiatry helps the neuroscience field and is helping to give a better
understanding of the psychiatry and neurological disorders in order to treat
them in a far better way.
Neuropsychiatrists are the physician who has clinical experience and experience
in psychiatry with knowledge of neurological disorders. Neuropsychiatrists
primarily treat patients suffering from brain malfunctions. Neuropsychiatrists
treats these condition with the help of some tools: functional magnetic
resonance tomography (fMRI), clinical neurogenetics, magnetic resonance
angiography, neuroimaging, electroencephalography, and neural network theory.
Neuropsychiatry addresses these various conditions under it: patients of
Parkinson's with delusion and hallucinations, obsessive-compulsive disorder,
schizophrenia, and other conditions as well.
Sub-tracks:
* Psychiatric genetics
* Psycho-oncology
* Mind/brain monism
* Psychiatric epidemiology
* Cultural and religious considerations
* Mental well-being and mental illness
Market Analysis: Psychiatric and neurological illnesses are becoming
increasingly prevalent in society, owing to rising prevalence of these disorders
in adolescents and children, as well as changing demographics. Neuropsychiatric
illnesses are the leading cause of decreased quality of life and decreased
ability to perform. Neuropsychiatric illnesses are responsible for more than 42%
of years spent with a disability in Europe. During the anticipated period, the
Neuropsychiatric Disorders and Treatment Market is expected to develop at a CAGR
of 6.2 percent. The global market for neuropsychiatric drugs was valued at US$
14,448.6 million in 2019, with a compound annual growth rate (CAGR) of 4.2
percent from 2019 to 2030. Neuropsychiatric disorders are the most common among
those over 65. Some of the important factors driving the growth of the
neuropsychiatric medicines market are the rising prevalence of neuropsychiatric
illnesses globally and the rising desire for better treatment.
Tags
Psychology Conferences Parkinson Disease Conferences Neurology Conferences
Europe Neurology Conferences 2025 USA Epilepsy Conferences Neurology Conferences
2024 Asia Spinal Disorders Conferences Clinical Neurology Conferences Neurology
Conferences 2025 Europe Neuroscience Conferences 2024 Dubai Brain Cancer
Conferences CNS Conferences Cerebrovascular Disease Conferences Seizures
Conferences Dementia Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
CENTRAL NERVOUS SYSTEM
The central nervous system or CNS comprises the brain and spinal cord. It is
part of our nervous system and it is termed as central because it is a center
that receives information, coordinates it and influences the activity of the
whole body. It controls our breathing, thoughts, heart rate, emotions, movement,
body temperature, the release of some hormones and other parts as well.
The CNS composed of white and gray matter. This can be found in the brain which
is encased by the skull. The outer cortex of the brain contains gray matter and
white matter in the tract. White matter works as a connector which connects the
various location of nerve cell bodies and carries nerve impulses between neuron.
White matter consists of myelinated axons. Gray matter is made of neuropil,
neuronal cell bodies, glial cells, synapses, and capillaries. The difference
between gray matter and white matter is that the latter contains few myelinated
axons and numerous cell bodies, while white matter contains few cell bodies and
more long-range myelinated axon tracts.
There are various CNS diseases and conditions. CNS infection causes encephalitis
and poliomyelitis, neurological disorders like ADHD, autism, Alzheimer's
disease, Parkinson's disease, Multiple Sclerosis (MS), and other, genetic
disorders as Krabbe's disease and Huntington's disease.
Sub-tracks:
* White and gray matter
* Spinal cord
* Brain
* Cranial nerves
* Difference from the peripheral nervous system
* Clinical significance
Market Analysis: By 2025, the global market for CNS therapeutics is anticipated
to reach USD 128.9 billion. The market is growing because to the rising
frequency of mental illnesses and increased awareness of psychiatric problems.
In addition, the global demand for CNS treatments is growing due to the growing
geriatric population and the increased prevalence of lifestyle-related CNS
illnesses. In 2016, global mental health therapies revenue accounted for 48% of
total revenue, and it is predicted to expand at a high rate between 2016 and
2025,by 2020, the global market for central nervous system pharmaceuticals was
worth $82 billion. In 2017, the United States was the largest country in the
market, accounting for about 30% of total market share, and is expected to grow
at a CAGR of 5.9% over the projected period. The industry is primarily driven by
advancements in diagnostics, therapeutics, and drug discovery approaches.
Furthermore, with the rising frequency of CNS diseases linked to sedentary
lifestyles and chronic mental disorders, the number of patients is predicted to
rise.
Tags
Psychology Conferences Neurology Conferences 2024 Asia Neurophysiology
Conferences Epilepsy Conferences Neurology Conferences 2025 Euro Neurology
Conferences Neurology Conferences 2025 Europe Alzheimer's Disease Conferences
Neurology Conferences Neurology Conferences 2024 Clinical Neurology Conferences
Sleep Disorders Conferences Neurological Disorders Conferences Brain Cancer
Conferences Headache Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
PEDIATRIC NEUROLOGY
Pediatric Neurology or Child Neurology covers the abnormalities of CNS, PNS,
brain and spinal cord of the children. The disorders related to above in infants
and adolescents are considered under this area of Neurology.
Some conditions under Pediatric Neurology or Child Neurology are:
1. Sleep disorders
2. Behavioral disorders
3. Childhood epilepsy
4. Cerebral palsy
5. Concussion and Migraine
6. Neonatal neurology
7. Degenerative disorders
Child neurologists are one who specializes in Child neurology to diagnose and
treat various disorders that occurs in infants, children, and adolescents.
Sub-tracks:
* Neuro-Oncology
* Pain
* Psychological disorders
* Case reports
* Childhood epilepsy
* Neonatal neurology
Market Analysis: Pediatric neurology is a specialty of medicine that deals with
neurological problems in kids, such as sleeplessness, speech disorders and
headaches. The number of children with neurological abnormalities is steadily
increasing. Approximately 600 distinct nervous system illnesses have been
identified around the world. During the projected period, 2017-2023, the
pediatric neurology devices market is expected to increase at a CAGR of 6.3
percent. The worldwide pediatric neurology device market is dominated by North
America. Furthermore, market expansion is supported by factors such as
widespread adoption of technologically improved medical equipment, increased
governmental support for R&D activities, and high spending in neurological care.
The market is predicted to rise exponentially by 2030, thanks to the rising
prevalence of neurological diseases in youngsters. Another lucrative market for
paediatric neurology devices is Europe. The market is growing as a result of a
growing focus on the development of advanced diagnostic equipment and increased
government assistance for R&D activities. The Asia Pacific region is quickly
emerging as another viable market for paediatric neurology products.
Tags
Epilepsy Conferences Psychiatry Conferences Neurology Conferences 2024 Neurology
Conferences 2025 Child Psychology Conferences Neurology Conferences 2024 Asia
Cerebrovascular Disease Conferences Stroke Conferences Neurodegenerative
Disorders Conferences Neurological Disorders Conferences Neurology Conferences
2024 Japan Brain Cancer Conferences Neurology Conferences Europe Psychology
Conferences Headache Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROPHYSIOLOGY
Neurophysiology is defined as the study of physiology and function of the
nervous system. It is to study the functional properties of nerves, glia, and
neural networks. Neurophysiology is a part of neuroscience and physiology.
Electrophysiological or molecular biological tools are often used in
Neurophysiology. Some other researchers define neurophysiology as a study of
brain cells.
It is related to mathematical neuroscience, neurochemistry, electrophysiology,
neuroanatomy, clinical neuroscience, and biophysics. Neurophysiology uses
biological techniques for neurophysiological researches.
Sub-tracks:
* Neurophysiology of Pain
* Surgical Neurophysiology
* Systemic Neurophysiology
* Neurochemistry
* Neurophysiology Facilitation of Respiration
* Clinical neurophysiology
* Metabolic Disorders in Neurophysiology
Market Analysis: The global neurophysiology devices and equipment market is
predicted to increase at a compound annual growth rate (CAGR) of 7.7% from $1.3
billion in 2020 to $1.4 billion in 2021. Geographically, the global
neurophysiology market is divided into five regions - North America, Europe,
Asia Pacific, Latin America, and Middle East & Africa. Companies are resuming
operations and adapting to the new normal as they recover from the COVID-19
impact, which had previously resulted in restrictive containment measures such
as social distancing, remote working, and the closure of commercial activities,
all of which created operational challenges. At a CAGR of 5.7 percent, the
market is estimated to reach $1.75 billion in 2025.
Tags
Neurology Conferences 2025 Europe Child Psychology Conferences Dementia
Conferences Brain Cancer Conferences Neurology Conferences 2024 Japan CNS
Conferences Euro Neurology Conferences Neurology Conferences Europe Headache
Conferences Parkinson Disease Conferences Neurology Conferences 2025 UK
Alzheimer's Disease Conferences Neurology Conferences 2024 USA Spinal Disorders
Conferences Psychology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROIMMUNOLOGY
Neuroimmunology is the study of links between neuroscience and immunology both
fields of medicine. It deals with relation to the central nervous system or
nervous system with immunology. The term Neuroimmunology is coined in the 1960s.
In various Neurological disorders, neuroinflammation and neuroimmune activation
have played a major role in understanding the etiology of these disorders.
Neuroimmunologists are the individuals who are supposed to understand these two
complex disciplines and draw various conclusions to find the exact causes of the
change happening during various neurological disorders, neurological disease, or
neurological injury. This research area is rapidly developing and providing us
the basic and complex both information to advance the researches of Neurology
and Neuroscience to treat neurological disorders in a better way to save many
lives.
Sub-tracks:
* Neuroinflammation
* Research in neuroimmunology
* Auto Immune Neuropathies
* Neuroimmunological disorders
Tags
Neurophysiology Conferences Parkinson Disease Conferences Seizures Conferences
Spinal Disorders Conferences Neurology Conferences 2025 Neurology Conferences
2025 UK Psychiatry Conferences Neurodegenerative Disorders Conferences Child
Psychology Conferences Neurology Conferences 2025 USA Neurology Conferences 2025
Europe Headache Conferences Epilepsy Conferences Neurology Conferences
Neurological Disorders Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROPATHOLOGY
Neuropathology, being an integral part of anatomic pathology, is to study the
nervous system diseases. This study can be in smaller surgical biopsies or can
be studied as whole-body autopsies. Neuropathology has been involved in and
playing a key role in characterizing the pathogenesis of neurological disorders.
Neuropathology has played a key role in providing major insights into the
pathophysiology of Multiple Sclerosis and neuropathology of neurodegenerative
disorders in an adult include nonspecific and disease-specific changes.
Neuropathologists are the physician having specialization in autonomic pathology
but they have undergone training of neuropathology for an additional two years.
Neuropathologists can handle autonomic pathology, autonomic pathology testing on
nervous system tissues as well as neurological or neuromuscular pathology.
Sub-tracks:
* Neuropathology of Neurodegenerative disorders
* Neuropathology of Aging
* Neuropathology of Neuro-Oncology
* Neuropathology of Brain Tumor
* Neuropathological techniques
* Treatment and advancement in neuropathology
* Neuropathology approaches
* Clinical Neuropathology
* Functional Neuroanatomy
Market Analysis: The disease of nerves that causes pain and numbness in the
limbs is known as neuropathology, and it is gaining popularity in this industry.
The global neuropathology market is growing due to an increase in the incidence
of musculoskeletal diseases and technical developments in medical diagnostic
instruments. During the forecast period 2017-2023, the Neuropathology Market is
expected to develop at a CAGR of around 6%. By 2027, the Neurology Devices
Market will be worth $ 21.02 billion, with a 10.2% compound annual growth rate.
The escalating incidence of neurological illnesses, substantial investments by
private companies in neurology equipment, increased R&D in the field of
neurotherapy, and the ageing population are all driving the market forward.
Tags
Child Psychology Conferences Neurology Conferences 2024 USA Neurology
Conferences 2024 Japan Spinal Disorders Conferences Muscular Dystrophy
Conferences Neurosurgery Conferences 2025 Dementia Conferences Psychology
Conferences Sleep Disorders Conferences Headache Conferences Cerebrovascular
Disease Conferences Stroke Conferences Brain Cancer Conferences Neurology
Conferences 2025 USA Neurology Conferences Europe
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEURODEGENERATIVE DISEASE AND NEURODEGENERATION
Neurodegenerative disease is the group of condition or disease which mainly
affect the neurons of the brain. The neurons are the building block of the brain
and spinal cords or nervous system. Neurons are irreplaceable as they cannot
replicate or reproduce after suffering damage which eventually death of the
neuron.
Neurodegeneration is a loss in the structure and function of neurons.
Aging is the main cause of neurodegenerative disease. Neurodegenerative disease
progress with age as the neurons become less functional. Oxidative stress,
mitochondrial DNA mutation, and other factors lead a human body to age.
Genetics, protein folding, DNA damage, mitochondrial dysfunction, programmed
cell death, protein degradation pathways and other leads to the mechanism of
neurodegenerative diseases. The cure of neurodegenerative disease is not yet
discovered as causes of most of the cases are still a mystery.
Sub-tracks:
* Batten disease
* Huntington's disease
* Parkinson's disease
* Amyotrophic lateral sclerosis (ALS)
* Alzheimer's disease
* Motor neuron disease
Market Analysis: Neurodegenerative diseases refer to a group of brain disorders
that lead to progressive degeneration of the structure and function of neurons
in the central nervous system (CNS) or peripheral nervous system (PNS). The
global neurodegenerative disease treatment market grew at a CAGR of around 8%
during 2015-2020.
The Neurodegenerative Disease market was worth around USD 39.24 billion in 2020,
and is predicted to reach USD 44.90 billion in 2026, with a CAGR of 2.30
percent.The global neurodegenerative disorder therapeutics market is predicted
to increase at a compound annual growth rate (CAGR) of 7.9% from $14.08 billion
in 2020 to $15.19 billion in 2021. The growth is mainly due to the companies
resuming their operations and adapting to the new normal while recovering from
the COVID-19 impact, which had earlier led to restrictive containment measures
involving social distancing, remote working, and the closure of commercial
activities that resulted in operational challenges. The market is expected to
reach $20.15 billion in 2025 at a CAGR of 7%.
Tags
Neurology Conferences 2024 Japan Neurodegenerative Disorders Conferences
Neurology Conferences 2025 UK Psychology Conferences Neurophysiology Conferences
Neurological Disorders Conferences Neurology Conferences 2024 Cerebrovascular
Disease Conferences Brain Cancer Conferences Parkinson Disease Conferences Child
Psychology Conferences Epilepsy Conferences Headache Conferences CNS Conferences
Clinical Neurology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROLOGICAL DISORDERS
Neurological disorders are defined as disorders that affect the brain, spine and
nerves throughout the human body. It is either associated with CNS or PNS or
both. Structural, biochemical or electrical abnormalities can cause a wide range
of neurological problems which eventually might lead to different types of mild
to severe neurological disorders.
Neurological disorders have different causes and symptoms. Most of them start or
emerge during the early stage of life or maybe diagnosed at birth. The symptoms
of Neurological disorders vary in each disorder. Congenital causes, gene
abnormalities, metabolic disorders, prenatal causes, nutritional deficiencies,
complications during childbirth, acquired causes, immune disorders, traumatic
brain injury, and toxins are some of the causes of Neurological disorders.
Some neurological disorders are:
Parkinson's disease
Amyotrophic lateral sclerosis or ALS
Brain tumors
Epilepsy
Stroke
Peripheral Neuropathy
Key treatment methods of Neurological disorders:
Neuroimaging techniques to diagnose
Brain mapping
Cognitive therapy treatment
Pain management
Physiotherapy
Deep brain stimulation
There are various other methods to treat these lifelong neurological disorders.
Sub-tracks:
* ALS
* Epilepsy
* Parkinson's Disease
* Brain Aneurysm
* Spinal Cord Tumor
* Memory Disorders
* Multiple Sclerosis
* Arteriovenous Malformation
* Headache
* Dural Arteriovenous Fistulae
* Stroke
* Brain Tumors
* Peripheral Neuropathy
* Post-Herpetic Neuralgia
Market Analysis: The global neurology market is expected to increase at a
compound annual growth rate (CAGR) of 3.5 percent from $33.3 billion in 2019 to
$39.4 billion in 2024. Anticholinergic, antiepileptic, antipsychotic, hypnotic &
sedative, analgesics, antihypertensive, anticoagulants, and others are the drug
types that make up the global neurological diseases treatment market. According
to a study, an estimated 5.4 million Americans suffer from Alzheimer's disease,
and someone in the United States acquires the condition every 68 seconds.Due to
key driving factors such as increasing prevalence of neurological disorders,
developing healthcare infrastructure, rising awareness associated with
neurological diseases, which is fueling the rate of diagnosis, and mounting
accessibility of modern treatments in developing countries such as China, India,
and Indonesia, Asia Pacific was identified as the fastest growing region between
2021 and 2029. According to the report, the global market for neurological
disease pharmaceuticals was worth US$ 70 billion in 2018 and is expected to grow
at a CAGR of 5% from 2019 to 2027.
Tags
Neurological Disorders Conferences Neurodegenerative Disorders Conferences
Cerebrovascular Disease Conferences Dementia Conferences Muscular Dystrophy
Conferences Psychology Conferences Child Psychology Conferences Sleep Disorders
Conferences Neurology Conferences 2025 Euro Neurology Conferences Neurology
Conferences Neurology Conferences 2025 UK Stroke Conferences Alzheimer's Disease
Conferences Neuroscience Conferences 2024 Dubai
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
SLEEP DISORDER
The group of condition which changes or alters or hinders the normal pattern of
sleep comes under Sleep disorders. This disorder can affect our overall health
and make us prone to stress and anxiety. There are various causes for sleep
disorders like medical conditions (heart disease, lung disease, and nerve
disorder), mental disorder, genetics, not enough sleep, stress, anxiety,
irregular sleep, medicines, and aging. Sometimes the reason for a sleep disorder
is unknown as these disorders are very complex.
Depression, lack of concentration, fatigue in the daytime, difficulty in
sleeping, and anxiety are the symptoms of sleep disorders. Some types of sleep
disorders are insomnia, parasomnias, sleep apnea, and narcolepsy. For the
diagnosis of sleep disorders, the doctor goes through the patient's medical
history and some tests. These tests include genetic blood testing,
electroencephalogram, polysomnography, breathing rate, and eye movements. Sleep
disorders can be treated by good sleeping habits, medical treatments, by
changing lifestyle, and relaxation techniques.
Sub-tracks:
* Insomnia
* Sleep Apnea
* Parasomnias
* Narcolepsy
* Obstructive sleep apnea
* Restless legs syndrome
* Sleepwalking
* Jet lag
Market Analysis: Sleep disturbance, also known as somnipathy, is a medical
illness in which the sleep cycle is disrupted. It can also be defined as a group
of disorders that have a regular impact on sleep patterns. Sleep disturbances
can be caused by a variety of circumstances, including health problems and high
stress levels. During the forecast period, the worldwide sleep disorders
treatment market is expected to grow at a CAGR of roughly 7.1 percent. Sleep
disorders are becoming more common around the world, and rising stress levels, a
growing geriatric population, and increased understanding about various
treatment choices for this illness are all likely to drive the industry
forward.North America currently dominates the market for sleep disorders, and it
is anticipated to do so for a few more years. The market is expected to be
driven by rising demand for sleep disorder treatment in the United States and
Canada, rising prevalence of sleep disorders, more awareness, and high
healthcare spending. From USD 7,852.54 million in 2020 to USD 14,732.08 million
in 2028, the global sleep disorder treatment market is predicted to increase at
an annual rate of 8.4% from 2021 to 2028.
Tags
Headache Conferences Brain Cancer Conferences Neurology Conferences 2024 Japan
Alzheimer's Disease Conferences Euro Neurology Conferences Neurophysiology
Conferences Neurology Conferences 2025 UK Neurology Conferences Parkinson
Disease Conferences Neurology Conferences 2025 Seizures Conferences Epilepsy
Conferences Neurology Conferences 2024 Psychology Conferences Neurology
Conferences Europe
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
MOVEMENT DISORDERS
Movement disorders, a neurological condition, in which an abnormal increase or
reduction in movement is observed, which is voluntary or involuntary. Movement
disorder is divided into two categories:
Hyperkinetic movement disorders: It is the involuntary movement which hinders
the normal movement of motor activity of the body. It refers to repetitive
movement or dyskinesia.
Hypokinetic movement disorders: It is the slow motion of the body parts or motor
activity. As it refers to hypokinesia - reduced amplitude of movement, akinesia
– lack of movement, rigidity, and bradykinesia – slow movement.
Some movement disorders are:
1. Ataxia
2. Cervical Dystonia
3. Chorea
4. Huntington's disease
5. Multiple system atrophy
6. Parkinson's disease
Treatment of these disorders depends on movement disorders.
Sub-tracks:
* Parkinson's disease
* Progressive Supranuclear Ophthalmoplegia
* Dystonia
* Blepharospasm
* Parkinson plus syndromes
* Secondary Parkinsonism
* Cerebral palsy
Market Analysis: Neurological diseases and syndromes that impact the ability to
create and govern movement are known as motor system disorders or Movement
Disorders. This condition mostly affects the brain, spinal cord, and nerves
throughout the body, resulting in cerebrovascular disorders, adult degenerative
diseases, and other complications. The primary growth drivers of the movement
disorder market are the recent development of efficient and advanced technology,
rising prevalence of neurodegenerative disorders, patent expiration of several
bestseller medications, and the appearance of new technologies globally.The
increasing cost of research and development, on the other hand, is a major
barrier for the worldwide Musculoskeletal Diseases market. From 2021 to 2030,
the global market for motor system disorders is expected to grow at a CAGR of
9.80%. Because of the high frequency of the illness, increased awareness among
the patient population, and technological improvements, North America held a
considerable market position in the worldwide neurological movement disorders
market in 2020.
Tags
Neurology Conferences 2025 Neurology Conferences 2024 Asia Alzheimer's Disease
Conferences Neurosurgery Conferences 2025 Neurology Conferences 2024 Japan
Neurological Disorders Conferences Seizures Conferences Spinal Disorders
Conferences Epilepsy Conferences Neurology Conferences 2025 USA Neurology
Conferences Europe Neurology Conferences 2025 Europe Parkinson Disease
Conferences Brain Cancer Conferences Sleep Disorders Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
PARKINSONS DISEASE
Parkinson's disease, a movement disorder, is a progressive neurological
disorder, the condition progresses over time. In Parkinson's disease, the cells
which are responsible to secrete dopamine begin to die. Dopamine is responsible
for the smooth functioning of the muscle of the body. Dopamine is secreted by
the cells of the substantia nigra, a part of the brain.
Parkinson's disease symptoms including the change in voice, slurry voice,
tremor, slow movements, anosmia, balancing problem, stiffness of arms, legs and
trunks, facial expression start to change, and loss of sense of smell. These
symptoms are due to a decrease in levels of dopamine leading to abnormal brain
activity.
The cause which leads to low levels of dopamine is not yet clear. But there are
many factors which lead to Parkinson's disease, maybe genetic factors and
environmental causes. As there is no specific test to diagnose Parkinson's
disease, a dopamine transporter test scan can be used.
Sub-tracks:
* Signs and symptoms of Parkinson's disease
* Secondary Parkinsonism
* Parkinsonian gait
* Brain cell death
* Parkinsonism
* Bradykinesia
* Parkinson’s care, rehabilitation, and treatments
Market Analysis:
In the United States, it is the second most common neurodegenerative disorder.The global Parkinson's disease treatment market is predicted to grow at a CAGR of 6.1 percent from USD 4.24 billion in 2017 to USD 5.69 billion in 2022. The market is being driven by the growing ageing population and government financing for Parkinson's disease research. The Parkinson's disease (PD) market is predicted to develop significantly in the next seven years, with a 12.6 percent compound annual growth rate starting in 2019. (CAGR). Parkinson's disease is expected to affect 1.2 million people in the United States by 2030, according to the National Institute of Health.
Tags
CNS Conferences Seizures Conferences Child Psychology Conferences Neurology
Conferences 2025 Neurology Conferences 2024 USA Neurology Conferences
Cerebrovascular Disease Conferences Psychiatry Conferences Neurodegenerative
Disorders Conferences Neurology Conferences 2025 Europe Muscular Dystrophy
Conferences Spinal Disorders Conferences Psychology Conferences Clinical
Neurology Conferences Neuroscience Conferences 2024 Dubai
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROMUSCULAR DISEASE
Neuromuscular disease encompasses various disease and disorders which affects
the nerves that control muscle function and neuromuscular system. Neuromuscular
disorders can generate difficulties with the nerves carrying information back to
the brain, nerves that control voluntary muscles, and transmission between nerve
and muscles. These disorders can make the muscles weak and may lose functioning
as well.
Some signs and symptoms of neurological disorders or neurological disease are
muscle loss, muscle weakness, double vision, trouble breathing and swallowing,
numbness, balancing problem, and movement issues. Signs and symptoms for some of
the neurological disorders can be visible in the infant stage as well. In
general, there is no cure for these disorders. But prevention, prognosis, and
management of these diseases vary according to the severity and types of these
disorders.
Sub-tracks:
* Spinal muscular atrophy
* Myasthenia gravis
* Researches on Neuromuscular disease and disorders
* Myositis, including polymyositis and dermatomyositis
* Myopathy
* Charcot-Marie-Tooth disease
* Amyotrophic lateral sclerosis (ALS)
* Neuromuscular Disorders
* Multiple sclerosis
* Neuromuscular disease causes and risk factors
* Autoimmune disorders
* Peripheral neuropathy
* Muscular dystrophy
Market Analysis: The global neuromuscular disorders therapeutics market is
expected to increase by USD 6.05 billion from 2019 to 2023, with a compound
annual growth rate (CAGR) of over 14% from 2021 to 2023. A number of innovative
therapies for the treatment of diverse indications have been approved in the
neuromuscular disorders therapeutics market. This is primarily owing to advanced
study on severely morbid and progressive indications.One of the major
neuromuscular illnesses for which treatment approvals have been granted is
spinal muscular atrophy. During the period 2019-2023, the global neuromuscular
disease treatments market would rise by USD 6.05 billion.
Tags
Neurology Conferences Europe Neurodegenerative Disorders Conferences Neurology
Conferences 2025 UK Psychiatry Conferences Euro Neurology Conferences Neurology
Conferences CNS Conferences Neurology Conferences 2025 Europe Muscular Dystrophy
Conferences Psychology Conferences Alzheimer's Disease Conferences Neuroscience
Conferences 2024 Dubai Neurology Conferences 2025 Sleep Disorders Conferences
Neurosurgery Conferences 2025
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
SPEECH DISORDERS
Speech is the process of producing specific sounds that convey meaning to the
listener. A speech disorder refers to the conditions in which an individual has
problems in creating or forming the speech sounds needed to communicate with
others. The act of speaking requires the specific coordination of multiple body
parts, including the brain, neck, chest, and abdomen.
Speech disorders can affects both adults and children. Many children will
experience a temporary delay in speech and language development. Most will
eventually catch up. Others will continue to have difficulty with communication
development.
Causes of speech disorders include:
Brain damage due to a stroke or head injury
Muscle weakness
Damaged vocal cords
A degenerative diseases
Dementia
Cancer that affects the mouth or throat
Autism
Down syndrome
Hearing loss
Sub-track
* Childhood apraxia of speech
* Orofacial myofunctional disorders
* Articulation disorders
* Receptive disorders
* Autism-related speech disorders
* Resonance disorders
* Selective mutism
* Dysarthria
* Diagnosis and Speech Therapy
Market Analysis: The speech disorder market is predicted to increase as a result
of key driving factors such as rising neurological disorders, rising birth rates
of speech abnormalities, and rising speech disorder services. Growing technology
advancements are predicted to provide new approaches, goods, and services to
treat speech impairments, giving the market room to expand. For the projection
period of 2021-2028, the speech impairment market would grow at a CAGR of
roughly 3.81 percent. The rising prevalence of brain injuries, tumours, and
Parkinson's diseases, as well as increased focus on medical device research and
development and adoption of advanced healthcare technologies, as well as rising
expenditure on healthcare infrastructure development, particularly in developing
economies, are all contributing to the growth of the speech impairment market.
The market for speech disorders is divided into three categories: category,
patient type, and service provider. The market is divided into apraxia,
cluttering, dysarthria, neurological speech problem, and others based on kind.
Tags
Psychiatry Conferences Seizures Conferences Neurology Conferences 2025 Neurology
Conferences 2024 USA CNS Conferences Epilepsy Conferences Euro Neurology
Conferences Stroke Conferences Neurology Conferences 2024 Japan Neurological
Disorders Conferences Neurology Conferences Europe Muscular Dystrophy
Conferences Neurology Conferences 2025 UK Neurodegenerative Disorders
Conferences Neurophysiology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
DEMYELINATING DISORDERS
The damage of the protective covering (myelin sheath) that surrounds nerve
fibers in brain, optic nerves and spinal cord leads to development of
demyelinating disorders. The damaged myelin sheath makes the nerve impulses slow
or even stop, causing neurological problems. Demyelination causes neurological
deficits, such as vision changes, weakness, altered sensation, and behavioral or
cognitive problems. Demyelination can occur at any age.
Symptoms of demyelinating diseases include
Loss of vision
Numbness or tingling of upper or lower limbs
Weakness of the arms or legs
Poor coordination/gait problem
Trouble walking
Difficulty in swallowing
Slurred speech
Deceased bowel or bladder control
Impaired memory
Mood or behavioral changes
Genetic mutations, infectious agents, autoimmune reactions, Vitamin
B12 deficiency and other unknown factors results in dysmyelination.
Sub-track
* Acute Disseminated Encephalomyelitis
* Balo’s Disease
* Charcot-Marie-Tooth Disease
* Guillain-Barre Syndrome
* HTLV-I Associated Myelopathy
* Neuromyelitis Optica
* Schilder’s Disease
* Transverse Myelitis
* Diagnosis and treatment
Market Analysis: In the forecast period of 2020 to 2027, the global market for
demyelinating disorders treatments is expected to increase. The myelin sheath, a
protective layer that surrounds nerve fibres in the brain, optic nerves, and
spinal cord, is damaged in demyelinating illnesses. The market for demyelinating
disorders therapies is divided into immunomodulators, immunosuppressants,
interferons, and others based on medication class. The market for demyelinating
disorders therapies is divided into two segments: oral and parenteral. he
demyelinating disorders therapeutics market is divided into hospitals, homecare,
specialty clinics, and others based on end users. The market for demyelinating
disorders therapeutics has been divided into three categories based on
distribution channels: hospital pharmacy, online pharmacy, and retail pharmacy.
Tags
Child Psychology Conferences Seizures Conferences Epilepsy Conferences
Neuroscience Conferences 2024 Dubai Neurodegenerative Disorders Conferences Euro
Neurology Conferences Psychiatry Conferences Neurology Conferences Dementia
Conferences Alzheimer's Disease Conferences Neurology Conferences 2024 Japan
Neurology Conferences 2024 Asia Sleep Disorders Conferences Neurology
Conferences 2025 USA Neurology Conferences 2025
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
CEREBROVASCULAR DISORDERS
Cerebrovascular disorder refers to the condition in which blood flow in the
brain is blocked or limited for temporarily or permanently. It includes all
disorders in which an area of the brain is affected by ischemia or bleeding.
Restrictions in blood flow may occur from vessel narrowing clot formation,
blockage or hemorrhage. Cerebrovascular disease can develop from a variety of
causes such as atherosclerosis, embolic arterial blood clot, cerebral venous
thrombosis, blood vessel damage, and hypertension. There are also many less
common causes of cerebrovascular disease, including those that
are congenital or idiopathic and include CADASIL, aneurysms, amyloid
angiopathy, arteriovenous malformations, fistulas, and arterial dissections.
Common symptoms include:
A severe and sudden headache
Hemiplegia
Hemiparesis
Confusion
Slurred speech
Vision loss on one side
loss of balance
Loss of conciousness
Sub-track
* Stroke
* Carotid stenosis
* Vertebral stenosis
* Intracranial stenosis
* Cerebral aneurysm
* Vascular malformations
* Psychological therapy
* Occupational therapy
* Emergency Medicine
Market Analysis: During the forecast period, the worldwide cerebrovascular
disease treatment market is expected to develop at a significant CAGR of 5.9%.
The advancement of technology and the rising occurrence of strokes are two main
factors driving the growth of the cerebrovascular disease treatment market. The
cerebrovascular disorders market may be divided into four key regions based on
geography: North America, Europe, Asia Pacific, and the Rest of the World (RoW).
North America leads the global market for cerebrovascular illness, followed by
Europe. During the projected period 2021-2027, the global "Cerebrovascular
Disease Market" is expected to develop at a stable rate.
Tags
Parkinson Disease Conferences Euro Neurology Conferences Neurology Conferences
2025 Europe CNS Conferences Epilepsy Conferences Brain Cancer Conferences
Muscular Dystrophy Conferences Neurology Conferences Europe Neurosurgery
Conferences 2025 Neurology Conferences 2025 Cerebrovascular Disease Conferences
Stroke Conferences Neurodegenerative Disorders Conferences Neurology Conferences
2024 Japan Psychology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
AUTOIMMUNE AND INFLAMMATORY DISORDERS
Immune system protects the human body from disease and infection. However incase
of autoimmune disease, immune system attacks healthy cells in the body by
mistake. There are many systemic disorders with possible involvement of the
nervous system with presumed inflammatory and autoimmune pathomechanisms.
Abnormal inflammatory response is closely associated with in autoimmune
diseases. These inflammations cause impaired functioning, resulting in
neurological or psychiatric symptoms. Multiple sclerosis, myasthenia gravis, and
Guillain-Barré syndrome are some of the most well known neurological diseases
induced by abnormal autoimmunity.
The exact cause of immune-system misfire is unknown although some people are
more likely to get an autoimmune disease than others. Certain autoimmune
diseases, like multiple sclerosis and lupus is hereditary. Not every family
member will necessarily have the disease, but they inherit a susceptibility to
an autoimmune condition. As the incidence of autoimmune diseases is rising,
researchers are also investigating environmental risk factors like infections
and exposure to chemicals. Autoimmune disorders of the nervous system may
affects both CNS and PNS, including the brain, spinal cord, peripheral nerves,
neuromuscular junction and skeletal muscle.
Sub-track
* Guillain-Barré syndrome
* Autoimmune encephalitis
* Myasthenia Gravis
* NMO Spectrum Disease
* Immune-Mediated Myopathies
* Immune-Mediated Neuropathies
* Novel Targeted Therapies for Autoimmune Diseases
* Antigen-Specific Immunosuppression
Market Analysis: The global autoimmune disease therapeutics market was worth
$109,833 million in 2017, and is expected to grow at a CAGR of 4.2 percent from
2018 to 2025, to reach $153,320 million. An autoimmune illness is a condition in
which the immune system attacks and destroys its own body tissue. During the
forecast period, the autoimmune disease diagnostics market is expected to grow
at a CAGR of roughly 8.3%. Rising global awareness of autoimmune disorders as a
result of research, education, support, and advocacy activities is a major
reason driving up the use of autoimmune disease diagnostics. The global
autoimmune disease diagnosis market is estimated to increase at a CAGR of 8.9%
from USD 4.1 billion in 2020 to USD 6.3 billion in 2025. The global autoimmune
disease therapeutics market was worth $109,833 million in 2017, and is expected
to grow at a CAGR of 4.2 percent from 2018 to 2025, to reach $153,320 million.
From 2018 to 2025, the global autoimmune disease treatments market is estimated
to increase at a CAGR of 4.2 percent, from about $109.83 billion in 2017 to
$153.32 billion in 2025.
Tags
Clinical Neurology Conferences Parkinson Disease Conferences Neurological
Disorders Conferences Neurology Conferences 2025 USA Neurology Conferences 2025
UK Neurology Conferences 2024 Japan Neuroscience Conferences 2024 Dubai
Neurology Conferences 2024 USA Neurophysiology Conferences Neurology Conferences
Europe Psychology Conferences Epilepsy Conferences Sleep Disorders Conferences
CNS Conferences Muscular Dystrophy Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROPATHY
Neuropathy, this term indicates damage or dysfunction of one or more nerves that
typically results in numbness, tingling, muscle weakness and pain in the
affected area. Neuropathy is mostly called as peripheral neuropathy. Peripheral
nervous system is the network of nerves outside the brain and spinal cord.
Neuropathy results when nerve cells, called neurons, are damaged or destroyed,
as it disrupts the way the neurons communicate with each other and with the
brain. Neuropathy can either affect one nerve (mononeuropathy) or nerve type, a
combination of nerves in a limited area (multifocal neuropathy) or many
peripheral nerves throughout the body (polyneuropathy).The peripheral nervous
system is made up of three types of nerves, sensory nerves carry messages from
the five senses (sight, hearing, smell, taste, touch) through the spinal cord to
the brain. On the other hand motor nerves travel in the opposite direction of
sensory nerves. They carry messages from brain to muscles. Motor nerves are
responsible for movement coordination. Autonomic nerves are responsible for body
functions by direct control, such as breathing, digestion, heart rate, blood
pressure, sweating, bladder control and sexual arousal.
Health conditions that can cause peripheral neuropathy include
* Autoimmune diseases
* Diabetes
* Infections
* Inherited disorders
* Tumors
* Bone marrow disorders
* Vitamin deficiencies
* Brain and Spine injury
Sub-track
* Diabetic neuropathy
* Peripheral neuropathy
* Cranial neuropathy
* Autonomic neuropathy
* Focal neuropathy
Market Analysis: According to the World Health Organization (WHO), it was
estimated that there would be 285 million diabetics by 2010 in the world. This
estimate is projected to increase by 65% to become 438 million in the year 2030.
Thus, rising prevalence of diabetes mellitus is expected to increase the
population of patients suffering from peripheral neuropathy. The global diabetic
neuropathy market size was valued at USD 3.61 billion in 2018 and is projected
to reach USD 7.12 billion by 2026, exhibiting a CAGR of 8.9% during the forecast
period. By 2030, all of these cases are predicted to rise. The Diabetic
Neuropathy Market is expected to grow at an annual rate of 8.9% till 2026. The
market was valued USD 3.61 billion in 2018 and is expected to grow at an annual
rate of 8.9% from 2019 to 2026. The global peripheral neuropathy market was
worth US$ 1,470.9 million in 2016, and is predicted to grow at a CAGR of 3.2
percent from 2017 to 2025, reaching US$ 1,998.8 million.
Tags
Neurosurgery Conferences 2025 Euro Neurology Conferences Neurological Disorders
Conferences Muscular Dystrophy Conferences Neurology Conferences Europe
Neurology Conferences Stroke Conferences Neurology Conferences 2025 Seizures
Conferences Neurology Conferences 2025 Europe Neurodegenerative Disorders
Conferences Neurology Conferences 2024 Japan Headache Conferences Neurology
Conferences 2024 Asia Neurology Conferences 2024 USA
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
COGNITIVE NEUROSCIENCE
Cognitive neuroscience investigates the cognitive function that emerges from the
physiochemical activity of neurons in the brain. It is associated with the study
of the biological processes and various aspects that trigger cognition, with an
explicit focus on the neural connections in the brain which are involved with
mental processes. This is definitely at the intersection of psychology and
neuroscience. Research in this field mostly focuses on the neural mechanisms of
perception, selective attention, memory, language, emotion and consciousness for
the better understanding the patients with brain damage and also to understand
how the healthy brain changes with aging.
Market Analysis: During the forecast period, the Neuroscience market is expected
to increase at a CAGR of roughly 4.1 percent. Rising illness burden of
brain-related disorders, innovation in the field of neuroscience and
neuro-technology, and increasing R&D spending and government support are some of
the factors driving market expansion.
Tags
Neurology Conferences 2024 Asia Neurosurgery Conferences 2025 CNS Conferences
Neurology Conferences 2025 Europe Sleep Disorders Conferences Alzheimer's
Disease Conferences Neurology Conferences 2025 UK Neurology Conferences Europe
Neurodegenerative Disorders Conferences Euro Neurology Conferences Seizures
Conferences Neurology Conferences 2025 USA Clinical Neurology Conferences Stroke
Conferences Headache Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
MOTOR SYSTEM DISORDERS
The term motor disorders refer to a group of disorders caused by the
malfunctions or damage of the nervous system which results in involuntary or
uncontrollable movements or actions of the body. These disorders manifest lack
of movement coordination or an excess of involuntary movement.
Symptoms of motor disorders include
• Tremors
• Gait problems
• Spasms and dystonia
• Spasticity
• Cognitive and behavioral problems
• Swallowing and speaking difficulties
Pathological changes in certain areas of the brain are the foremost causes of
most motor disorders. Besides that it could also cause due to some chronic
diseases such as overactive thyroid, Iron deficiency, Neurodegenerative
conditions etc. Some of the inherited genetic defects also lead to onset of
motor disorders.
Sub-track
• Motor neuron disease (MND)
• Ataxia
• Dystonia
• Essential Tremor
• Huntington's Disease
• Multiple System Atrophy (MSA)
• Progressive Supranuclear Palsy (PSP)
• Rett Syndrome
• Spasticity
• Tourette Syndrome
• Wilson's Disease
• Physiotherapy
• Occupational therapy
• Deep brain stimulation
Market Analysis: Neurological diseases and syndromes that impact the ability to
create and govern movement are known as motor system disorders or Movement
Disorders. This condition mostly affects the brain, spinal cord, and nerves
throughout the body, resulting in cerebrovascular disorders, adult degenerative
diseases, and other complications. The primary growth drivers of the movement
disorder market are the recent development of efficient and advanced technology,
rising prevalence of neurodegenerative disorders, patent expiration of several
bestseller medications, and the appearance of new technologies globally.The
increasing cost of research and development, on the other hand, is a major
barrier for the worldwide Musculoskeletal Diseases market. From 2021 to 2030,
the global market for motor system disorders is expected to grow at a CAGR of
9.80%. Because of the high frequency of the illness, increased awareness among
the patient population, and technological improvements, North America held a
considerable market position in the worldwide neurological movement disorders
market in 2020.
Tags
Neurology Conferences Neuroscience Conferences 2024 Dubai Spinal Disorders
Conferences Neurology Conferences 2024 Asia Dementia Conferences Clinical
Neurology Conferences Psychiatry Conferences Stroke Conferences Epilepsy
Conferences Child Psychology Conferences Cerebrovascular Disease Conferences
Neurology Conferences 2025 USA Seizures Conferences Neurology Conferences 2025
CNS Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
BEHAVIORAL NEUROLOGY
The impact of neurological damage and disease on behaviour, memory, and
cognition is studied in behavioural neurology, a specialisation of neurology.
Neuropsychiatry and neuropsychology are two areas related to behavioural
neurology. Three types of clinical syndromes are covered by behavioural
neurology: 1) brain diseases impacting cognition and behaviour, both diffuse and
multifocal 2) Neurobehavioral syndromes linked with localised brain lesions, and
3) neurological illnesses with neuropsychiatric symptoms. These syndromic
categories can be split into neurodegenerative) and systemic toxic-metabolic
brain illnesses based on their aetiology. A behavioural neurologist investigates
and treats cognitive and behavioural problems caused by a brain illness or
damage.
Sub-tracks:
• Cognitive Rehabilitation
• Geriatric Behavioral Neurology
• Childhood-Onset Neurobehavioral Disorders
• Neuropsychiatry
• Autoimmune and inflammatory encephalopathies
• Meningoencephalopathy
• Prion disorders
Market Analysis:The global market for behavioural neurology is predicted to
expand at a compound annual growth rate (CAGR) of 3.5 percent from $33.3 billion
in 2019 to $39.4 billion in 2024. The availability of a disproportionately high
number of products and services in behaviour analysis utilising various animal
models is projected to fuel this segment's growth. Because of its applicability
in chronic brain dysfunction analysis utilising static markers, neural activity
implants are projected to account for significant increase in the segment of
stereotaxic procedures.
Tags
Neurological Disorders Conferences Child Psychology Conferences Euro Neurology
Conferences Spinal Disorders Conferences Headache Conferences Seizures
Conferences CNS Conferences Neurology Conferences 2025 UK Clinical Neurology
Conferences Neurology Conferences 2024 Epilepsy Conferences Sleep Disorders
Conferences Alzheimer's Disease Conferences Neuroscience Conferences 2024 Dubai
Neurology Conferences 2025 Europe
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
COMPUTATIONAL NEUROSCIENCE
Computational neuroscience is a branch of neuroscience that investigates brain
function using mathematical techniques and theories. It is an interdisciplinary
discipline that focuses on the construction, simulation, and analysis of
multi-scale models and theories of brain function, ranging from molecules to
cells and networks, and finally to cognition and behaviour. In order to
understand how the nervous system processes information, it can also include
various methodologies from electrical engineering, computer science, and
physics. Computational neuroscience's ultimate goal is to explain how electrical
and chemical signals in the brain are used to represent and interpret
information. It covers biophysical computation mechanisms in neurons, computer
simulations of neural circuits, and learning models.The study of brain dynamics
can be separated further into two streams. One school of thought, epitomised by
Hodgkin and Huxley's work, focuses on the biophysics of single neurons. The
other is concerned with the dynamics of networks, namely phenomena that arise
from the interconnections of neurons. As a result, there are three
subspecialties in computational neuroscience: neural coding, neurobiophysics,
and neural networks.
Sub-tracks:
• Computational Vision
• Neural Circuits and Neural Coding
• Neuro AI
• Statistical Analysis of Neural Data
• Neural Models and Theory
• Neuromorphic engineering, and Robotics
• Brain–computer Interfaces
• Neuroinformatics
Market Analysis : Because of the high market prices of instruments used in
neuro-analytical investigations, the instrumentation for neuroscience market in
technological components accounted for the greatest market share in terms of
revenue. Because of developments in the creation of effective data tracing and
manipulation algorithms, data analysis and software tools are expected to
increase significantly throughout the projection period. Over the next five
years, the Neuroscience Market will increase at a CAGR of 4.1 percent.
Computational neuroscience is one of neuroscience's fastest-growing subfields.
To make sense of the reams of data produced by newer large-scale recording
technologies, new analysis and modelling tools are urgently needed.
Tags
Neurology Conferences Neurology Conferences 2025 Psychiatry Conferences
Neurology Conferences 2024 Japan Muscular Dystrophy Conferences Neurology
Conferences 2024 USA Child Psychology Conferences Alzheimer's Disease
Conferences Neurophysiology Conferences Seizures Conferences Neurology
Conferences 2024 Headache Conferences Neurodegenerative Disorders Conferences
Spinal Disorders Conferences CNS Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROGENETICS
Neurogenetics is a new field of science that aims to better understand the
causes of brain and nerve illnesses by utilising current developments in genome
sequencing. A branch of research aimed at better understanding the genetic roots
of mental illnesses. The role of genetics in the development and function of the
nervous system is studied in neurogenetics. It treats neural traits as
phenotypes and is based on the observation that individuals' neurological
systems, even within the same species, are not always identical. As the name
implies, it incorporates elements from both neuroscience and genetics research,
with a special focus on how an organism's genetic code influences its manifested
features. Neurogenetics is used to investigate neurological illnesses,
behaviour, and personality. Neurogenetics is also assisting in the advancement
of the individualised clinical care paradigm. Physicians can build highly
personalised treatment programmes for each patient based on a thorough
understanding of their genetic profile and medical history.
Sub-tracks:
• Autism spectrum disorder
• Brain malformations
• Developmental delay
• Intellectual and cognitive disability
• Neurologic disorders in children
• Pediatric Genetic Counseling.
• Molecular diagnosis and therapeutic approaches
• Gentetic testing and screening
Market Analysis : According to Persistence Market Research's newest research,
the neurogenetic testing market is expected to develop at a CAGR of 7% from 2021
to 2031. Neurogenetic disorder is caused by a mutation in one or more genes that
impact the neurological system. Dementia, genetic neuropathy, Parkinson's
disease, epilepsy, and other neurological illnesses are examples. Advancements
in DNA sequencing technology and increased research in the life science area are
driving the Neurogenetic Testing market. These techniques provide a precise
therapy plan for the disease. The increasing frequency of neurological
illnesses, public awareness of genetic screening, availability of current
diagnostic technologies, and increased life science R&D are the main drivers of
demand for neurogenetic testing. DNA sequencing is undergoing a number of
technological breakthroughs.
Tags
Dementia Conferences Muscular Dystrophy Conferences Neurology Conferences 2025
UK Neurology Conferences Neurology Conferences 2024 Asia Neuroscience
Conferences 2024 Dubai Neurology Conferences 2025 USA CNS Conferences
Cerebrovascular Disease Conferences Brain Cancer Conferences Child Psychology
Conferences Seizures Conferences Clinical Neurology Conferences Neurology
Conferences 2024 USA Euro Neurology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
CHILD PSYCHOLOGY
Child psychology is a subfield of psychology, concerned with how a child's
psychological development changes from conception and before, through infancy
and childhood, to adolescence and adulthood.
Numerous ailments throughout life cause mental issues because, as we know,
psychological well-being is the absence of mental illness. Few juveniles and
children experience mental illness. If left untreated, these conditions have an
effect on the healing process.
Some people have even questioned if mental illness is real. We'll discuss the
most recent concerns with children's mental health as well as research on
emotional wellness screening and assessment methods, how the environment affects
children, the role of parents in their development, and the psychological
characteristics of young children.
The significance of child psychology:
• To better comprehend a child
• To understand the psychologically based issue
• To effectively and meaningfully provide dental treatments
• To develop effective communication between the parent and the child
• To emphasise the value of basic and preventive care to the kid and parents
Child psychology focuses on five key topics:
• Development might have a significant impact on that in another. For
instance, writing words involves both fine-motor coordination and linguistic
processing abilities. Research has proven that development adheres to specific
patterns or principles in addition to its various fields of application. How we
care for, treat, and educate children today has been greatly impacted by our
understanding of these concepts.
Three areas of Child Development include:
1. Physical development
2. Cognitive or intellectual development
3. Social and emotional development
• Milestones: Psychologists frequently use developmental milestones to assess
a child's development in a number of crucial areas. They serve as developmental
checkpoints to determine what the typical child can perform at a certain age.
Understanding the developmental milestones for various ages benefits child
psychologists in understanding typical child development and helps spot
potential issues with delayed development.
Four Major Groups of Developmental Milestones:
1. Physical milestones
2. Cognitive or mental milestones
3. Social and emotional milestones
4. Communication and language milestones
• Behaviour
• Emotions
• Socialisation
Market Analysis: According to the WHO, 10-20% of children and adolescents
worldwide experience mental health issues. The majority of psychiatric illnesses
begin between the ages of 14 and 20 on average. Major obstacles for kids with
mental illnesses include stigma, exclusion, and prejudice, as well as limited
access to educational and medical services. The Care Quality Commission
discovered that between 2019–2023, 50% of the wards were almost full with a 90%
occupancy rate, and 16% of the units visited by their officers were beyond
capacity. Only 65% of those who have psychiatric problems really obtain
treatment, according to observations.
The cost of providing services has increased along with the number of patients,
and it is now predicted to be £1.6 trillion more expensive globally than the
combined costs of heart disease, cancer, diabetes, chronic respiratory illness,
and cancer. Only 5.5% of the overall UK health research budget, or £115 million,
is currently allocated to studying the mental health of society's most
vulnerable members.
Tags
Epilepsy Conferences CNS Conferences Neurology Conferences 2024 Sleep Disorders
Conferences Headache Conferences Stroke Conferences Neurology Conferences 2025
USA Brain Cancer Conferences Alzheimer's Disease Conferences Dementia
Conferences Psychology Conferences Cerebrovascular Disease Conferences
Neurosurgery Conferences 2025 Psychiatry Conferences Neurology Conferences 2024
USA
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
SOCIAL COGNITIVE NEUROSCIENCE
Social cognitive neuroscience is the study of the neural mechanisms in the human
brain that enable individuals to effectively comprehend themselves, understand
others, and interact with others.
Social cognitive neuroscience is an emerging interdisciplinary field of study
that aims to comprehend phenomena in terms of interactions between three levels
of analysis:
• The social level, which is interested in the motivational,
• Social factors that affect behaviour and experience
• The cognitive level, which is interested in the information-processing
mechanisms that give rise to social-level phenomena; and the neural level, which
is interested in the brain mechanisms that instantiate cognitive-level
processes.
Social cognitive neuroscience investigates social events and processes using
cognitive neuroscience research techniques such as neuroimaging and
neuropsychology.
According to the social cognitive theory, goals, outcome expectations,
self-efficacy, and sociostructural variables all have a role in determining
behaviour.
Cognitive neuroscience techniques include:
• Functional neuroimaging
• Electrophysiology
• Cognitive genomics
• Behavioral genetics
As a result, there are no effective treatments for either the illness that
causes neurocognitive dysfunction or the problem itself. Although many drugs,
including antidepressants and antipsychotic alternatives alert that address
blackout and other activity symptoms, could help treat the condition. The
symptoms and their effects are only suppressed; nonetheless, these are not the
right answers. Targeting particular brain regions will be made easier with the
use of recently created mental exercises like "computerised brain coaching
programmes." Memory loss is not diagnosed in diseases like dementia if an
underlying condition like an infection is to blame. Many methods, as opposed to
just medicine, can be used to identify most knowledge-related ailments if they
are delicate.
Market Analysis: The Neuroscience market is anticipated to grow at a CAGR of
about 4.1 percent during the forecast period. Some of the reasons driving market
expansion include the rising prevalence of brain-related illnesses, advancements
in neuroscience and neurotechnology, rising R&D spending, and government
assistance. By 2031, the market for brain imaging technologies will be worth
$20,209.2 million.
Tags
Euro Neurology Conferences Neurology Conferences 2024 Epilepsy Conferences
Neurodegenerative Disorders Conferences Neurology Conferences 2024 Japan
Neurology Conferences 2025 USA Neurology Conferences 2025 Europe Neurosurgery
Conferences 2025 Neurology Conferences Europe Stroke Conferences Neurology
Conferences 2025 UK Neurology Conferences 2024 USA Neurophysiology Conferences
Neurology Conferences 2024 Asia Dementia Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROPHYSICS
Neurophysics or neurobiophysics is the field of biophysics focuses on the
development and application of physical strategies to learn more about the
neurological system.
Neurophysics is an interdisciplinary field of study that integrates different
branches of neuroscience with physics to better understand brain processes.
Other physical measurements like EEG, which are primarily used to study
electrical, mechanical, or fluidic properties, are combined with theoretical and
computational methods in the methodologies used.
Neurophysics Therapy: The very advanced exercise-based therapeutic procedure
known as neurophysics therapy. This method successfully treats a large number of
disorders and has a high success rate.
The following is a list of some serious conditions that can be treated with
neurophysics therapy.
• Arthritis
• Rehabilitation
• Migraine
• Chronic pain
• Degenerative disorders
• Depression
• Epilepsy
• Parkinson’s disease
• Hereditary spastic paraplegia
Additionally, practising neurophysics helps us stay healthy and perform better
in daily life since it teaches us a technique for distributing stress throughout
the body evenly and preventing it from being isolated.
Market Analysis: The market for neuroscience is anticipated to increase at a
compound annual growth rate (CAGR) of 3.49 percent from 2019 to 2024, reaching
$36.27 billion. On average market growth, a number of government and healthcare
sector initiatives are anticipated to have an impact. The sector is also being
impacted by the rising incidence of neurological diseases. The market for
neuroscience products and services was valued at USD 28.42 billion in 2016, and
it is anticipated to grow at a CAGR of 3.1 percent over the following five
years.
Tags
CNS Conferences Neurophysiology Conferences Alzheimer's Disease Conferences
Neurology Conferences 2024 Neurology Conferences 2025 USA Neurology Conferences
2025 Europe Headache Conferences Cerebrovascular Disease Conferences Epilepsy
Conferences Spinal Disorders Conferences Neurology Conferences 2025 UK Child
Psychology Conferences Brain Cancer Conferences Neuroscience Conferences 2024
Dubai Neurology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NANO-NEUROSCIENCE
Nano-neurology is an interdisciplinary field that studies the relationship
between nanotechnology and neuroscience. It entails studying and manipulating
the nervous system at the molecular and cellular levels using nanoscale
materials, equipment, and techniques. The basic goals of nano-neuroscience are
to increase our understanding of the structure and function of the nervous
system, develop new diagnostic tools, and discover novel therapeutics for
neurological illnesses.
Here are some of the most important aspects of nano-neuroscience:
Imaging and Sensing: Nanotechnology allows for the development of
high-resolution imaging techniques capable of displaying neural architecture and
activity in unprecedented detail. This covers imaging techniques such as
super-resolution microscopy and nanoparticle- based contrast agents.
Drug Delivery: Drugs or therapeutic compounds can be carried and delivered
directly to specific parts of the nervous system using nanoparticles. This
method of medicine delivery reduces negative effects while increasing
therapeutic efficacy.
Neural Interfaces: Highly sensitive neural interfaces can be created using
nano-sized materials and electrodes. These interfaces can precisely record brain
impulses or trigger neurons for therapeutic purposes. They are critical for
developing brain-computer interfaces (BCIs) and neuroprosthetic devices.
Regenerative Medicine: Nano-neuroscience contributes to tissue engineering and
regenerative medicine by providing scaffolds and materials that encourage neural
tissue growth and repair. This is critical in the treatment of disorders such as
spinal cord injuries and neurodegenerative diseases.
Diagnostic Tools: Nanoscale biosensors and biomarkers can be utilized to detect
and monitor neurological illnesses early on. They are capable of detecting
specific proteins or compounds linked to neurodegenerative illnesses, offering
crucial diagnostic information.
Neuropharmacology: Nanotechnology can help in medication development in
neuropharmacology by making it easier to create nanoparticles that can penetrate
the blood-brain barrier, which is a protective barrier that limits the entry of
chemicals into the brain. This enables more effective drug administration for
the treatment of neurological disorders.
Fundamental Research: Nano-neuroscience advances fundamental research by giving
instruments for studying the complicated molecular and cellular processes that
occur in the nervous system. This research contributes to the understanding of
the mechanisms behind neurological disorders and normal brain function.
Therapeutic Approaches: Novel nanotherapies are being investigated for the
treatment of disorders such as brain tumors, neurological diseases (such as
Alzheimer's and Parkinson's disease), and stroke. Nanoparticles can be used to
deliver medications, DNA, or even stem cells to specific parts of the brain or
spinal cord.
Ethical and Safety problems:The use of nanotechnology in neuroscience presents
ethical and safety problems, specifically the possibility of unintended
repercussions or unexpected risks when modifying neural systems at the
nanoscale.
Tags
Cerebrovascular Disease Conferences Psychology Conferences Parkinson Disease
Conferences Epilepsy Conferences Neurology Conferences Child Psychology
Conferences Neurology Conferences 2025 UK Neurology Conferences 2024 USA Sleep
Disorders Conferences Neurology Conferences 2024 Neuroscience Conferences 2024
Dubai Brain Cancer Conferences Neurological Disorders Conferences Alzheimer's
Disease Conferences Clinical Neurology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROSURGICAL INNOVATIONS
Neurosurgery is a medical speciality that focuses on the surgical treatment of
nervous system illnesses and ailments, including the brain, spinal cord, and
peripheral nerves. Numerous advances in neurosurgery have been made throughout
the years with the goal of improving patient outcomes, reducing invasiveness,
and enhancing precision.
Here are some important neurosurgical breakthroughs:
Minimally Invasive Techniques: Neurosurgery has been transformed by less
invasive techniques. Endoscopic brain surgery and minimally invasive spine
surgery, for example, have smaller incisions, less tissue damage, and quicker
recovery times.
Stereotactic radiosurgery: Techniques such as Gamma Knife and Cyber Knife enable
surgeons to accurately deliver large doses of radiation to brain tumors or
lesions without the need for open surgery.
Functional Neurosurgery: Deep brain stimulation (DBS) and responsive neuro
stimulation (RNS) are functional neurosurgery procedures used to treat illnesses
such as Parkinson's disease, epilepsy, and depression by implanting electrodes
in specific brain areas and altering neural activity.
Neuro endoscopy: This procedure is used to treat problems such as hydrocephalus
and some brain cancers. They utilize the use of a thin, flexible tube equipped
with a camera to access and treat brain regions.
Intraoperative Imaging: Advanced imaging technologies, such as intraoperative
MRI and CT scans, enable surgeons to see the brain and spinal cord in real time
during surgery, improving precision and reducing the risk of complications.
3D Printing: 3D printing technology has permitted the development of
patient-specific models and implants, increasing the precision of difficult
surgeries and decreasing operative time.
Robot-Assisted Surgery: Neurosurgery has included robotics and automation to
increase precision and dexterity in sensitive procedures such as tumor excision
and spinal fusion.
Neuro prosthetics: Brain-computer interfaces (BCIs) and neuro prosthetic devices
allow people with severe neurological disabilities to communicate and move by
connecting the brain to external equipment.
Genomic Medicine: Genetic testing and customized medicine are increasingly being
used in the diagnosis and treatment of neurological illnesses, allowing
medications to be tailored to an individual's genetic profile.
Neurostimulation Devices: Implantable devices that modulate neural activity,
such as spinal cord stimulators and vagus nerve stimulators, are used to manage
chronic pain and neurological diseases.
Advanced Neuroimaging: Advances in neuroimaging, such as functional MRI (fMRI)
and diffusion tensor imaging (DTI), provide insights into brain function and
connection, assisting in surgical operation planning and monitoring.
Nanotechnology: Nanotechnology applications for drug delivery to the brain and
the development of nanoscale devices that can interact with neurons for
diagnostic and therapeutic purposes are being investigated.
Tags
Neurosurgery Conferences 2025 Seizures Conferences Euro Neurology Conferences
Neurology Conferences 2025 USA Neurology Conferences 2025 UK Cerebrovascular
Disease Conferences Muscular Dystrophy Conferences Neurology Conferences 2024
Asia CNS Conferences Headache Conferences Dementia Conferences Alzheimer's
Disease Conferences Sleep Disorders Conferences Neurology Conferences 2024 Japan
Neuroscience Conferences 2024 Dubai
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROETHICS
Neuroethics is an interdisciplinary discipline that investigates the ethical,
legal, and social implications of neuroscience developments. It tackles
questions and concerns about the use of neuroscientific information and
technologies, as well as the ethical treatment of people whose brains are being
studied or treated in clinical settings. Neuroethics is concerned with a wide
range of issues, including:
Informed Consent: A crucial ethical aspect is ensuring that individuals engaging
in neuroscience research or undergoing neurosurgery treatments completely
understand the risks and benefits and freely give their informed consent.
Privacy: Advances in brain imaging and neurotechnology create worries about
individuals' mental and neurological states being kept private. There are
ethical concerns about who gets access to this information and how it should be
protected.
Enhancement: The employment of neuroscientific procedures for cognitive
improvement, mood modulation, or other objectives raises ethical concerns
regarding justice and equity, as well as the possibility of societal pressure to
enhance.
Neuroimaging and the Law: The use of brain imaging as evidence in court raises
concerns about its reliability and the possibility of abuse, such as
"neuroprediction" of criminal behavior.
Brain-Computer Interfaces (BCIs): While BCIs have the potential to increase
human abilities, they also raise questions about privacy, autonomy, and
unforeseen consequences.
Neurodiversity: This discipline explores the social and ethical aspects of
understanding neurological diseases, opposes stigma, and promotes acceptance and
support for neurodiverse people.
Brain Stimulation: The use of therapeutic treatments such as transcranial
magnetic stimulation (TMS) and deep brain stimulation (DBS) raises ethical
concerns concerning safety, consent, and the possibility of personality and
identity changes.
Neuroscientific Behavior Explanations: Using neuroscience to explain human
behavior might raise problems about individual responsibility, free will, and
determinism.
Neuroethics in Education: When neuroscientific tools are employed for
evaluation, intervention, or tracking student performance, ethical problems may
arise.
Neuroscience and Identity: Understanding the neurological basis of personal
identity and consciousness raises issues about the nature of self and
personhood.
Global Health and Neuroscience: Ethical considerations in global health and
neuroscience extend to questions of access to neuroscientific knowledge and
tools, as well as the ethical conduct of research in international settings.
Tags
Brain Cancer Conferences Neurology Conferences 2025 USA Spinal Disorders
Conferences Neurology Conferences 2025 Europe Stroke Conferences Dementia
Conferences Neuroscience Conferences 2024 Dubai Clinical Neurology Conferences
Neurology Conferences 2025 UK Sleep Disorders Conferences Neurology Conferences
2024 Asia Neurology Conferences Neurosurgery Conferences 2025 Neurological
Disorders Conferences Psychiatry Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
PRECISION PSYCHIATRY
Precision psychiatry, also known as personalized psychiatry or precision
medicine in psychiatry, is a new approach to mental health care that strives to
match the diagnosis, treatment, and prevention of psychiatric diseases to the
particular characteristics of each patient. This approach emphasizes that mental
health diseases vary greatly in terms of their underlying causes as well as
their reactions to therapy. Precision psychiatry aims to use discoveries in
genetics, neurology, and data analytics to deliver more effective, customized
therapy for individuals suffering from mental illnesses.
The following are major components and concepts related to precision psychiatry:
Genomic and genetic Factors: Specific genes and genetic variations have been
linked to an elevated risk of different mental health conditions, including
depression, schizophrenia, bipolar disorder, and autism. Precision psychiatry is
the use of genetic data to predict susceptibility to mental health disorders and
guide treatment decisions.
Biomarker Discovery: Researchers are working hard to develop biomarkers, or
measurable biological indications, that can aid in the diagnosis of psychiatric
diseases, the monitoring of disease progression, and the prediction of therapy
responses. Neuroimaging data, blood indicators, and other physiological
parameters are examples of biomarkers.
Neuroimaging: Neuroimaging techniques, such as functional magnetic resonance
imaging (fMRI) and positron emission tomography (PET), have advanced, allowing
clinicians to observe and examine brain function and structure. These methods
can help guide treatment decisions by providing insights into the underlying
neurobiology of psychiatric diseases.
Machine Learning and Data Analytics: Precision psychiatry depends on advanced
data analysis tools, such as machine learning and artificial intelligence, to
examine big datasets combining genetic, clinical, and neuroimaging data. These
approaches can aid in the identification of trends and the prediction of
individual treatment responses.
Tailored Treatment Plans: Precision Psychiatry strives to build individualized
treatment programs based on an individual's unique genetic, neurobiological, and
clinical profile, rather than using a one-size-fits-all approach to treatment.
This may entail determining the best medication, counseling, or other therapies
for a specific patient.
Early Intervention and Prevention: Precision Psychiatry also focuses on
identifying individuals who are at risk of developing mental health illnesses
before symptoms appear. Interventions can then be tailored to either prevent the
disorder from developing or to lessen its severity.
Patient Involvement: Precision psychiatry frequently emphasizes the need of
involving patients in treatment decisions and informing them about their own
genetic and neurobiological traits. Patients who are better informed can take a
more active role in their care.
Ethical Considerations: As with other aspects of precision medicine, there are
ethical concerns about privacy, permission, and the potential misuse of genetic
and neurobiological data. To protect patient rights, ethical rules and
safeguards are required.
Research and Collaboration: Precision psychiatry is based on interdisciplinary
collaboration between geneticists, neuroscientists, psychiatrists,
psychologists, and other healthcare experts. Validation of biomarkers and
treatment approaches also necessitates ongoing research.
Tags
Neurology Conferences 2025 UK Headache Conferences Dementia Conferences
Neurology Conferences 2025 Europe Seizures Conferences Neurology Conferences
2024 Neuroscience Conferences 2024 Dubai Cerebrovascular Disease Conferences
Neurosurgery Conferences 2025 Euro Neurology Conferences Muscular Dystrophy
Conferences Psychiatry Conferences Neurology Conferences Europe Sleep Disorders
Conferences Neurology Conferences 2024 USA
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROMODULATION AND NEW THERAPEUTIC APPROACHES
The altering or modulation of brain activity through various approaches and
treatments is referred to as neuromodulation. In recent years, this sector has
experienced considerable improvements, leading to new therapy methods for a
variety of neurological and neuropsychiatric diseases.
Here are some of the most important neuromodulation techniques and their
applications:
Deep Brain Stimulation (DBS): DBS involves implanting electrodes in specific
parts of the brain and delivering electrical impulses to control neuronal
activity. It has been used to treat diseases such as Parkinson's, essential
tremor, dystonia, and obsessive-compulsive disorder (OCD). Ongoing study is
looking into its potential for treating additional illnesses such as depression
and epilepsy.
Transcranial Magnetic Stimulation (TMS): TMS is a non-invasive technology that
uses magnetic fields to stimulate specific sections of the brain's surface. It
is an FDA-approved medication for depression and is also being studied for
anxiety disorders, schizophrenia, and chronic pain.
Transcranial Direct Current Stimulation (TDCS): This technique includes applying
a low electrical current to the scalp in order to regulate cortical
excitability. It's being looked into as a possible treatment for depression,
pain management, and cognitive enhancement.
Vagus Nerve Stimulation (VNS): To treat epilepsy and depression, a device that
stimulates the vagus nerve is implanted. It's also being researched for its use
in other ailments like anxiety disorders and Alzheimer's disease.
Spinal Cord Stimulation (SCS): SCS uses electrical spinal cord stimulation to
treat chronic pain, particularly neuropathic pain syndromes such as failed back
surgery syndrome and complicated regional pain syndrome.
Peripheral Nerve Stimulation (PNS): PNS is a technique that involves placing
electrodes on peripheral nerves to relieve pain in disorders such as chronic
migraine, peripheral neuropathy, and neuralgias.
Responsive Neurostimulation (RNS): RNS is a closed-loop device that monitors
brain activity and delivers electrical stimulation in response to seizure
activity. Its primary application is in the treatment of epilepsy.
Neurofeedback: Neurofeedback is a technology that uses real-time monitoring of
brain activity, commonly electroencephalography (EEG), to give users with
information about their brain state. It has implications in illnesses such as
ADHD, anxiety, and post-traumatic stress disorder (PTSD) and can be used to
train patients to self-regulate their brain activity.
Optogenetics: Optogenetics is a cutting-edge method that includes genetically
altering neurons to make them light responsive. It enables researchers to
selectively activate or inhibit certain brain circuits, which could lead to
therapeutic applications in disorders such as Parkinson's disease, depression,
and addiction.
Ultrasound Neuromodulation: Non-invasive ultrasonic techniques are being
investigated in order to influence brain activity. When compared to other
neuromodulation approaches, this technology has the potential for precision
targeting and less adverse effects.
Tags
Neurology Conferences 2025 USA Neurophysiology Conferences Muscular Dystrophy
Conferences Seizures Conferences Headache Conferences Dementia Conferences
Neurosurgery Conferences 2025 Neurology Conferences 2024 Asia Neurology
Conferences Sleep Disorders Conferences Cerebrovascular Disease Conferences
Neuroscience Conferences 2024 Dubai Epilepsy Conferences Neurological Disorders
Conferences Neurology Conferences 2024 USA
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
MICROBIOME AND NEUROLOGICAL HEALTH
The microbiome is the billions of microorganisms that live in various regions of
the body, including the stomach, skin, and mouth cavity. Emerging evidence
suggests a strong link between the gut flora and neurological health. The
"gut-brain axis" relationship has consequences for a variety of neurological
diseases and mental health.
Here are a few examples of how the gut microbiota can affect brain health:
Neurotransmitter Production: Gut bacteria can create neurotransmitters such as
serotonin and dopamine, which are essential for mood regulation and brain
function. Changes in the composition of the gut microbiota can influence the
production of these neurotransmitters, thereby contributing to mood disorders
such as sadness and anxiety.
Immune System Regulation: The gut microbiota is essential for immune system
regulation. Multiple sclerosis and Parkinson's disease have both been linked to
dysbiosis, or an imbalance in the gut microbiome. Chronic inflammation can harm
neurons and hasten disease progression.
Metabolite Production: Gut bacteria digest food components and generate a
variety of metabolites, some of which are neuroactive. Short-chain fatty acids
(SCFAs) generated by gut bacteria, for example, have been proven to have
neuroprotective properties.
Blood-Brain Barrier Integrity: The gut microbiota can affect the blood-brain
barrier (BBB), which is a protective barrier that separates the bloodstream from
the brain. A weakened BBB is linked to a variety of neurological diseases, and
particular gut bacteria have been linked to its dysfunction.
Neurodevelopment: Emerging data suggests that the gut microbiome influences
neurodevelopment in childhood. Microbiome disruptions during important
developmental phases may lead to neurodevelopmental diseases such as autism
spectrum disorder.
Stress Response: The gut-brain axis is also involved in the body's stress
reaction. Stress can have an impact on the gut microbiota, and the gut
microbiome can influence the body's reaction to stress. Dysregulation in this
axis may contribute to stress-related diseases such irritable bowel syndrome
(IBS) and post-traumatic stress disorder (PTSD).
Epilepsy and Seizures: Some research has suggested a link between the gut
microbiome and epilepsy. Alterations in the gut microbiome composition may
influence seizure susceptibility and response to antiepileptic medications.
Tags
Spinal Disorders Conferences Headache Conferences Psychiatry Conferences
Psychology Conferences Neurology Conferences 2024 Japan Alzheimer's Disease
Conferences Cerebrovascular Disease Conferences Stroke Conferences Seizures
Conferences Neurology Conferences 2025 USA Neurology Conferences 2025 UK
Neurodegenerative Disorders Conferences Clinical Neurology Conferences Muscular
Dystrophy Conferences Brain Cancer Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROLOGICAL IMPLICATIONS OF COVID-19
The COVID-19 pandemic, caused by the new coronavirus SARS-CoV-2, predominantly
affects the respiratory system, but it can also impact the nervous system.
According to new research, COVID-19 can cause a variety of neurological symptoms
and problems.
COVID-19 has the following neurological consequences:
Smell and taste loss (Anosmia and Ageusia): The rapid loss of smell (anosmia)
and taste (ageusia) is one of the most common neurological signs of COVID-19.
These symptoms may appear early in the infection and may be among the earliest
indications of COVID-19.
Headaches: Many COVID-19 patients describe headaches that range with intensity
and length. Headaches may be caused by virus-related inflammation, fever, or
other reasons.
Encephalopathy: Some people with severe COVID-19 develop encephalopathy, which
is characterized by impaired brain function. Confusion, disorientation, and
other cognitive problems might result from this.
Seizures: While seizures are uncommon, they have been reported in some COVID-19
patients. These seizures could be caused by the virus's direct influence on the
brain or by fever and metabolic abnormalities.
Ischemic and Hemorrhagic Strokes: COVID-19 has been related to an increased risk
of ischemic strokes (caused by blood clots) and hemorrhagic strokes (induced by
bleeding in the brain). These strokes can develop in those who have severe
COVID-19.
Neuropathy: Some patients have reported peripheral neuropathy symptoms such as
tingling, numbness, and pain in the extremities. The processes at work are
currently being studied.
Guillain-Barré Syndrome (GBS): GBS is a rare but deadly neurological condition
linked to COVID-19. It is an autoimmune disorder in which the immune system
assaults the peripheral nerves, causing weakening, numbness, and, in extreme
cases, paralysis.
Meningitis and Encephalitis: Although uncommon, cases of viral meningitis
(inflammation of the membranes protecting the brain and spinal cord) and viral
encephalitis (inflammation of the brain) have been recorded in some COVID-19
individuals.
Psychiatric Symptoms: COVID-19 can also have psychological and psychiatric
impacts, such as anxiety, depression, and post-traumatic stress disorder (PTSD),
which might be considered neurological symptoms.
Long COVID and Brain Fog: Some people who have healed from acute COVID-19
continue to have neurological symptoms, which is known as "long COVID." This can
include persistent brain fog, weariness, and cognitive impairments.
Tags
Parkinson Disease Conferences Stroke Conferences Seizures Conferences Clinical
Neurology Conferences Neurology Conferences 2024 USA Neurology Conferences
Epilepsy Conferences Sleep Disorders Conferences Spinal Disorders Conferences
Alzheimer's Disease Conferences Neurology Conferences 2025 Europe Neurology
Conferences 2025 Psychiatry Conferences Neurodegenerative Disorders Conferences
Child Psychology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROSURGERY
Neurosurgery is a procedure that diagnoses and treats neurological disorders,
injury and disease. Neurological surgery uses invasive techniques to
investigate, diagnose and treat the neurological problem. This medical specialty
treats any neurological disease which has affected any portion of the brain,
peripheral nervous system (PNS), central nervous system (CNS), extra-cranial
cerebrovascular system, and spinal cord.
A neurosurgeon is the individuals who have done their specialization course in
neurosurgery. They learn how to treat various disorders on CNS, PNS, brain and
spinal cord. Some important conditions treated by neurosurgeons are:
1. Meningitis
2. Spinal cord trauma
3. Tumors of the spine, spinal cord, and peripheral nerves
4. Spinal disc hernia
5. Cervical spinal stenosis and other
Some neurosurgery methods are:
1. Microsurgery
2. Stereotaxy
3. Endoscopic surgery
4. Neuroradiology
5. Conventional open surgery
Sub-tracks:
* Pediatric neurosurgery
* Stereotactic neurosurgery/ functional neurosurgery
* Skull base surgery
* Vascular neurosurgery
* Spinal neurosurgery
* Oncological neurosurgery
Market Analysis: Neurosurgery deals with the diagnosis and surgical treatment of
the nervous system, which includes the brain, spinal cord, spine, and nerves.
The global neurosurgery market is divided based on different product categories.
Neurostimulation services, neurointerventional devices, cerebral spinal fluid
(CSF) management devices, neurosurgical navigation systems, and other
subsegments make up the product type segment. The greatest market for
neurosurgery is in North America, followed by Europe. This is attributable to an
increase in the number of patients with neurological disorders, the availability
of technologically advanced neurosurgery equipment, increased research and
development activities, increased public awareness of brain-related diseases,
and enhanced regional healthcare infrastructure. In the coming years, Asia's
neurosurgery market is predicted to rise at a rapid pace. The global
neurosurgery market is expected to develop at a CAGR of 11.71 percent from 2014
to 2019.
Tags
Child Psychology Conferences Headache Conferences Alzheimer's Disease
Conferences Stroke Conferences Epilepsy Conferences Psychiatry Conferences
Neurology Conferences 2024 USA Dementia Conferences Cerebrovascular Disease
Conferences Sleep Disorders Conferences Neurology Conferences 2025 USA Clinical
Neurology Conferences Neurology Conferences 2025 Neurological Disorders
Conferences Neurophysiology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
PAIN DISORDER AND MANAGEMENT
Pain disorder is in which patients suffer from extreme or chronic pain in one or
more parts of the body. It is believed to be caused by psychological stress.
Pain disorder is also classified as a mental disorder as a psychological factor
plays important role maintenance, severity, and worsening of pain. Sometimes the
pain is so severe it often refrains patients form proper functioning.
Pain disorder symptoms include hopelessness, despair feeling from intuition,
sleep disturbance, fatigue, worsening of social and personal relationships,
depression, anxiety, and disability. There are several causes of pain: trauma,
abuse, emotions, psychodynamic theory, social causes, and communication. The
behavior during pain put the psychological aspect of pain in the spotlight.
Pain disorders treatment or pain management involves sleep therapy,
psychotherapy, and medication. Pain management center runs a pain control
program, which is a multifaceted program using the blend of behavior, cognitive,
group therapies to treat patients without conventional medical procedures.
Sub-tracks:
* Pain management programs
* Sleep therapy
* Psychotherapy
* Psychogenic Pain Disorder
* Chronic Pain Syndrome
Market Analysis: An overwhelming majority of the world's population (85%) has
suffered both head and body pain at some point in their lives, prohibiting
people from fully living their lives, hurting their ability to parent, and
negatively damaging their careers and social lives. In 2019, the global chronic
pain treatment market was worth $77.8 billion, and it is predicted to increase
at a 6.5 percent CAGR from 2020 to 2030. Because of increased government support
for chronic pain treatment, the growing senior population, and the rising
prevalence of chronic health disorders, the chronic pain treatment sector is
booming.
Tags
Neurology Conferences 2024 Japan Epilepsy Conferences Seizures Conferences
Muscular Dystrophy Conferences Psychology Conferences Alzheimer's Disease
Conferences Neurological Disorders Conferences Cerebrovascular Disease
Conferences Neurology Conferences Clinical Neurology Conferences Dementia
Conferences Child Psychology Conferences Sleep Disorders Conferences Neurology
Conferences 2024 Spinal Disorders Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEURO-ONCOLOGY AND BRAIN TUMORS
The nervous system getting affected by cancer is one of the severe conditions.
The study of cancers of the nervous system is called Neurooncology.
Neuro-Oncology is a branch of medicine concerned with the neoplasms of the brain
and spinal cord. In the end, it becomes lethal in most cases. It does study,
investigation, identification, and treatment for malignant and benign spinal
cord and brain tumors.
Neuro-Oncology deals with various tumors like primary tumors of the Central
nervous system (CNS) and metastatic tumors of CNS, and their numerous factors
causing them at first place. Some worst cancer forms are gliomas of the pons,
gliomas of the brainstem, glioblastoma multiforme, and astrocytoma.
The diagnosis of these brain tumors depends heavily on the diagnostic imaging or
imaging of the brain. For diagnosis, Magnetic Resonance Imaging (MRI) and
Computed Tomography (CT) are mainly used and other tests include Positron
Emission Tomography (PET), Myelography and Angiography. The main treatment
includes chemotherapy, surgery, radiotherapy, corticosteroids, cancer pain
management, and neurosurgical interventions.
Neuro-Oncologists – they are the physician trained to investigate, interpret,
diagnose and to treat patients with a brain tumor and tumors of the nervous
system.
Sub-tracks:
* Neuro-Oncological disorders
* Spinal metastasis
* Intracranial metastasis
* Skull metastasis
* Psychosocial Advances in Neuro-Oncology
Market Analysis: The global brain tumour medications market is estimated to
increase at a compound annual growth rate (CAGR) of 6.3 percent from $1.89
billion in 2020 to $2.01 billion in 2021. In 2020, the market for Brain Tumors
in the seven largest markets is expected to be worth USD 2,089.4 million. The
United States has the largest market for brain tumours, with a market size of
USD 986.0 million in 2020. Italy had the largest market size among the EU5
countries in 2020, with USD 214.4 million, while the United Kingdom had the
smallest market size, with USD 129.8 million. In 2020, the Japan Brain Tumors
market will be worth USD 256.7 million. This market is expected to increase at a
CAGR of 10.4 percent over the forecast period, from USD 2.83 billion in 2021 to
USD 5.64 billion in 2028.
Tags
Neurology Conferences Neurology Conferences 2025 Sleep Disorders Conferences
Clinical Neurology Conferences Headache Conferences Psychiatry Conferences Child
Psychology Conferences Neurology Conferences 2024 USA Psychology Conferences
Neurology Conferences 2024 Japan Muscular Dystrophy Conferences Spinal Disorders
Conferences Stroke Conferences Seizures Conferences Epilepsy Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROIMAGING
Neuroimaging is an essential part of diagnosis and to study in the area of
Neurology and Neuroscience. It is an addition to a clinical and cognitive
evaluation in the assessments of cognitive, behavioral and neurological
disorders. Neuroimaging or brain imaging is to image the structure, function,
and pharmacology of the nervous system mainly the brain and spinal cord.
Neuroradiologists are the one who specializes in neuroimaging techniques.
Neuroimaging or brain imaging is a new discipline in medicine, neuroscience, and
psychology to study the changes during various neurological and psychological
conditions.
Neuroimaging can be classified into two major parts:
1. Structural Imaging: It deals with the structure of the nervous system and to
diagnose intracranial disease and injury
2. Functional Imaging: It is used for research purposes: neurological and
psychology and building brain-computer interface through cognitive neuroscience.
It is also used to diagnose metabolic disease on a finer scale.
Sub-tracks:
* Neuroimaging techniques and their relation with Neurology
* Recent advancements in Neuroimaging
* Functional magnetic resonance imaging
* Functional Magnetic Resonance Imaging (fMRI)
* Magnetoencephalography
* Cranial ultrasound
* Magnetic resonance imaging
* Positron emission tomography
* Diffuse optical imaging
* Computed axial tomography
* Single-photon emission computed tomography
* Positron Emission Tomography (PET)
* Event-related optical signal
* Magnetoencephalography (MEG) & Electroencephalography (EEG)
* Computed Tomography (CT) Scan
Market Analysis: From 2021 to 2027, the global medical imaging market is
predicted to increase at a CAGR of 3.99 percent, from USD 26.52 billion in sales
in 2020 to USD 35.78 billion in 2027. Due to many driving factors, the worldwide
medical imaging market is predicted to rise at a significant rate. The global
medical imaging market is divided into X-Ray Systems, Ultrasound, Computed
Tomography (CT), Magnetic Resonance Imaging (MRI), and Others, based on imaging
technique. The market is divided into hospitals, ambulatory centres, radiology
centres, and others based on the end user. The global diagnostic imaging market
is expected to grow at a CAGR of 5.7 percent from 2021 to 2026, from USD 26.6
billion in 2021 to USD 35.0 billion in 2026. The increasing demand for early
disease diagnosis and the broadening scope of clinical applications, the rapidly
growing geriatric population and the resulting increase in the prevalence of
associated diseases, technological advancements in the diagnostic imaging
industry, and increasing investments, funds, and grants by public-private
organizations are all driving this market forward. In 2020, the global medical
imaging market was worth USD 15.9 billion, and it is predicted to increase at a
compound yearly growth rate of 5.2 percent until 2028.
Tags
Neurological Disorders Conferences Epilepsy Conferences Neurology Conferences
Neurology Conferences 2024 Asia Neurology Conferences 2024 USA Neurosurgery
Conferences 2025 Neurology Conferences 2025 Europe Seizures Conferences Muscular
Dystrophy Conferences Cerebrovascular Disease Conferences Euro Neurology
Conferences Neurology Conferences 2024 Japan Neurology Conferences 2025
Neurology Conferences 2025 USA Neurodegenerative Disorders Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
STROKE
Stroke, a medical emergency, occurs when blood flow or arteries carrying blood
to the brain is interrupted or blocked. It leads to a gradual decline of oxygen
and nutrient in the brain leading to the rapid death of brain cells in minutes.
Stroke is of two types: Ischemic, reduce blood flow and Haemorrhagic, internal
bleeding. High blood pressure is one of the main risks of stroke and other risks
include smoking, high cholesterol, obesity, and diabetes.
Signs of a stroke include paralysis, numbness, headache, trouble with speaking
and understanding, confusion, and loss of coordination. Stroke diagnosis
involves a physical exam to see balance, numbness, coordination, weakness or
sign of confusion. Test through which we can diagnose stoke is MRI, CT scan,
blood test, cerebral angiogram, echocardiogram, and carotid ultrasound.
Prevention of stroke includes reducing the risks by doing exercise, controlling
high blood pressure and diabetes, maintain a healthy weight, lowering the amount
of cholesterol, taking anticoagulants or anti-platelet drugs.
Sub-tracks:
* Ischemic Stroke
* Haemorrhagic Stroke
* Thrombotic stroke
* Rehabilitation
* Stoke Management
* Stoke Case reports
* Angioplasty and stenting
Market Analysis:
Stroke is a medical emergency that occurs when blood supply to the brain is reduced, and brain cells begin to die as a result.The global stroke management market was worth $22,581 million in 2016, and it is expected to expand to $36,756 million by 2023, with a CAGR of 7.1 percent over the forecast period (2017-2023).A stroke is a medical emergency that occurs when the blood supply to the brain is cut off, causing brain cells to die. The global stroke management market is estimated to reach $36.7 billion by 2023, with a 7.4 percent compound annual growth rate (CAGR) over the forecast period.
Tags
Neurology Conferences Europe Neurology Conferences 2024 Asia CNS Conferences
Neurology Conferences 2025 UK Epilepsy Conferences Cerebrovascular Disease
Conferences Neurological Disorders Conferences Muscular Dystrophy Conferences
Psychology Conferences Neurology Conferences 2025 Dementia Conferences Sleep
Disorders Conferences Neuroscience Conferences 2024 Dubai Neurodegenerative
Disorders Conferences Neurology Conferences 2024 Japan
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
EPILEPSY
Epilepsy, a chronic disorder, is a central nervous system disorder in which
seizures occur frequently. In epilepsy, brain activity becomes abnormal leading
to recurrent seizures, unusual behavior, loss of awareness, and sensations.
Epilepsy can happen to anyone irrespective of gender, race, and age.
The major symptom of Epilepsy is seizures. There are mainly two types of
seizures: focal seizure and generalized seizure. The other symptoms include the
sudden fall of a person with no reason, unresponsiveness, and convulsion with no
temperature, inappropriate repetitive movements, blackout, and confused memory.
Epilepsy caused by the effect of genes or the surrounding environment. Acquired
epilepsy causes include stroke, tumors, brain trauma, and infection in the
brain. The genetic cause of epilepsy is more common among young people and in
older people, brain tumors and stroke are more common. The exact cause of
Epilepsy in most of the cases is unknown.
Epilepsy can be observed by electroencephalogram, computed tomography (CT) scan,
magnetic resonance imaging (MRI), and neuroimaging. These techniques can give a
better picture to understand the abnormalities of the brain during a seizure,
and to look at the minute changes in the structure of the brain.
There is no proven cure of epilepsy, being alert and proper care the
consequences of epilepsy and seizures can be averted. Some antiepileptic drugs
are in the market to keep seizures in check. We can reduce the chance of
seizures by a healthy daily routine.
Sub-tracks:
* Seizure
* Epilepsy surgery
* Epileptogenesis
* Photosensitive epilepsy
* Focal seizures
* Generalized seizures
* Epilepsy treatment
Market Analysis: In the projection period of 2021 to 2028, the epilepsy market
is predicted to increase at a rate of 7.78 percent. The expansion of the
epilepsy market is accelerating due to an increase in epilepsy awareness. By
2023, the Epilepsy Market is expected to be worth USD 9.50 billion, with a CAGR
of 8.20 percent over the forecast period (2018-2023). The rising prevalence of
epilepsy in the senior population, as well as an increase in accident-related
brain injury cases, are driving market expansion. The epilepsy market has been
developing at a healthy rate in recent years, and it is predicted to rise at a
CAGR of 7.36 percent from 2021 to 2028. The rise in the number of accidents and
brain injuries, as well as the greater rate of post-traumatic seizure occurrence
in patients with brain injuries, is driving the Global Epilepsy Market. The
Global Epilepsy Market research offers a comprehensive analysis of the industry.
Tags
Neurology Conferences 2024 Japan Parkinson Disease Conferences Neuroscience
Conferences 2024 Dubai Cerebrovascular Disease Conferences Neurology Conferences
2024 USA Neurodegenerative Disorders Conferences Spinal Disorders Conferences
Clinical Neurology Conferences Neurology Conferences 2024 Asia Brain Cancer
Conferences Neurology Conferences 2025 Europe Epilepsy Conferences Neurological
Disorders Conferences Neurology Conferences 2025 UK Neurosurgery Conferences
2025
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
MULTIPLE SCLEROSIS
Multiple Sclerosis (MS) is a chronic, unpredictable disease that leads to the
loss of information exchange in the brain and between the brain and body. MS
affects the central nervous system principally spinal cord, optic nerves, and
the brain. In Multiple Sclerosis, damaging of insulating covers of nerve cells
by demyelinating of these covers in the brain and spinal cord.
In MS, symptoms are like numbness, tingling, dizziness and fatigue, sexual
dysfunction, muscle weakness, ataxia, acute or chronic pain, change in
sensation, vision problems, tremor, memory problems, and muscle spasms. Signs
and symptoms may vary in MS and it depends on the level of the damage to nerve
cells.
Multiple Sclerosis is an autoimmune disorder, in which the immune system attacks
the myelin sheath which protects the nerve cells leads to communication problems
in the body. The main cause behind this is not yet found. But it is believed
that it is a result of accumulated genetic and environmental factors. Some cause
may be genetic, geographical, infection, and acquired factors as well.
Multiple Sclerosis has no cure. Medication helps to prevent new attacks or to
stabilize functioning after an attack.
Sub-tracks:
* Primary progressive MS
* Relapse-remitting MS (RRMS)
* Secondary progressive MS (SPMS)
* Clinically isolated syndrome (CIS)
* Multiple Sclerosis Treatment and Management
* Multiple Sclerosis case reports
Market Analysis: The global market for multiple sclerosis (MS) medicines was
worth $22.99 billion in 2018, and is expected to reach $28.00 billion by 2026,
with a CAGR of 2.5 percent between 2019 and 2026. Multiple sclerosis is a
chronic inflammatory disease that causes demyelination, axonal transection, and
neurodegeneration in the brain and spinal cord's nerve cells. The global market
for multiple sclerosis medications is valued at $27.38 billion in 2021 and is
predicted to grow at a CAGR of 6.3 percent to $41.99 billion in 2028. MS affects
around 57.8 people per 100,000 in the United States. The prevalence is stated
to be 68.8 per 100,000 above the 37th parallel and 35.5 per 100,000 below it.
Scientists are still working hard to develop new and improved treatments for MS.
By 2028, the global market for multiple sclerosis drugs will be valued $ 42.46
billion, with a 6.3 percent compound annual growth rate.
Tags
Muscular Dystrophy Conferences Neuroscience Conferences 2024 Dubai Neurology
Conferences 2025 USA Neurology Conferences 2024 Neurological Disorders
Conferences Dementia Conferences Neurology Conferences 2025 UK Parkinson Disease
Conferences Neurology Conferences 2025 Headache Conferences Psychology
Conferences Psychiatry Conferences Euro Neurology Conferences Neurophysiology
Conferences Neurology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
ALZHEIMERS DISEASE AND DEMENTIA
Alzheimer's disease is a neurodegenerative disorder that leads to the death of
brain cells. It progresses over time and worsens at the end. Alzheimer's is the
cause of 60-70% of dementia. Dementia is a neurological condition in which the
ability to think and remember small things becomes so severe that is starting to
affect their daily routine.
The most common symptoms of Alzheimer's and dementia are forgetting becomes very
often, difficulty in remembering some events occurs, and in some severe cases,
patients suffer difficulty in remembering recent events and conversations.
Alzheimer's disease and dementia patients develop hindrances in making
judgments, reasoning, thinking, decision and performing daily tasks.
The precise cause of Alzheimer's and dementia are not fully understood but most
of the researchers think that it is a result of various factors: genetics,
environmental, and lifestyle. The risk factors associated with Alzheimer's and
dementia are age, syndrome, sex, trauma, lifestyle, social engagement, and
family genetics.
As these diseases are progressive, not even a single cure proves to revert this
process. Patients affected with this disease need help from others.
Sub-tracks:
* Causes and Prevention of Alzheimer’s
* Vascular Dementia
* Alzheimer’s Disease Diagnosis and Symptoms
* Recent Studies & Case Reports
* Alzheimer prevention and risk factors
* Alzheimer’s Clinical Trials and Studies
* Managing Dementia
Market Analysis: The Alzheimer's disease diagnostics and therapeutics market was
worth USD 6,632.82 million in 2020, and it's predicted to grow to over USD 9,073
million in 2026, with a CAGR of nearly 5.36 percent from 2021 to 2026. The
rising frequency of chronic diseases such as dementia, as well as increased
pipeline drug research, investment in biomarkers for drug development, and
better diagnostics for early detection, are all driving this industry
forward.According to the World Alzheimer Report, over 50 million individuals
worldwide suffer from Alzheimer's disease and related dementia in 2019, with
that figure anticipated to rise to 152 million by 2050. Alzheimer's disease is
thought to afflict up to 6% of the population over the age of 65. With the
discovery of some therapeutic procedures and the rising frequency of Alzheimer's
disease, there are markets for Alzheimer's treatments. The growing number of
people over the age of 65 is partly to blame for the rising incidence of
Alzheimer's disease. Although there have been occasional cases of young-onset
Alzheimer's, which is defined as Alzheimer's symptoms in adults under the age of
65, this is rare.
Tags
Psychiatry Conferences Neurology Conferences 2025 UK Neurodegenerative Disorders
Conferences Neurosurgery Conferences 2025 Headache Conferences Seizures
Conferences Neurophysiology Conferences Neuroscience Conferences 2024 Dubai
Neurology Conferences 2024 Child Psychology Conferences Neurology Conferences
2024 Japan Neurology Conferences 2025 Europe Neurology Conferences 2024 Asia
Spinal Disorders Conferences Dementia Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
CASE STUDIES AND CLINICAL TRIALS
Case studies can be defined as the intensive study of any particular individual,
community or group in which the researcher analyses several variables to derive
a conclusion. Case studies are the best way to study any particular field by
getting a practical overview of the respective case. Case studies do not have
any set of procedures to follow. It helps another person to gain practical
knowledge and help them to enhance or improve their own ability to perform the
same task with better precision.
Clinical trials are the study that concludes how safe the treatments, tests, and
medicine are.
Sub-tracks:
* Neurology Case Studies
* Neurosurgery Case Studies
* Parkinson's Case Studies
* Epilepsy Case Studies
* Alzheimer's Case Studies
* Movement Disorder Case Studies
* Neurology Clinical Trials
* Neurosurgery Clinical Trials
* Parkinson's Clinical Trials
* Epilepsy Clinical Trials
* Alzheimer's Clinical Trials
* Movement Disorder Clinical Trials
Market Analysis: The global market for neurology clinical trials is expected to
reach USD 7.4 billion by 2028, according to a new study by Grand View Research,
Inc. The market is expected to increase at a 5.5 percent CAGR between 2021 and
2028. This is due to big pharma companies conducting new neurology trials,
increased government financing from the National Institute of Neurological
Disorders and Stroke (NINDS), and strict regulatory standards for clinical
trials. The global market for neurology clinical trials is expected to reach USD
7.4 billion by 2028. From 2021 to 2028, the market is estimated to grow at a
CAGR of 5.5 percent. Neuroscience continues to attract a good amount of early
funding. In 2018, it attracted USD 1.5 billion in venture capital funding,
second only to cancer, indicating that investors believe a huge pharma
acquisition will pay off soon. Early detection of diseases is attracting
investment and driving dealmaking in the complex neuroscience sector,
particularly for pain and Alzheimer's disease, as the industry attempts to move
past the many late-stage clinical failures of recent years.
Tags
Child Psychology Conferences Neurology Conferences Brain Cancer Conferences Euro
Neurology Conferences Neurology Conferences 2025 Europe CNS Conferences
Neurology Conferences 2024 USA Alzheimer's Disease Conferences Headache
Conferences Seizures Conferences Parkinson Disease Conferences Muscular
Dystrophy Conferences Neurology Conferences 2025 UK Spinal Disorders Conferences
Neuroscience Conferences 2024 Dubai
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NOVEL TREATMENT STRATEGIES
These are the approach taken to eradicate or treat a particular disease.
Neurology integrated with neuroscience provides an ample amount of useful data
to innovate or develop new ways of treatment of various neurological diseases
and disorders.
Sub-tracks:
* Neuroprotective strategies
* Multiple sclerosis therapeutic strategies
* Emerging therapies
* Stem-cell therapy
* Gene therapy
* Deep-brain stimulation
* Antiepileptic drugs
* Hurdles in treating neurological diseases
Market Analysis: The global neurology market is expected to increase at a
compound annual growth rate (CAGR) of 3.5 percent from $33.3 billion in 2019 to
$39.4 billion in 2024.
Between 2018 and 2028, the global market for rare neurological illness
treatments is expected to increase at an impressive CAGR of over 8.5 percent,
growing 2.3 times. The incidence of rare diseases, the evolving trend of orphan
pharmaceuticals, and rising healthcare spending have all contributed to a
significant increase in overall sales of rare neurological treatments during the
previous decade. As a result, global sales in the uncommon neurological illness
treatment market reached a new high in 2019, surpassing the US$ 6.5 billion
mark. Furthermore, the rare neurological disease treatment market is expected to
be the most attractive market among the rare illness treatment markets, owing to
their comparatively high market value share and growth rate. On the back of
rising demand for orphan pharmaceuticals, ongoing research and development
activities in the field of rare neurological illness therapy are multiplying.
Between 2018 and 2028, this is expected to generate an absolute monetary
potential of US$ 8.1 billion.
Tags
CNS Conferences Muscular Dystrophy Conferences Cerebrovascular Disease
Conferences Alzheimer's Disease Conferences Epilepsy Conferences Neurology
Conferences 2024 Spinal Disorders Conferences Neurology Conferences 2024 USA
Neurodegenerative Disorders Conferences Neurophysiology Conferences Neurology
Conferences 2025 Neurology Conferences 2024 Asia Euro Neurology Conferences
Dementia Conferences Brain Cancer Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
HEADACHE AND FACIAL PAIN
Headache is describes as a painful sensation in any part of the head, the pain
can be dull or sharp and it may also occur with other symptoms. Headache and
facial pain are common complaints in OPD facilities. Headaches are treated with
medication, stress management and biofeedback.
Trigeminal neuralgia is the most common term associated with a chronic facial
pain condition that affects the trigeminal nerve, which carries sensation from
face to brain. Trigeminal neuralgia pain most commonly affects only one side.
Primary headaches are those that aren’t due to any underlying medical condition.
It includes
Cluster headaches.
Migraine.
New daily persistent headaches (NDPH).
Tension headaches.
Secondary headaches are mostly symptoms of other diseases, such as:
Disease of blood vessels in the brain.
Head injury.
High blood pressure (hypertension).
Infection.
Medication overuse.
Sinus congestion.
Trauma.
Tumor.
Market Analysis: In the foreseeable term, the migraine market is expected to
rise at a considerable CAGR. .Migraine is a medical disease in which people
suffer from intense headaches. From 2018 to 2025, the global migraine
medications market is predicted to increase at a CAGR of 3.1 percent, from
$1,713 million in 2017 to $2,190 million in 2025. Migraine medicines are used to
treat headaches that are caused by migraines.
Anti Migraine Drugs Market size is expected to reach $10.56 billion by 2025,
with a CAGR of 9.7% over the forecast period of 2020-2025.
Around 15% of people worldwide suffer from migraine, and the market will be
driven by growing use of anti-migraine drugs during the projected period.
Tags
Dementia Conferences Clinical Neurology Conferences Neurology Conferences 2025
USA Parkinson Disease Conferences Psychology Conferences Neuroscience
Conferences 2024 Dubai Neurology Conferences 2024 Japan Psychiatry Conferences
Neurophysiology Conferences Headache Conferences Neurology Conferences 2025
Neurology Conferences 2024 USA Neurosurgery Conferences 2025 Neurological
Disorders Conferences Alzheimer's Disease Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
DIAGNOSIS AND SCREENING OF NEUROLOGICAL DISORDERS
Early diagnosis and proper screening of neurological disorders is the key for
better prognosis and cure. Investigating the damage caused to the nervous system
is extremely complicated and complex. Most of the similar symptoms happen in
different disorders. There are many disorders which doesn't have definitive
causes, markers, or tests, that makes a diagnosis even harder.
To confirm a neurologic condition such as brain injury, tumors, hydrocephalus,
aneurysm, epilepsy or stroke, a range of neurologic tests are performed.
Sub-track
* CT scan
* Electroencephalogram (EEG
* MRI
* nerve conduction velocity
* electromyography
* Positron emission tomography
* Arteriogram
* Spinal tap
* Neurosonography
* Ultrasound
Market Analysis: Several neurological disorders, such as Multiple Sclerosis,
Alzheimer's disease (AD), and Parkinson's disease, are diagnosed with
neurological disorder diagnostic instruments (PD).
Furthermore, the recent rise in the prevalence of neurological disorders is
expected to drive the global neurological disease diagnostic market.
The neurodiagnostics market is estimated to grow at a CAGR of 7.3 percent from
USD 5.9 billion in 2019 to USD 8.4 billion in 2024.
The growing prevalence of neurological disorders and diseases, technological
advancements, growing patient emphasis on effective and early disease diagnosis,
the growing number of diagnostic centres and hospitals, and the use of biomarker
profiling for disease diagnostics are all expected to drive demand for
neurodiagnostics products. The global neurological biomarkers market was valued
at USD 6.1 billion in 2020, with a compound annual growth rate (CAGR) of 12.9
percent predicted from 2020 to 2028. Furthermore, technological improvements are
fueling market expansion by increasing the requirement for early identification
of neurological illnesses.
Tags
Neurosurgery Conferences 2025 Headache Conferences Neurology Conferences 2025
Neurodegenerative Disorders Conferences Neurology Conferences Clinical Neurology
Conferences Sleep Disorders Conferences Neurology Conferences 2024 Japan
Alzheimer's Disease Conferences Neurology Conferences 2025 USA Stroke
Conferences Neurology Conferences 2024 Brain Cancer Conferences Neurophysiology
Conferences Muscular Dystrophy Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROPHARMACOLOGY AND NEUROCHEMISTRY
Neuropharmacology refers to the study of the effects of drugs on the nervous
system, this field involve the study and research on the actions of medications
for psychiatric and neurologic disorders as well as those of drugs of abuse.
Neuropharmacology also uses drugs as tools for better understanding of normal
nervous system functioning. The main objective of neuropharmacology is to apply
mechanisms of drugs to develop effective treatments and preventive measures for
nervous system abnormalities. It helps to understand how drugs affect cellular
function in the nervous system. Behavioral and molecular are the two different
parts of neuropharmacology . Behavioral neuropharmacology focuses on the study
of how drugs affect human behavior and molecular neuropharmacology involves the
study of neurons and their neurochemical interactions, with an aim of developing
drugs that helps in improving neurological function.
The study of neurotransmitters, psychopharmaceuticals and neuropeptides, that
control and influence the physiology of the nervous system is known as
Neurochemistry. Research in this field is focused on the biochemistry and
molecular biology of organic compounds in the nervous system, and their roles in
neural processes like cortical plasticity, neurogenesis, and neural
differentiation. Neurochemicals are basically oxytocin, serotonin, dopamine and
other neurotransmitters and neurotransmitter-regulating substances. This
particular field investigates how neurochemicals influence the operation
of neurons, synapses, and neural networks.
Market Analysis: Pharmaceuticals are one of the most valuable endeavours on the
planet. In 2008, the pharmaceutical industry sold $773 billion in goods around
the world, a figure that has been consistent for up to 8 years and is expected
to rise by 2.5 to 3.5 percent in 2017. By 2025, the global pharmaceutical market
is expected to reach $10.27 billion USD. The pharmaceutical market is expected
to grow from just over $22.85 billion in 2016 to $25.2 billion in 2020, with a
compound annual growth rate (CAGR) of 2%. It is expected to reach USD 2,151.1
billion by 2027, growing at a CAGR of 7%.
Tags
Neurology Conferences 2025 USA Muscular Dystrophy Conferences Cerebrovascular
Disease Conferences Psychiatry Conferences Parkinson Disease Conferences
Neurology Conferences Neurology Conferences 2025 UK Spinal Disorders Conferences
Headache Conferences Psychology Conferences Brain Cancer Conferences Sleep
Disorders Conferences Neurology Conferences Europe CNS Conferences Neurology
Conferences 2024 USA
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
STEM CELLS AND NEUROREGENERATION
The term neuroregeneration refers to the regrowth or repair of nervous
tissues, cells or cell products. Research in this field in going on to
understand the basic mechanisms involved in neurodegeneration or neurologic
injury. However, due to the complex structures of the nervous system, the
regeneration process becomes extremely challenging. The brain, spinal cord and
peripheral nerves which are susceptible to various types of injury ranging from
trauma to neurodegenerative diseases that cause progressive deterioration is
unfortunately often irreversible, and a very little spontaneous regeneration,
repair or healing occurs.
Stem cell therapies hold promising future in terms of neurological treatment.
Neural stem cells (NSCs) has the potential to replace lost tissue after nervous
system injury. Hence, stem cells can promote host neural repair in part by
secreting growth factors. Stem cells holds a great promise
for treating many neurological disorders, researches showed that it can reduce
the total damage to peripheral nerves and improving tissue regeneration.
Neurological disorders such as Parkinson's disease, Huntington's disease,
amyotrophic lateral sclerosis (ALS), Alzheimer's disease, multiple sclerosis
(MS), stroke, and spinal cord injury are caused by a loss of neurons and glial
cells in the brain or spinal cord.
Researchers have successfully generated neurons and glial cells from stem
cells.Investigators have done extensive research to develop and carry out stem
cell-based brain transplantation therapies.Stem cell research is in progress for
the development of novel therapies to cure a wide range of neurological
disorders.
Market Analysis: The primary drivers driving the market's growth are an increase
in stem cell research and approvals of GMP certified facilities. For the years
2021-2026, the overall market development of the Stem Cell Marker is expected to
be boosted by rising demand for gene treatments and the rising prevalence of
chronic diseases. In 2020, the worldwide stem cell industry is expected to
produce USD 9.38 billion in sales. From 2021 to 2028, it is predicted to
increase at a compound annual growth rate (CAGR) of 8.8%. The global stem cell
therapy market is expected to grow at a CAGR of 16.5 percent to USD 401 million
by 2026, up from USD 187 million in 2021. Factors such as expanding stem cell
research activities and increasing approvals of GMP-certified facilities to
generate stem cells are driving market expansion. The global stem cell therapy
market is predicted to increase at a compound annual growth rate (CAGR) of 18.3
percent from $8.62 billion in 2020 to $10.2 billion in 2021.
Tags
Alzheimer's Disease Conferences Psychiatry Conferences Neurosurgery Conferences
2025 Sleep Disorders Conferences Psychology Conferences Parkinson Disease
Conferences Muscular Dystrophy Conferences Neurology Conferences 2024 Asia
Neuroscience Conferences 2024 Dubai Neurology Conferences 2024 Japan Spinal
Disorders Conferences Neurophysiology Conferences Headache Conferences Clinical
Neurology Conferences Neurology Conferences 2025 Europe
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
SPINAL NEUROSURGERY
Operations on the bones, discs, and soft tissues of the spine with the goal of
reducing pressure on the spinal cord or spinal nerve roots, or the removal of
masses inside the spine, are referred to as spinal neurosurgery. Pressure on the
lower spinal nerve roots in the lumbar spine or the upper spinal nerve roots in
the cervical spine is the most common reason for considering spinal
neurosurgery. This frequently occurs in the foramen, which is the region where
the nerves exit the spine and are held. Spinal stenosis is a word used to
describe an issue that occurs in the space known as the central
canal.Unfortunately, resecting masses from around the spinal cord or within the
dura itself is another rationale for spinal neurosurgery. These masses may not
be cancerous, but because they can compress the spinal cord, they are frequently
treated using spinal neurosurgery.
Sub-tracks:
• Degenerative Diseases
• Spinal Deformity and Malformations
• Vertebral Tumors
• Spin injury and Trauma
• Spinal Infectious Diseases
• Craniocervical Junction Anomalies
• Spinal Cord Tumors
• Intradural Extramedullary Spinal Tumors
Market Analysis : The developments in spine surgery technologies, the rising
frequency of spinal illnesses, the introduction of enhanced bone grafting
materials, and the growing use of minimally invasive spine procedures are all
driving the global spinal surgery market. However, the high cost of spinal
surgery and reimbursement uncertainty are projected to limit market expansion
throughout the projection period. The market for spinal surgery devices was
valued at around USD 9,350 million in 2020, and it is predicted to reach USD
12,245 million in 2026, with a CAGR of nearly 4.50 percent from 2021 to 2026.
Tags
Child Psychology Conferences Cerebrovascular Disease Conferences Euro Neurology
Conferences Parkinson Disease Conferences Neurosurgery Conferences 2025
Neurophysiology Conferences Epilepsy Conferences Neurodegenerative Disorders
Conferences Neurology Conferences Europe Neurology Conferences 2025 Europe
Neurological Disorders Conferences Neuroscience Conferences 2024 Dubai
Alzheimer's Disease Conferences CNS Conferences Spinal Disorders Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
PEDIATRIC NEUROSURGERY
Pediatric neurosurgery is a branch of neurosurgery that treats children with
operable neurological problems. It involves surgical treatments involving the
nervous system, brain, and spinal cord. Pediatric neurosurgeons work with
children from the time they are born until they reach adolescence. They have
chosen to make paediatric care the centre of their medical practise, and they
have understood the particular nature of paediatric medical and surgical care
via extensive training and practise. Pediatric neurosurgeons deal with a variety
of neurosurgical issues that aren't always the same as those addressed by adult
or general neurosurgeons. It is critical to have specialised expertise in
paediatric disorders as they pertain to paediatric neurosurgery problems.
Sub-tracks:
• Hydrocephalus and CSF Dynamics
• Cranial congenital malformations
• Spinal dysraphisms
• Supratentorial Tumors
• Posterior Fossa Tumors
• Spinal Tumors
• Pediatric Trauma
• Pediatric Vascular Diseases
Market Analysis : In the projected period of 2021 to 2028, the global paediatric
neurosurgery market is expected to increase at a CAGR of 6.20 percent, reaching
USD 2,794.36 billion. The increased awareness of the importance and benefits
connected with the usage of paediatric neurosurgery among people and patients
has had a direct impact on the growth of the worldwide paediatric neurosurgery
market.
Tags
Dementia Conferences Neurology Conferences Euro Neurology Conferences Neurology
Conferences 2025 USA Clinical Neurology Conferences Neurology Conferences 2025
Neurology Conferences Europe Sleep Disorders Conferences Neurosurgery
Conferences 2025 Epilepsy Conferences Psychiatry Conferences Stroke Conferences
Brain Cancer Conferences Cerebrovascular Disease Conferences Muscular Dystrophy
Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
Points within the brain are located using an external, three-dimensional frame
of reference, usually based on a Cartesian coordinate system, in functional
neurosurgery. Because the disease paradigms handled in functional neurosurgery
are continually changing and evolving, it stands out among other neurosurgical
disciplines. The basic idea is that functional neurosurgery does not necessarily
treat a structural issue, but rather alters central nervous system circuits to
bring about a change within or outside the nervous system. This is a strong
indication of the breadth of functional neurosurgery's use. Movement disorders
such as Parkinson's disease, essential tremor, and dystonia have been
transformed through functional neurosurgery.Advances in the understanding of the
physiology of the target structures and the pathophysiological underpinnings of
movement problems have occurred concurrently with the development of deep brain
stimulation. In order to influence brain function, functional neurosurgery
entails careful surgical targeting of anatomic components. The technique of
stereotactic neurosurgery is used to locate surgical targets within the brain in
relation to an external frame of reference. The term "stereotactic" refers to
the accurate location of objects deep within the brain using a three-dimensional
coordinate system and an imaging technique such as computed tomography scanning
or magnetic resonance imaging. Other neurosurgical operations, such as the
biopsy of deep brain tumours, frequently employ these techniques.
Sub-tracks:
• Deep brain stimulation for movement disorders
• Epilepsy
• Pain
• Spasticity
• Neuromodulation
• Restorative Techniques
Market Analysis : The surgical speciality of neurosurgery deals with the
diagnosis and surgical treatment of the nervous system, which includes the
brain, spinal cord, spine, and nerves. A neurosurgeon is a doctor who
specialises in neurosurgery. The global neurosurgery market was worth $3.9
billion in 2020 and is predicted to reach $4.57 billion by 2025, with a CAGR of
5.8%. Medtronic, Boston Scientific Corporation, Stryker, Conmed Corporation, and
Smith & Nephew are the market's major participants. The rising incidence of
neurological disorders, efforts to expand the application base for
neuromodulation, the advantages of neuroendoscopic procedures over traditional
brain surgeries, and the growing prevalence of neurological diseases all
contribute to the market's growth.
Tags
Neurology Conferences 2025 Neurosurgery Conferences 2025 Clinical Neurology
Conferences Seizures Conferences Neurodegenerative Disorders Conferences
Neurology Conferences 2025 Europe Neurology Conferences 2024 Asia Neurology
Conferences 2025 UK Neurology Conferences 2024 Neurological Disorders
Conferences Parkinson Disease Conferences Cerebrovascular Disease Conferences
Neuroscience Conferences 2024 Dubai Neurology Conferences 2024 USA Alzheimer's
Disease Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROVASCULAR SURGERY
Blood vessels that are damaged, injured, or deformed can cause bleeding or
circulation difficulties, which can lead to strokes, headaches, and other
symptoms. Neurovascular surgery treats abnormalities with the blood arteries of
the brain, spine, and spinal cord using open or minimally invasive surgical
procedures. The subject of neurovascular surgery is becoming increasingly
complicated and technological, embracing classic surgical approaches as well as
endovascular and neurointerventional techniques. Clinicians in the Neurovascular
programme specialise in the treatment of all vascular disorders of the brain and
spinal cord using a variety of therapeutic strategies such as surgery,
endovascular interventional treatments, stereotactic radiation, and
rehabilitation.
Sub-tracks:
• Aneurysms and Subrachnoid Hemorrhage Pathophysiology
• Arteriovenous Malformations
• Cerebral Ischemia and Revascularization
• Spontaneous Intracerebral Hemorrhages
• Endarterectomy
• Endovascular Neurosurgery
• Open Neurovascular Surgery
• Hybrid Surgery & Advanced Technology
• Cerebrovascular Surgery
• Ischemic Stroke and Vascular Insufficiency
• Cerebral and Spinal Aneurysms
• Cerebral and Spinal Arteriovenous Fistulae and Malformations
• Vascular Tumors
• Revascularization techniques
• Vascular Stereotactic Radiosurgery
Market Analysis : The market for neurovascular devices and interventional
neurology is predicted to increase at an annual rate of 8.6% from USD 2.5
billion in 2021 to USD 3.8 billion in 2026. The market for neurovascular devices
is likely to be driven by the rising frequency of neurological illnesses,
technical developments, and the growing desire for minimally invasive
operations. Interventional neurology devices are used to diagnose and treat
brain and central nervous system vascular disorders. Interventional neurology
entails a variety of procedures. From 2021 to 2030, the Neurovascular Devices
Market is expected to develop at a compound annual growth rate (CAGR) of 5.7
percent, reaching US$ 4.52 billion.
Tags
Child Psychology Conferences Spinal Disorders Conferences Parkinson Disease
Conferences Neuroscience Conferences 2024 Dubai Clinical Neurology Conferences
CNS Conferences Psychology Conferences Stroke Conferences Epilepsy Conferences
Neurology Conferences 2024 Psychiatry Conferences Neurology Conferences 2024
Asia Headache Conferences Dementia Conferences Euro Neurology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
INTRAOPERATIVE NEUROPHYSIOLOGY
The use of electrophysiological technologies to monitor the functional integrity
of particular brain regions during surgery is known as intraoperative
neurophysiological monitoring (IONM) or intraoperative neuromonitoring. During
the procedure, various intraoperative neurophysiological monitoring techniques
evaluate the function of the brain, brainstem, spinal cord, cranial nerves, and
peripheral nerves. They are extremely useful in detecting and preventing brain
injury. Intraoperative monitoring is increasingly commonplace in medical
practise, and it's used to assess the risk of brain impairment during a variety
of surgical operations. IONM makes use of a wide range of physiological
principles, each with its own set of applications that are frequently combined
in the same procedure to improve patient outcomes.The adoption of various
neuromonitoring techniques throughout the extra surgical procedure has increased
as the benefits of monitoring became clear. IOM has been used to try to avoid or
reduce substantial postoperative deficits by minimising neurological injury
during surgery, identifying critical brain structures in the operational field,
and so on.
Sub-tracks:
• Neuromonitoring
• Electroencephalography (EEG)
• Electromyography (EMG)
• Somatosensory evoked potential (SSEP)
• Motor evoked potential (MEP)
• Brainstem auditory evoked potential (BAEP)
• Visual evoked potential (VEP)
Market Analysis : Intraoperative neurophysiological monitoring is a group of
treatments used to monitor neural pathways during high-risk neurosurgery,
orthopaedic, peripheral nerve, and vascular procedures. It is primarily used to
minimise the risk of neurological impairments following nervous system
surgeries. By 2025, the market for intraoperative neuromonitoring (IONM) is
expected to grow at a CAGR of 6.5 percent. The rising incidence of various
lifestyles linked to chronic diseases such as neurological and cardiovascular
problems, as well as an increased focus on patient safety during intricate
surgeries, are projected to fuel market growth.
Tags
Cerebrovascular Disease Conferences Neurology Conferences 2025 UK Neurology
Conferences 2025 Parkinson Disease Conferences Neurodegenerative Disorders
Conferences Neurology Conferences Neurology Conferences 2024 Japan Clinical
Neurology Conferences Seizures Conferences Stroke Conferences CNS Conferences
Headache Conferences Neurosurgery Conferences 2025 Psychology Conferences Euro
Neurology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
PERIPHERAL NERVE SURGERY
The peripheral nervous system (PNS) is a network of 43 motor and sensory nerves
that connects the brain and spinal cord (the central nervous system) to the rest
of the body. The brain and spinal cord are connected to the rest of the body by
peripheral nerves. Peripheral nerve problems damage one or more nerves and can
impair communication from the brain to the rest of the body. People with
peripheral nerve problems, such as acute nerve injuries, entrapment
neuropathies, and nerve sheath tumours, undergo peripheral nerve surgery to
restore function and reduce pain and impairment. It entails rerouting healthy
nerves to take over the function of nerves that have been damaged, diseased, or
otherwise compromised by your injury, disease, or condition.43 pairs of
peripheral nerves extend from the spinal cord, similar to electrical lines, and
provide movement, motor coordination, and sensation throughout the body. Carpal
tunnel syndrome, ulnar nerve compression, peroneal nerve compression in the
knee, meralgia parasthetica, and tarsal tunnel syndrome are the most common
problems of this sort. Surgery works wonders for nerve entrapment. Recovery is
swift, and patients can resume their normal routines.
Sub-tracks:
• Traumatic nerve injury
• Carpal tunnel syndrome and surgery
• Thoracic outlet syndrome
• Ulnar nerve neuropathy
• Guillain-Barre syndrome
• Schwannoma and Neurofibroma
• Brachial plexus surgery
• DREZ procedure
• Nerve repair or nerve graft
• Nerve entrapment surgery
• Nerve sheath tumor surgery
• Nerve transplant surgery
• Open decompression surgery
Market Analysis : From 2017 to 2023, the global Nerve Repair and Regeneration
Market is expected to increase at a CAGR of 13.0 percent, from $5,927 million in
2016 to $13,938 million in 2023. Peripheral Nerve Repair market size was USD
135.3 million in 2015, and it is predicted to grow at a CAGR of 20.8 percent to
USD 514.9 million by the end of 2026. The high frequency of nerve injuries,
expanding prevalence of neurological disorders, growing elderly population, and
increased government support for neurologic disorders are driving this market's
expansion.
Tags
Alzheimer's Disease Conferences Brain Cancer Conferences Psychiatry Conferences
Neurology Conferences 2025 Europe Dementia Conferences Euro Neurology
Conferences Neurology Conferences 2024 Asia Spinal Disorders Conferences CNS
Conferences Epilepsy Conferences Seizures Conferences Neurophysiology
Conferences Neurology Conferences Psychology Conferences Neuroscience
Conferences 2024 Dubai
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
ROBOTICS IN NEUROSURGERY
Robotics is a fast-moving discipline that is changing neurosurgery in
combination with breakthroughs in artificial intelligence and machine learning.
Robotic surgery has the potential to eliminate mechanical errors, save operating
hours, and give the same or better resective margins than minimal-access
surgery. This will result in great surgical outcomes with the fewest possible
problems. Because of the physical complexity of the brain and the space limits
inherent in neurosurgical procedures, we can observe some encouraging steps in
this direction, but there is still a long way to go. The NeuroMate robot was the
first FDA-approved robotic equipment intended exclusively for neurosurgery
usage. There are various robotic technologies available for spinal surgery that
provide tool guiding and implant placement confirmation.ROSA Brain, an advanced
surgical tool, is used in robot-assisted neurosurgery to do minimally invasive
surgeries in the brain. Robotic operating surgical assistant (ROSA) is an
acronym for robotic operating surgical assistant. It combines a robotic arm with
the ability to take comprehensive brain images of your child.
Market Analysis : Robotic neurosurgery is a rapidly evolving technology that
offers a number of advantages over traditional neurological surgery, including
improved outcomes, enhanced accuracy, faster recovery, and a shorter hospital
stay, to name a few. From 2020 to 2030, the number of surgeries performed with
robotic surgical systems in the United States will increase at a CAGR of 10.5
percent. The growing incidence of neurological diseases, ageing population,
improved benefits with robotics-based procedures, and decreasing price of
robot-assisted neurology surgery will drive the global neurosurgical robotics
market to $2,010.7 million by 2027, growing at a 16.8 percent annual rate from
2020 to 2027. Surgical robots allow surgeons to perform more precise difficult
surgical procedures. Furthermore, the introduction of new and advanced robots
will meet the ever-increasing demands of end users.
Tags
Brain Cancer Conferences Stroke Conferences Neurology Conferences 2024 USA CNS
Conferences Neurological Disorders Conferences Neurology Conferences 2024
Neuroscience Conferences 2024 Dubai Neurology Conferences 2024 Japan Muscular
Dystrophy Conferences Child Psychology Conferences Clinical Neurology
Conferences Psychology Conferences Spinal Disorders Conferences Sleep Disorders
Conferences Psychiatry Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
LATEST ADVANCEMENT IN BRAIN SURGERY
The term "brain surgery" is a catch-all term for a variety of medical operations
involving the treatment of structural problems in the brain. Head and brain
surgery is a very difficult procedure. Tumors, blood clots, aneurysms, epilepsy,
and Parkinson's disease are among the disorders for which brain surgery is
utilised. There are several different kinds of brain surgery. The type of
treatment depends on the brain area and the condition being treated. Surgeons
can now operate on parts of the brain without making a single incision in or
near the head because to advances in medical technology. Brain surgery is used
to treat physical problems with the brain. These can be caused by a birth flaw,
a disease, an injury, or a variety of other issues.
Sub-tracks:
• Biopsy
• Craniectomy
• Minimally invasive endonasal endoscopic surgery
• Stereotactic radiosurgery
• Endoscopic brain surgery
• Laser interstitial thermal therapy
• Deep brain stimulation (DBS)
• Craniotomy
• Posterior fossa decompression
• Thrombectomy and cerebral aneurysm repair
Market Analysis : The global market for brain surgery is expected to increase at
a CAGR of 12.9 percent from $1.1 billion in 2018 to $2.0 billion in 2023.
Neuroendoscopy is an advanced brain surgery method in which the neurosurgeon
uses an endoscope to navigate and access the tumour. Neurosurgeons attach
specific devices to the endoscope, frequently an additional endoscope with
forceps and scissors on the end, to remove a tumour or take a sample of it, as
opposed to traditional open brain surgery, which takes longer to heal and causes
less discomfort. Up to 2025, the neuroendoscopy market is expected to grow at a
rate of about 4.6 percent.
Tags
Cerebrovascular Disease Conferences Neurological Disorders Conferences Neurology
Conferences Europe Stroke Conferences Neurology Conferences 2024 Japan Seizures
Conferences Neurosurgery Conferences 2025 Muscular Dystrophy Conferences
Neurology Conferences 2024 USA Alzheimer's Disease Conferences Neurophysiology
Conferences Clinical Neurology Conferences Neurology Conferences 2024 Asia
Headache Conferences Brain Cancer Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
SKULL BASE SURGERY
The face and the cranium, which surround the brain, are made up of bones and
cartilage that make up the skull. The base of the skull is a busy and convoluted
location with numerous openings through which the spinal cord, numerous blood
arteries, and nerves all travel. Noncancerous and cancerous growths, as well as
anomalies on the underside of the brain, the skull base, or the top few
vertebrae of the spinal canal, may be removed by skull base surgery. Skull base
surgery is a form of specialty surgery that treats problems at the base of the
skull. Reaching these locations without cutting through the skull and retracting
the brain is a problem in skull base surgery.
Sub-tracks:
• Pituitary tumors
• Meningiomas
• Chordomas and Schwannomas
• Trigeminal neuralgia
• Vestibulocochlear nerve disorders
• Craniopharyngiomas and Pineal Region Tumors
• Hemifacial spasms
• Craniostenosis
• Cerebro-spinal fluid fistulas
• Cerebral aneurysms
• Arteriovenous Malformations (AVMs)
• Approaches and Reconstructive Techniques
• Endoscopic Techniques Traditional or open skull base surgery
• Endoscopic or minimally-invasive skull base surgery
• Advanced Microscopic, Laser and Ultrasonic Techniques
Market Analysis : In the market for skull base therapy, endoscopic approaches
have played a significant role. In the projected period of 2021 to 2028, the
surgical endoscopes market is expected to increase at a CAGR of 6.1 percent,
reaching USD 4,185.80 million. The growing preference for minimally invasive
surgeries is propelling the surgical endoscope market forward. From 2021 to
2028, the global endoscopy devices market is predicted to increase at a compound
annual growth rate (CAGR) of 7.3 percent. One of the primary factors driving the
market is the shift in the trend of healthcare professionals and patients
switching from traditional open surgeries to minimally invasive procedures.
Tags
Neuroscience Conferences 2024 Dubai Child Psychology Conferences Neurology
Conferences 2025 USA Neurodegenerative Disorders Conferences Stroke Conferences
Neurological Disorders Conferences Neurology Conferences Neurology Conferences
2024 Seizures Conferences Psychology Conferences Epilepsy Conferences
Neurosurgery Conferences 2025 Neurology Conferences 2024 Japan Neurology
Conferences 2025 Europe Neurology Conferences 2024 Asia
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
TRAUMA AND CRITICAL CARE
A abrupt injury to the head or spine causes neurotrauma. Concussions, traumatic
brain injuries, skull fractures, spinal column fractures, and spinal cord
injuries are all part of this category. Traumatic brain injury can be classified
as either primary or secondary, depending on whether it is caused by the force
associated with the neurotrauma or develops as a result of the neurotrauma.
Neurotrauma is still a leading source of morbidity and mortality in the United
States. Primary neurologic injury prevention is a major public health priority.
The goal of critical care for a patient who has suffered a neurotrauma is to
prevent further damage. Potential neuroprotection medicines still require a lot
more investigation.
Sub-tracks:
• Mild TBI, Blast Injuries and Sports-related Concussion
• Moderate to Severe TBI
• Chronic Subdural Haematoma
• Traumatic Spinal Cord Injury
• Neuro Intensive care
• Preclinical studies
• Pediatric trauma
• Quality assessment
• Patient safety
• Rehabilitation
• Prehospital management
• Neuroimaging
• Neurocritical Care for TBI and SCI
Market Analysis : Treatment for neurotrauma is a long-term commitment. The
global market for non-invasive brain trauma monitoring devices is estimated to
reach USD 16.99 billion by 2026, growing at a 7.7% CAGR. The use of non-invasive
brain trauma monitoring devices in neurotrauma and other brain illnesses is
expected to drive the market. According to the report, the worldwide critical
care equipment market is expected to increase at an annual rate of 8.7% from
2019 to 2025. Critical care equipment in intensive care units is designed to
provide round-the-clock care and monitoring.
Tags
Neurodegenerative Disorders Conferences Sleep Disorders Conferences Headache
Conferences Neurology Conferences 2024 Neurology Conferences 2024 Asia
Psychiatry Conferences Neurophysiology Conferences Neurological Disorders
Conferences Neurology Conferences 2025 USA Parkinson Disease Conferences Euro
Neurology Conferences Neurology Conferences 2025 UK Muscular Dystrophy
Conferences Neurology Conferences 2024 Japan Dementia Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEURORADIOLOGY
Neuroimaging techniques are used in the field of radiology known as
neuroradiology to recognise and categorise abnormalities of the spine, head and
neck, and central and peripheral nervous systems. Neuroradiology has the ability
to identify a variety of medical disorders, including arteriovenous
malformations, tumours, aneurysms, and strokes.
Neuroradiology is becoming more important in the diagnosis of neuropathologic
illnesses as current technology develops. Cross-sectional imaging, particularly
computed tomography (CT) and magnetic resonance (MR) imaging, has revolutionised
diagnostic procedures for disease of the central and peripheral nervous systems.
Modern, sophisticated imaging techniques like functional MRI, diffusion tensor
imaging, and perfusion imaging can provide extra, helpful information that can
aid in diagnosis and therapy response monitoring. Therefore, the
neuroradiologist and neuropathologist should collaborate to provide knowledge
that is clinically useful. The practising neuropathologist can tremendously
benefit from being conversant with neuroradiology imaging tests and fundamental
neuroimaging patterns.
Market Analysis: The market for interventional neuroradiology has shown steady
expansion over the past few years, and it is anticipated that the market will
expand significantly from 2020 to 2027.
The global market for radiology was valued at USD 26.6 billion in 2021 and is
anticipated to grow to USD 43.04 billion by 2029, displaying a CAGR of 6.20%
over the forecast period of 2022-2029.
Tags
Brain Cancer Conferences Cerebrovascular Disease Conferences Neurology
Conferences 2025 UK Neurological Disorders Conferences Neurology Conferences
2024 Neurodegenerative Disorders Conferences Neurology Conferences 2025
Neurophysiology Conferences Muscular Dystrophy Conferences Child Psychology
Conferences CNS Conferences Psychology Conferences Alzheimer's Disease
Conferences Parkinson Disease Conferences Neurosurgery Conferences 2025
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROROBOTICS
Neurorobotics is a new transdisciplinary research field that combines the fields
of robotics, artificial intelligence, and neurology.
Neurorobotics is the design and manufacture of robot bodies that mimic the
structure and function of the nervous system while incorporating an embedded
brain and embedded control systems.
Neurorobots can be categorised into a number of major groups depending on their
intended function. Research on motor control, memory, action selection, and
perception regularly make use of neurorobots.
• Locomotion and motor control
• Learning and memory systems
• Action selection and value systems
• Sensory perception
Neurorobotics helps neuroscientists test numerous hypotheses about how the brain
functions since it gives them a clean slate to do so in a regulated setting.
Robots are more specialised and allow for more direct examination of the problem
at hand, despite being simplified copies of the systems they replicate.
Furthermore, they have the advantage of always being visible, whereas it is more
challenging to observe a significant amount of an animal's brain when it is
moving, especially individual neurons.
The development of neuroscience has led to new neurological therapies.
Pharmaceuticals and neurological rehabilitation fall within this category.
Understanding the complicated workings of the brain is necessary for progress.
Due to the risk involved with cranial procedures, studying the brain is
challenging, especially in humans. The kind of testing and investigations that
can be run to better understand neurological processes are made possible by
neurorobots.
The following characteristics describe a neurorobot:
• It performs a behavioural action.
• It is located in a real-world setting.
• It is capable of recognising environmental stimuli and responding to them.
• Its behaviour is managed by a synthetic neurological system whose
architecture and dynamics, to some extent, correspond to those of the brain.
Market Analysis: The size of the global market for neurorehabilitation was
estimated at $1,097.69 million in 2020 and is expected to grow to $ 2,451.25
million by 2030, with a CAGR of 8.3% from 2021 to 2030.
In order to reduce and/or make up for any functional changes brought on by a
nervous system damage, neurorehabilitation is a sophisticated medical procedure.
Its goals are to speed up recovery after a nervous system injury.
The Global Neurorehabilitation Devices Market was valued at USD 1,448.97 Million
in 2020 and is anticipated to reach USD 4,933.67 Million by 2028, increasing at
a CAGR of 16.75% from 2021 to 2028, according to Verified Market Research.
Tags
Psychiatry Conferences Neuroscience Conferences 2024 Dubai Neurology Conferences
Europe Clinical Neurology Conferences Neurology Conferences 2025 Europe
Parkinson Disease Conferences Headache Conferences CNS Conferences Neurology
Conferences 2025 USA Alzheimer's Disease Conferences Neurology Conferences
Dementia Conferences Brain Cancer Conferences Seizures Conferences Child
Psychology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
ADVANCED IMAGING TECHNIQUES
Advanced imaging techniques are a group of cutting-edge methods and technologies
that are used to observe and study objects, chemicals, or biological structures
in greater detail and with higher resolution than traditional imaging methods.
These methods have applications in medicine, biology, materials science, and
physics.
Here are some examples of advanced imaging techniques:
Magnetic Resonance Imaging (MRI): Functional MRI (fMRI): Maps brain activity by
measuring changes in blood flow.
Diffusion Tensor Imaging (DTI): This imaging technique visualizes white matter
tracts in the brain.
MRS (Magnetic Resonance Spectroscopy): This technique provides chemical
information about tissues.
Computed Tomography (CT):
Dual-Energy CT: Determines the energy absorption of different materials.
Cone Beam CT: A 3D imaging technique used in dentistry and orthopedics.
Positron Emission Tomography (PET): A hybrid imaging technique that combines PET
with CT (PET-CT) or MRI (PET-MRI).It is used to investigate metabolic and
functional processes in the body.
Single-Photon Emission Computed Tomography (SPECT): This technique is similar to
PET, except it employs different radioactive tracers.
Contrast-Enhanced Ultrasound (CEUS): Improves image quality by using microbubble
contrast agents.
Elastography: A technique for measuring tissue stiffness that can be used to
diagnose liver fibrosis and breast lesions.
Optical imaging:
Confocal Microscopy: This technique generates high-resolution 3D images of
biological specimens.
Multiphoton Microscopy: Enables deep tissue imaging while causing little
photodamage.
Optical Coherence Tomography (OCT): A high-resolution imaging technique used in
ophthalmology and dermatology.
Nuclear Magnetic Resonance (NMR): Solid-State NMR: Investigates the atomic
structure of solid materials.
Electron Microscopy :
Transmission Electron Microscopy (TEM): This technique produces
ultra-high-resolution images of thin sections of specimens.
SEM (Scanning Electron Microscopy): Creates 3D pictures of specimen surfaces.
X-ray Imaging:
Phase-Contrast Soft tissue contrast in X-ray pictures is improved.
X-ray Fluorescence (XRF): Maps the element distribution in a sample.
Functional Near-Infrared Spectroscopy (fNIRS): This technique measures
variations in blood oxygenation in the brain and is valuable for cognitive
research.
Structured Illumination Microscopy (SIM) and Stimulated Emission Depletion
Microscopy (STED) provide sub-diffraction-limit resolution.
Magnetic Particle Imaging (MPI): High-contrast imaging with superparamagnetic
nanoparticles, primarily in preclinical research.
Elastography: A technique for measuring tissue stiffness in order to diagnose
various disorders such as liver fibrosis and breast cancer.
Cryo-Electron Microscopy (Cryo-EM): A technique for examining the
three-dimensional structures of biological macromolecules like proteins and
viruses at near-atomic resolution.
MSI (Mass Spectrometry Imaging): This technique combines mass spectrometry with
spatial data to map the distribution of molecules in tissues.
Tags
Brain Cancer Conferences Sleep Disorders Conferences Euro Neurology Conferences
Psychiatry Conferences Neurological Disorders Conferences Dementia Conferences
Cerebrovascular Disease Conferences Epilepsy Conferences Child Psychology
Conferences Neurology Conferences Spinal Disorders Conferences Psychology
Conferences Neurosurgery Conferences 2025 Neurology Conferences 2024 Asia
Neurology Conferences 2025 USA
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
PERSONALIZED MEDICINE
Precision medicine, also known as personalized medicine, is a medical treatment
and healthcare method that tailors medical decisions, practices, interventions,
and therapies to individual patients based on their unique characteristics.
These variables may include genetic make-up, genomic data, environmental
factors, lifestyle decisions, and other patient-specific information.
Personalized medicine seeks to improve the efficacy and safety of medical
therapies while minimizing adverse effects.
Among the key components and principles of customized medicine are:
Genomic Data: Genetic and genomic data, including DNA sequencing, are critical
components of customized treatment. Healthcare providers can identify genetic
differences that may predispose an individual to certain diseases, change their
reaction to specific treatments, or influence their overall health by evaluating
an individual's genetic composition.
Tailored Treatment Plans: Personalized medicine involves creating treatment
plans that are unique to each patient. This may include selecting drugs, doses,
and treatment regimens based on a specific individual's genetic and clinical
profile.
Risk Assessment: Genetic testing and other diagnostic technologies can assist
determine a person's risk of developing certain diseases. This data enables
proactive techniques such as early diagnosis and prevention.
Pharmacogenomics: is the study of how a person's genetic composition effects
their reaction to drugs. It can assist healthcare providers in selecting the
most appropriate medications and dosages, lowering the risk of adverse reactions
or treatment failure.
Disease prevention: Personalized medicine emphasizes disease prevention by
identifying an individual's unique risk factors and adapting interventions that
reduce those risks. Lifestyle suggestions, for example, might be adjusted to an
individual's genetics and environmental circumstances.
Cancer Treatment: Personalized medicine has significantly influenced cancer
therapy. It involves discovering the genetic alterations that are causing a
patient's cancer and then selecting targeted medicines that selectively target
those mutations. This method has the potential to improve treatment outcomes
while reducing adverse effects.
Data Integration: Personalized medicine is based on the integration of multiple
forms of patient data, such as genetics, clinical history, imaging, and
environmental factors. To make sense of this complicated information, advanced
data analysis and computational techniques are frequently applied.
Patient Engagement: Patients are frequently actively involved in their
healthcare decisions in personalized medicine. They may be encouraged to undergo
genetic testing, share lifestyle information, and work with healthcare
specialists to develop individualized treatment strategies.
Ethical and privacy concerns: Because customized medicine is strongly reliant on
genetic and personal data, ethical and privacy concerns are crucial. Patient
data security and informed consent are critical features of this discipline.
Research and Innovation: Personalized medicine is a developing subject that
benefits from going on research and technological improvements. New discoveries
in genetics, biomarkers, and treatment techniques continue to change
personalized medical practice.
Tags
Brain Cancer Conferences Neurology Conferences Europe Clinical Neurology
Conferences Euro Neurology Conferences Neuroscience Conferences 2024 Dubai
Neurology Conferences 2024 Japan Epilepsy Conferences Muscular Dystrophy
Conferences Seizures Conferences Headache Conferences Neurology Conferences 2024
USA Neurology Conferences 2025 UK Neurodegenerative Disorders Conferences
Psychology Conferences Neurosurgery Conferences 2025
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROINFORMATICS
Neuroinformatics is a multidisciplinary area that develops and applies
computational tools and data management approaches to enhance neuroscience
research. It combines neuroscience, computer science, and information technology
to enable the collection, organization, analysis, and sharing of data pertaining
to the anatomy and function of the nervous system. Neuroinformatics is critical
to furthering our understanding of the brain and its problems.
Here are some of the most important aspects of neuroinformatics:
Data Integration and Management: Neuroinformatics is the development of
databases and data management systems that store and organize massive volumes of
neuroscientific data, such as MRI, fMRI, and PET brain imaging data,
electrophysiological recordings, genetic information, and clinical data. These
databases enable researchers to share and collaborate on data.
Data Analysis and Visualization: Neuroinformatics tools include software and
algorithms that are used to handle and analyze neuroimaging and
electrophysiological data. These technologies aid scientists in identifying
patterns, correlations, and abnormalities in brain data. Complex brain
structures and functions are shown using advanced visualization techniques.
Platforms for Neuroinformatics: Several platforms and efforts for
neuroinformatics have been formed to give researchers with access to
standardized datasets, software tools, and resources. The Human Brain Project
and the Allen Brain Atlas are two examples. By encouraging collaboration and
data exchange, these platforms hope to accelerate brain research.
Brain Atlases and Mapping: Neuroinformatics helps to create detailed brain
atlases and mapping projects. These atlases contain detailed anatomical and
functional information about the brain, allowing researchers to explore and
investigate brain structures and regions.
Modeling and stimulation: Computational models and simulations are critical in
neuroscience for testing ideas and understanding brain functioning.
Neuroinformatics is concerned with the creation of neural network models and
simulations that imitate the behavior of neurons and brain circuits.
Connectomics: is the study of the brain's connectivity patterns, including
neural network mapping. Neuroinformatics is critical in processing and
evaluating large-scale connectome data, which helps us comprehend brain
connectivity.
Neuroimaging Informatics: In neuroimaging investigations, neuroinformatics tools
are used to preprocess, analyze, and visualize data from techniques such as MRI,
fMRI, and diffusion tensor imaging (DTI). These instruments aid in the
identification of brain structures and functional regions.
Critical applications: Neuroinformatics is utilized in clinical neuroscience to
help in the diagnosis and treatment of neurological disorders. It can aid in the
integration of patient data, medical imaging, and genetic information in order
to improve patient care and provide tailored treatment strategies.
Ethical and privacy considerations: Working with sensitive brain data poses
ethical and privacy concerns. To preserve individuals' privacy and rights,
neuroinformatics researchers work on building secure and ethical norms for data
sharing and preservation.
Machine Learning and AI: In neuroinformatics, machine learning and artificial
intelligence techniques are rapidly being used to automate data analysis, find
trends, and forecast outcomes. These technologies have the potential to speed
neuroscience breakthroughs.
Tags
Neurodegenerative Disorders Conferences Cerebrovascular Disease Conferences Euro
Neurology Conferences Neurology Conferences 2024 Japan Brain Cancer Conferences
Neurology Conferences Headache Conferences Child Psychology Conferences
Neurology Conferences 2025 Neurology Conferences 2025 USA Clinical Neurology
Conferences Neurology Conferences Europe Muscular Dystrophy Conferences
Parkinson Disease Conferences Neurosurgery Conferences 2025
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
GENE THERAPY
Gene therapy is a medical treatment that includes replacing or modifying faulty
genes with healthy ones in order to treat or prevent genetic disorders and
certain diseases. It is a promising topic of biotechnology and medicine with the
ability to address the molecular origins of numerous hereditary disorders.
The following are some important characteristics of gene therapy:
Gene Therapy Types:
Somatic Gene Therapy (SGT): This involves modifying the genes within an
individual's body cells other than their reproductive cells (germ line). It
tries to treat or reduce the symptoms of a disease in the individual being
treated but has no effect on their offspring.
Germline Gene Therapy: This therapy focuses on the genetic material found in
reproductive cells (sperm and egg cells) or very early embryos. It has the
capacity to pass on genetic alterations to future generations. Germline gene
therapy is very controversial due to ethical and safety concerns, and it is now
prohibited in a number of nations.
Methods of Delivery:
Viral vectors: Most gene therapy techniques rely on viruses to deliver
therapeutic genes into the patient's cells. Viruses are modified to remove
disease-causing qualities while still carrying the desired genes.
Non-viral Vectors: Some approaches use non-viral methods means to transport
genes, such as liposomes or nanoparticles.
Applications:
Monogenic disorders: Gene therapy has showed promise in treating single-gene
disorders such as cystic fibrosis, muscular dystrophy, and certain types of
inherited blindness.
Cancer: It can be used to modify a patient's immune cells so that they can
target and destroy cancer cells (for example, CAR-T cell therapy).
hereditary Diseases: Gene therapy has the potential to treat hereditary diseases
such hemophilia, sickle cell anemia, and thalassemia.
Neurodegenerative disorders: Research on gene treatments for disorders such as
Parkinson's and Huntington's disease is ongoing.
Rare Diseases: Although there is no cure for many rare genetic disorders, gene
therapy gives hope for some of these conditions.
Challenges:
Safety: It is critical to ensure the safety of gene therapy since unintended
genetic changes can have unpredictable consequences.
Efficacy: Not all gene therapies are equally effective, and their success might
vary depending on factors such as the precise genetic mutation, the method of
administration, and the patient's immunological reaction.
Ethical Issues: Germline gene therapy poses ethical concerns due to the
possibility of hereditary changes and unintended consequences.
Cost and Accessibility: Gene therapies can be expensive and may not be available
to everyone, raising affordability and fair distribution difficulties.
Regulation: To assure the safety and efficacy of gene therapy products,
regulatory agencies in various countries, such as the United States Food and
Drug Administration (FDA), actively monitor and regulate them.
Tags
Alzheimer's Disease Conferences Neurology Conferences 2025 USA Sleep Disorders
Conferences Neurology Conferences 2024 USA Neurology Conferences 2025 UK
Muscular Dystrophy Conferences Child Psychology Conferences CNS Conferences
Neurology Conferences 2025 Neurology Conferences 2025 Europe Clinical Neurology
Conferences Neurological Disorders Conferences Neurophysiology Conferences
Headache Conferences Neurodegenerative Disorders Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEURAL INTERFACE AND BRAIN-COMPUTER INTERFACE BCI
A neural interface is a technology that allows direct connection between the
brain and external equipment such as computers or robotic systems. It is also
known as a Brain-Computer Interface (BCI) or Brain-Machine Interface (BMI).
Medical applications, assistive technology, and even enhancing human capacities
can all benefit from these interfaces.
Here are some of the most important aspects of brain interfaces and BCIs:
Neural Interface Types:
Invasive BCIs: These procedures involve implanting electrodes or microelectrode
arrays directly into brain tissue. Invasive BCIs have a high degree of precision
and are frequently employed in research and medical applications.
Non-invasive BCIs: These interfaces do not require surgical implantation and
typically detect brain activity using external sensors. Non-invasive BCIs that
are commonly used include electroencephalography (EEG) and functional magnetic
resonance imaging.
Medical Applications: BCIs have been used to help people who are paralyzed or
have significant motor limitations. They can help individuals manipulate robotic
limbs, connect with computers, and restore some of their freedom.
Research: BCIs are critical instruments for investigating brain functioning and
recording brain activity in research. They're used in neuroscience, psychology,
and cognitive science.
Augmentation: Some BCIs are designed to improve human capacities, such as
memory, cognition, or sensory perception. These are still in the early stages of
development.
Control and communication:
Brain-computer interfaces (BCIs) can convert brain signals into commands for
external devices. A person with motor neuron disease, for example, may utilize a
BCI to control a computer cursor or a robotic arm just by thinking about the
desired movements.
BCIs can also enable two-way communication by allowing users to transmit and
receive data via brain signals. This is especially crucial for those who have
locked-in syndrome or other diseases that limit their capacity to move or
communicate.
Limitations and difficulties:
Non-invasive vs. invasive: Invasive BCIs provide more precision but come with
surgical risks and are more difficult to adopt. Non-invasive BCIs are less
dangerous, but have inferior spatial resolution.
Training and Adaptation: Users frequently require training to use BCIs
efficiently, and the technology may not be appropriate for everyone.
Ethical and privacy concerns have emerged as BCIs progress, raising concerns
about privacy, security, and the potential exploitation of brain data.
Future Prospects:
Ongoing research attempts to increase BCI safety, accuracy, and use.
Tags
Neurology Conferences 2024 USA Neurology Conferences 2024 Euro Neurology
Conferences Neurosurgery Conferences 2025 Neurology Conferences 2025 USA Stroke
Conferences Cerebrovascular Disease Conferences Neurology Conferences
Neurophysiology Conferences Psychiatry Conferences Neuroscience Conferences 2024
Dubai CNS Conferences Seizures Conferences Clinical Neurology Conferences
Alzheimer's Disease Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
NEUROREHABILITATION
Neurorehabilitation is a multidisciplinary approach to treating and recovering
people who have neurological illnesses or injuries. Its primary goal is to
assist patients in regaining functional abilities, independence, and a higher
quality of life after diseases such as strokes, traumatic brain injuries (TBIs),
spinal cord injuries, Parkinson's disease, multiple sclerosis, and other
neurological disorders.
Here are some important components of neurorehabilitation:
Multidisciplinary Group: A team of healthcare professionals, including
neurologists, physical therapists, occupational therapists, speech therapists,
neuropsychologists, social workers, and rehabilitation nurses, is typically
involved in neurorehabilitation. Each team member brings specialized knowledge
to bear on various areas of the patient's needs.
Assessment and Goal Setting: The rehabilitation process starts with a thorough
evaluation of the patient's physical, cognitive, emotional, and social
functioning. Based on this evaluation, rehabilitation goals are developed in
consultation with the patient and their family, with a focus on particular
functional gains and milestones.
Physical Therapy: Physical therapy is an essential component of
neurorehabilitation. It aids in the recovery of patients' mobility, strength,
balance, and coordination. Gait training, exercises, and the use of assistance
devices such as walkers or wheelchairs are examples of techniques.
Occupational therapy: assists patients in relearning or adapting daily routines
such as dressing, cooking, and grooming. Therapists help patients develop their
fine motor skills, cognitive abilities, and adaptive methods in order to
increase their independence.
Speech and Language Therapy: Speech therapists work with individuals who have
communication problems as a result of neurological issues. They also assist
people who have difficulty swallowing (dysphagia) in improving their ability to
eat comfortably.
Cognitive Rehabilitation: is provided by neuropsychologists and other
professionals to address memory, attention, problem-solving, and other cognitive
impairments caused by neurological injuries or disorders.
Psychological and Emotional Support: Neurorehabilitation understands the need of
addressing the psychological and emotional issues that frequently accompany
neurological diseases. Psychologists and social workers provide counseling and
support to patients and their families in order to help them cope with the
emotional effects of these diseases.
Community reintegration: Rehabilitation frequently includes training to assist
patients in reintegrating back into their communities. This could include
putting abilities to use in real-world situations and dealing with social
issues.
Assistive equipment and Technology: To increase the patient's independence,
neurorehabilitation may include the use of assistive equipment such as mobility
aids, communication devices, and adaptive technology.
Patient and Family Education: A major element of neurorehabilitation is
educating patients and their families about the nature of the neurological
disorder, treatment alternatives, and coping strategies.
Long-term Care and Support: Individuals with chronic neurological diseases may
require continuous care and support in order to sustain functional progress and
effectively manage symptoms.
Research and Innovation: Advances in neurorehabilitation techniques and
technologies continue to evolve as a result of continuing study and innovation
in the field.
Tags
Euro Neurology Conferences Parkinson Disease Conferences Alzheimer's Disease
Conferences Headache Conferences Neuroscience Conferences 2024 Dubai Neurology
Conferences 2024 Sleep Disorders Conferences Neurology Conferences Child
Psychology Conferences Brain Cancer Conferences Neurophysiology Conferences
Neurology Conferences 2025 Europe Neurology Conferences 2024 Japan Neurosurgery
Conferences 2025 Stroke Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
REGENERATIVE MEDICINE AND STEM CELL THERAPY
Regenerative medicine and stem cell treatment are cutting-edge fields of medical
science that hold enormous promise for treating a wide range of diseases and
injuries. They are primarily concerned with utilizing the body's innate ability
to repair and replace damaged or diseased tissues.
Here is an overview of these two disciplines:
1. Regenerative Medicine:
Regenerative medicine is a vast interdisciplinary area that incorporates ideas
from biology, chemistry, physics, engineering, and medicine to restore, replace,
or regenerate damaged tissues and organs in the body.
Regenerative medicine's essential components include:
Cell-based therapy: Cell-based therapy is introducing cells into the patient's
body, such as stem cells or specialized cells, in order to encourage tissue
regeneration.
Tissue engineering: In the lab, scientists use a combination of cells,
scaffolds, and growth factors to create artificial tissues and organs.
Biomaterials: The creation of materials that are compatible with the body in
order to facilitate tissue regeneration and repair.
Gene therapy: Gene therapy is the process of altering or replacing faulty genes
in order to remedy genetic illnesses.
Regenerative medicine has the potential to transform the treatment of ailments
such as heart disease, diabetes, and spinal cord injuries, among others. It is
especially important in the field of organ transplantation, since it may one day
eliminate the need for donor organs by developing lab-grown alternatives.
2. Stem Cell Therapy: A subgroup of regenerative medicine that focuses on the
use of stem cells to treat various diseases and injuries is stem cell therapy.
Stem cells are special in that they can develop into several cell types in the
body.
Stem cells are classified into various types:
Embryonic stem cells are pluripotent stem cells that can develop into any cell
type in the body and are derived from early-stage embryos.
Adult stem cells: Adult stem cells are multipotent or tissue-specific stem cells
present throughout the body in diverse tissues and organs. They can only
differentiate into a few different cell types.
Induced pluripotent stem cells (iPSCs): Adult cells that have been reprogrammed
to become pluripotent, comparable to embryonic stem cells, are known as induced
pluripotent stem cells (iPSCs).
The extraction and manipulation of stem cells to treat specific illnesses is
known as stem cell therapy.
For example:
Hematopoietic stem cell transplantation: This procedure is used to treat blood
problems and certain types of cancer.
Mesenchymal stem cell therapy: Mesenchymal stem cell treatment has been used to
treat a variety of musculoskeletal and inflammatory diseases.
iPSC-based therapy: This type of therapy is used for customized medicine and
disease modeling.
Tags
Neurology Conferences Europe Spinal Disorders Conferences Neurology Conferences
2025 UK Alzheimer's Disease Conferences Parkinson Disease Conferences Psychology
Conferences Neurological Disorders Conferences Psychiatry Conferences
Neurodegenerative Disorders Conferences Neurology Conferences 2024 Japan
Neurology Conferences 2025 USA Neurology Conferences 2025 Neuroscience
Conferences 2024 Dubai Neurology Conferences 2024 Neurology Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
TELEMEDICINE IN NEUROLOGY
Telemedicine in neurology refers to the use of telecommunication technology to
assist patients with neurological diseases with remote medical care,
consultation, and monitoring. Neurology is a medical speciality that focuses on
nervous system problems, which include the brain, spinal cord, nerves, and
muscles. Telemedicine in neurology has grown in importance, particularly in
situations where access to neurological care is limited or patients are unable
to conveniently travel to a healthcare institution.
Here are some major characteristics of telemedicine in neurology:
Consultations and Diagnosis: Telemedicine enables neurologists to conduct
virtual consultations with patients in order to assess symptoms, examine medical
history, and provide preliminary diagnoses.
Neurologists can use diagnostic techniques such as video conferencing to watch
patient movements, speech, and other neurological indicators that can aid in
diagnosis.
While some neurological diseases may still necessitate in-person exams and
tests, telemedicine can assist in determining the urgency of the problem and
directing patients to the right care.
Follow-Up Care: Patients with chronic neurological diseases including epilepsy,
multiple sclerosis, or Parkinson's disease can benefit from telemedicine
follow-up consultations.
Through virtual consultations, neurologists can monitor disease development,
change medications, and address any concerns or side effects, improving patient
convenience and adherence to therapy regimens.
Second opinions:Telemedicine allows patients to obtain second opinions from
specialized neurologists without having to travel long distances.
This is especially useful in complex neurological conditions or when patients
seek more information about their treatment options.
Remote Monitoring: Some neurological diseases, such as epilepsy, necessitate
constant monitoring, such as seizure activity tracking.
Patients can use wearable gadgets and smartphone apps to record and transmit
data to their neurologists, who can subsequently make therapy adjustments as
needed.
Education and Counseling: Telemedicine can be used to educate and counsel
patients and caregivers about neurological diseases, medications, and lifestyle
modifications.
Virtual support groups and instructional seminars are also available.
Telestroke Programs: Telestroke programs are specialized telemedicine
initiatives that link rural hospitals or clinics with stroke specialists.
By administering clot-busting drugs or arranging for transfer to a stroke center
when necessary, timely evaluation and treatment of stroke patients via
telestroke can greatly improve outcomes.
Rural and Underserved Areas: Telemedicine in neurology can help patients in
rural or underserved areas have access to neurological care when professional
neurologists are rare.
Tags
Parkinson Disease Conferences Neurology Conferences 2024 Japan CNS Conferences
Neurology Conferences 2024 USA Euro Neurology Conferences Stroke Conferences
Epilepsy Conferences Neurodegenerative Disorders Conferences Neurophysiology
Conferences Psychiatry Conferences Neurology Conferences 2024 Child Psychology
Conferences Brain Cancer Conferences Neurology Conferences Seizures Conferences
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
SCOPE & IMPORTANCE
The scope of this report is to discuss the market of Neurology and Neurosurgery:
The Neurology Device market is growing rapidly with CAGR of 4% from USD 33
billion in 2019 to USD USD 39 billion in by 2023. The neurology device market
can be divided into two segments. The neurology market segmented according to
device types which includes neurosurgical devices, CSF devices, neurostimulation
devices, and the cerebrospinal fluid devices accounts for the maximum share of
the market. According to the geography segment, it is divided into the following
regions: North America, Eastern Europe, Middle East, South America,
Asia-Pacific, and Africa. Among these Asia-Pacific is the fastest-growing region
and North America is the largest market for Neurological devices.
Global Neurosurgery market was valued at USD 12500 million in 2017 which is
expected to increase during 2018-2026 at a rate of 8.0% CAGR. The global
neurosurgery market is growing at substantial growth. Neurosurgery device market
has major role of countries form North America (USA, Canada, and Mexico), Europe
(UK, France, Germany, and Russia), Asia-Pacific (India, China, and Korea), South
America (Colombia, Brazil, and Argentina) and Africa and Middle East (Egypt,
Saudi Arabia, UAE, and South Africa).
The major companies playing role in Neurology and Neurosurgery market are
Zeppelin Medical Instruments, Abbott Laboratories, Ackermann, Zeiss, Medtronic,
Merit Medical, Toshiba Medical, Boston Scientific Corporation, and Stryker
Corporation.
According to a study, there are 17,000 neurologists are there in the USA with an
average per annum salary is USD 160,000 and the number of neurologists is likely
to increase to 18000+ till 2025. There are approximately 3,600 neurosurgeons in
the USA and getting annual pay of USG 540,000.
Target Audience:
Neurologists | Neurosurgeons | Neuroscientists | Neuroradiologists | Physicians
| Neuromuscular Specialist | Adult & Pediatric Neurologist | Neuroimmunologists
| Medical Students, Researchers, Residents (Neurosurgery, Neurology, Psychiatry,
Radiology, and Rehab) | Nurses | Nurse Practitioners | Physician Assistants |
Professors | Academicians | Associations | Organizations | Hospitals | Medical
Labs | Research Laboratories | Drug Development Companies | Research Institutes
and Members | Scholars | Manufacturing Companies | Training Institutes |
Healthcare Workers and Druggist | Industries
Neurology Market Overview in USA :
USA Neurology Market growth is due to an increased prevalence of neurological
disorders such as migraine, dementia, Alzheimer's disease, brain tumors and
epilepsy. In addition, technological advances and the need for early diagnosis
of neurological disorders are contributing to market growth. Furthermore, it is
expected that the increase in the elderly population will also contribute to the
growth of the market.
According to the United States, for example, the Census Bureau predicts that the
elderly population in the United States will reach 77 million by 2034.
Increasing government funding for neurological research and development is also
expected to support market growth. For example, in December 2019, the US
Congress approved US $ 350 million annual funding for research and development
in the areas of Alzheimer's disease and dementia.
The global neurobiomarker market is estimated to be US $ 6.1 billion in 2020 and
is projected to grow at a compound annual growth rate (CAGR) of 12.9% from 2020
to 2028. The US neurological disorder market is estimated to be US $ 19291.20M
in 2021, growing at a CAGR of 3.64% during the forecast period and reaching US $
24770.44M by 2028. North America dominated the global neural device market with
a 58.5% share in 2019, followed by Europe and Asia Pacific.
In 2016, epilepsy accounted for approximately 13 million disability-adjusted
life years and more than 0.5% of the world's disease burden, according to the
WHO. The increase in cases of Alzheimer's disease in the elderly is expected to
spur market growth. For example, according to WHO, about 50 million people
worldwide suffer from dementia, and about 10 million new cases are reported each
year. In addition, according to the Alzheimer's Disease Association, an
estimated 13.8 million people over the age of 65 will have Alzheimer's disease
by 2050. In the United States, it is estimated that in 2020, approximately 5.8
million people over the age of 65 will be affected by Alzheimer's disease.
Of the 800,000 strokes that occur each year in the United States, up to 15% of
these patients are candidates for neurovascular thrombectomy. It takes less than
5% to reach a stroke center with a stent recovery device or suction catheter.
With the rapid introduction of suction catheters, the amount of thrombectomy is
increasing to meet the needs of patients. Patients suffering from Covid-19 are
reported to have neurological symptoms that are expected to create a favorable
environment for further growth in the market.
Neurology Market Overview in Europe :
The main drivers of growth in the European market are increasing prevalence of
neurological disorders, huge private investment in neurosurveillance devices,
increased R & D in the field of neurotherapy, and an increasing population
aging. The growth of the European neuro-monitoring device market also increases
the incidence of neurological disorders such as cerebral aneurysms, brain
tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson's disease,
peripheral neuropathy, postherpetic neuralgia, and spinal cord tumors.
Germany has a world-class health care system that offers affordable treatment.
The stroke rate is 51.7 per 100,000 people in the country. Germany also has a
very high stroke mortality rate, with 75,861 deaths annually. Due to this
increased incidence, the demand for neurovascular disease is expected to
increase during the prediction interval.
In Italy, the healthcare system is growing with the development of neurology.
Each year, 120,000 people suffer a stroke and an additional 930,000 are affected
by stroke-related disorders. In addition, the elderly population is increasing
in Italy, contributing to the increase in neurological disorders such as
Parkinson's disease and multiple sclerosis.
In Spain, stroke is the third leading cause of death after Alzheimer's disease
and ischemic heart disease. The government is also increasing investment in the
healthcare system. Such factors drive market growth in these countries. The
prevalence of Parkinson's disease has increased over the years in the developed
regions of Europe. This is mainly due to the increase in the elderly population.
In addition, according to the United Nations 2017 World Aging Population
Report, the population over the age of 60 accounts for 23.9% of the UK
population, and the report estimates that it will increase to 31.5% by 2050. As
a result, the prevalence of Parkinson's disease is expected to increase in the
future. This will increase the demand for Parkinson's disease monitoring devices
that support market growth.
The size of the European interventional neurology market is estimated to be
worth US $ 583.82 million in 2022 and reach US $ 890.07 million by the end of
2027. The specific increase in benefits provided by the methods of
interventional neurology and the increase in the number of hospitals and
diagnostic centers create even more favorable market growth opportunities.
The neurovascular devices market is estimated for $2,935 million in 2019, and is
estimated to reach $3,712 million by 2027, registering a CAGR of 5.2% from 2020
to 2027. Increasing prevalence of neurovascular disease will drive market
growth. For example, according to the European Stroke Alliance, stroke will
increase by 34% between 2015 and 2035.
Neurology Market Overview in Asia :
Neurological disorders are steadily increasing in Asia. According to a 2015 WHO
survey, Asia is home to 60% of the world's population, but Asia has only about
20% of the world's neurologists, further reducing the proportion of treatments
available. I am. This unmet demand for treatment provides opportunities for
Western neurology companies to expand and grow in the region.
Of the more than 600 neurological disorders worldwide, cerebrovascular and
neurodegenerative disorders are the most common in Asia. Currently, more than a
quarter of Japan's population is over 65, but other countries such as South
Korea, China, Taiwan and Singapore are all expected to age rapidly. It is the
most common neurodegenerative disease in Asia, accounting for more than 60% of
all cases. There are an estimated 7 million people with Alzheimer's disease in
China, 4 million in India and 1.5 million in Japan. Parkinson's disease (PD) is
the second most common neurodegenerative disease in Asia, but its prevalence in
Asia is slightly lower than in Europe and North America.
Japan dominates the interventional neural device market in terms of market share
and market profits and is set to further increase its dominance during the
forecast period. This is due to the presence of major major players and a large
target patient population in the region. Meanwhile, the Asia Pacific region is
projected to show the highest growth rates during the forecast period due to
improved healthcare infrastructure and increased awareness of neurosurgeons
about the benefits of interventional neural devices in the region.
The Asia Pacific neurology devices market was valued at USD 13,572.1 Mn in 2019
and expected to grow at a significant CAGR 5.9% and will reach USD 44,045.9 Mn
by 2027. Key factors driving market growth include an increase in the aging
population, an increasing prevalence of neurological disorders, and the
development of new and drug development technologies. The Asia Pacific
interventional neurology market is worth US $ 450 million in 2022 and US $
724.13 million by the end of 2027. It is estimated to grow at a CAGR of 4.1%
from 2020 to 2027. Market growth is due to key factors such as increased
prevalence of neurological disorders and increased attention to neurobiomarker
research.
Neurology Market Overview in Middle East :
The Middle East Neurological device market is estimated to be US $ 19.6 billion
in 2019 and is projected to grow at a CAGR of over 5.5% during the forecast
period. Market value is projected to increase to $ 40.7 million during the
forecast period from 2020 to 2027. This growth is expected to be driven by
dynamic innovation and technological advances. The majority of Middle Eastern
countries are adopting technological advances early on, providing a wide range
of opportunities for medical device companies. Technological advances focused on
improving efficiency and accuracy are expected during the forecast period.
Neurology market in The Middle East is estimated to be USD 168.81million as of
2022 and it is expected to grow with CAGR 8.56% and expected to reach USD 254.54
million by 2027 .The Middle East neurological monitoring markets are expected to
grow at a CAGR of 7.5% during the forecast period. Neuropathy is increasingly
recognized as one of the most common illnesses that place a heavy burden on
patients, their families and society. Therefore, neurological disorders
contribute significantly to morbidity and mortality in the region.
The Middle East and Africa neurorehabilitation device market states that the
market is expected to grow at a CAGR of 13.63% during the forecast period
2019-2028. Saudi Arabia, Turkey, South Africa, the United Arab Emirates, and
other countries make up the markets in the region. By 2030, approximately 74.7
million people are expected to be affected by Alzheimer's disease. And that
number is expected to grow to 131.5 million by 2050. Therefore, the increased
burden of neurological disorders leads to a huge demand for neurorehabilitation
equipment in these countries.
In addition, according to data released by WHO in 2018, deaths from Alzheimer's
disease and dementia in Egypt account for 3.23% of all deaths in the country.
About 600,000 people in Turkey are affected by dementia, of which 400,000 have
Alzheimer's disease. In recent years, the elderly population in Japan has
increased significantly. The increasing prevalence of disease as the population
ages is expected to drive the Turkish neurorehabilitation device market during
the forecast period. Neurological devices are used to treat illnesses and
various neurological disorders. They are pathophysiological conditions that
occur in the nervous system, brain, and spinal cord.
According to the World Population Aging 2019 Report, the United Arab Emirates
population was 1,13,000 (1.2%) in 2019 for those aged 65 and over, but this
figure is expected to increase to 5,48,000 (5.1%) annually by 2030. There are
large categories of the elderly and the elderly population in this country,
which may increase the need for treatment associated with neurological
disorders. This is expected to steadily increase the number of patients with
neurological disorders and increase the interest of existing players in
investing in this country.
50 Neurological Treatments that are commonly used in the field of Neurology:
Antiepileptic medications (AEDs): Are used to control seizures in people with
epilepsy.
Deep Brain Stimulation (DBS): This treatment is used to treat Parkinson's
disease and essential tremor.
Stroke Thrombolysis: Stroke thrombolysis is the treatment of ischemic strokes
with clot-busting medicines.
Brain Surgery: To remove brain tumors or treat epilepsy.
Physical Therapy: Physical therapy is used to restore movement and function
following neurological injury.
Neuromuscular Blocking Agents: Used in surgery to relax muscles.
Intravenous Immunoglobulin (IVIG): Used to treat autoimmune neuromuscular
diseases.
Ventricular Shunting: A procedure that drains extra cerebrospinal fluid to cure
hydrocephalus.
Botulinum Toxin (Botox): This substance is used to treat illnesses such as
dystonia and migraines
Gamma Knife Radiosurgery: Targeted radiation therapy for brain malignancies.
Neuromodulation: Transcranial magnetic stimulation (TMS) is one example of
neuromodulation.
Medications for Multiple Sclerosis: Multiple Sclerosis medications include
disease-modifying treatments (DMTs).
Anticoagulants: These medications prevent blood clots that can lead to strokes.
Neurorehabilitation: Neurorehabilitation is a comprehensive therapy for the
recovery of neurological injuries.
Carotid Endarterectomy: A procedure used to remove plaque from the carotid
arteries.
Corticosteroids: These medications are used to alleviate inflammation in
illnesses such as multiple sclerosis.
Nerve Blocks: Nerve blocks, such as epidural or peripheral nerve blocks, are
used to relieve pain.
Antiparkinsonian Medications: Used to treat Parkinson's disease symptoms.
Lumbar Puncture (Spinal Tap): Used in some circumstances for diagnosis and
therapy.
Antidepressants and anxiolytics: Are used to treat mood problems caused by
neurological diseases.
Intrathecal Baclofen Pump: Used to treat severe spasticity caused by disorders
such as cerebral palsy.
Biofeedback Therapy: This therapy assists patients in gaining control over
physiological functioning.
Vestibular Rehabilitation: Is used to treat balance and dizziness issues.
Palliative care: Is used to improve the quality of life of those suffering from
severe neurological disorders.
Gene Therapy: Gene Therapy is a new therapy method for certain genetic
neurological illnesses.
Stem Cell Therapy: Stem cell therapy is being researched for several
neurological illnesses in attempt to improve tissue restoration.
Gene Editing: CRISPR technology is being used to change genes in specific
neurological diseases.
Fecal Microbiota Transplantation (FMT): Is being researched for its potential
advantages in neurological illnesses associated with the gut-brain axis.
Neuro prosthetics: Implantable devices that restore lost neurological function,
such as brain-computer interfaces, are known as neuro prosthetics.
The ketogenic: Diet is used to treat epilepsy and is being researched for other
neurological diseases.
Virtual Reality Therapy: Neurorehabilitation and pain management are aided by
virtual reality therapy.
Targeted Therapies for Brain Tumors: Treatments that are tailored to the
patient's genetic profile.
Neuromuscular Electrical Stimulation (NMES): Aids in muscle recovery following
injury or surgery.
Intracranial Pressure Monitoring: Monitoring intracranial pressure is critical
in the treatment of serious brain injuries and hydrocephalus.
Cognitive Behavioral Therapy (CBT): Used to treat the psychosocial elements of
neurological illnesses.
Nanotechnology in Drug Delivery: Improves drug delivery precision to the brain.
Brain-Computer Interfaces (BCIs): Enables direct connection between the brain
and external devices.
Transcranial Direct Current Stimulation (tDCS): Is being researched for the
treatment of mood disorders and cognitive enhancement.
Optogenetics: The use of light to regulate individual neurons, which is being
investigated for various neurological investigations.
Minimally Invasive Spinal Surgery: Less invasive techniques for the spine.
Extracorporeal Shock Wave Therapy (ESWT): Is being researched for the treatment
of neuropathic pain.
Custom Implant 3D Printing: Creating patient-specific implants for cranial and
spinal surgery.
Telemedicine and remote monitoring: These technologies improve access to
neurological care and follow-up.
Neurofeedback Training: Assists individuals in regulating brain activity for a
variety of functions.
Non-Invasive Brain Stimulation: Techniques such as transcranial electrical
stimulation (tES) are examples of non-invasive brain stimulation.
Immunotherapies for Autoimmune Neurological Disorders: Examining the involvement
of the immune system.
Exoskeletons: Mobility and rehabilitation aids following spinal cord injury.
Neuro pharmacogenomics: Personalized pharmacological treatment based on genetic
characteristics is known as neuro pharmacogenomics.
Microbiome Manipulation: Exploring the gut-brain relationship for neurological
health through microbiome manipulation.
Biomarker Detection: Advances in detecting early symptoms of neurological
illnesses in order to intervene more effectively.
General overview of Neurologists salaries across the Globe:
Neurologists pay can vary greatly depending on factors such as geography, years
of experience, the country's specific healthcare system, and the need for
neurologists in that region.
Here is a broad breakdown of neurologists' wages around the world:
The United States: Neurologists annual salaries in the United States often range
from $250,000 to $400,000 or more, depending on criteria such as location and
sub-specialization.
Canada: Neurologists in Canada earn an average annual compensation of CAD
300,000 to CAD 400,000 or more.
United Kingdom: Neurologists pay in the United Kingdom vary depending on
experience and location within the National Health Service (NHS). Neurologists
in the United Kingdom can make between £80,000 and £150,000 per year on average.
Australia: Neurologists in Australia earn a good living. Neurologists in
Australia earn an average annual pay of AUD 150,000 to AUD 300,000 or more.
Germany: Neurologists salary in Germany can vary depending on the healthcare
sector (public or private). Neurologists in Germany might make between €80,000
and €150,000 per year on average.
India: Neurologists salary in India might vary widely depending on factors such
as geography, experience, and the type of healthcare facility. Neurologists in
India might make anything from INR 10 lakhs to INR 30 lakhs or more per year on
average.
South Africa: Neurologists in South Africa are often paid well. Neurologists in
South Africa earn an average annual compensation of ZAR 800,000 to ZAR 2 million
or more.
Middle East: Neurologists salaries in Middle Eastern nations such as the UAE and
Saudi Arabia can be fairly appealing, ranging from $150,000 to $300,000 or more
per year, including benefits.
different Countries: Neurologists salary in different countries might vary
greatly, thus it is critical to assess the region and its healthcare system.
Neurology and Neurosurgery societies:
USA:
American Academy of Neurology / American Neurological Association (ANA) /
Society for Neuroscience / Child Neurology Society / World Federation of
Neurology / Florida Society of Neurology / American Association of Neurological
Surgeons / Congress of Neurological Surgeons (CNS) / American Board of
Psychiatry and Neurology / Neurosurgical Society of America (NSA) / Western
Neurosurgical Society / Society of Neurological Surgeons / World Federation of
Neurosurgical Societies / International Society for Pediatric Neurosurgery /
Epilepsy Foundation / American Epilepsy Society / Epilepsy Society / American
Clinical Neurophysiology Society / Child Neurology Society / American Clinical
Neurophysiology Society / American Academy of Pediatrics / Epilepsy Association
/ Professional Stroke Organizations / Academy of Neurologic Physical Therapy /
North American Neuro-Ophthalmology Society / Neurocritical Care Society /
American Osteopathic Board of Neurology and Psychiatry / Alzheimer Association /
American Headache Society / Massachusetts Neurologic Association / The American
Society of Neuroimaging / North American Neuromodulation Society / Professional
Stroke Organizations / World Stroke Organization / Epilepsy Center of Northwest
Ohio / Dravet Syndrome Foundation / Citizens United for Research in Epilepsy /
National Association of Epilepsy Centers / American Parkinson Disease
Association / Brooklyn Parkinson Group / Capital Area Parkinson's Society /
Central Ohio Parkinson Society / Hawaii Parkinson Association / Houston Area
Parkinson Society / Michael J. Fox Foundation for Parkinson's Research /
Muhammad Ali Parkinson's Center & Movement Disorders Clinic / National Parkinson
Foundation / Parkinson Alliance / Parkinson Association of the Rockies /
Parkinson's Disease Foundation / Parkinsons Institute and Clinical Center /
Parkinson's Resource Organization / International Federation of Clinical
Neurophysiology
Europe:
European Academy of Neurology / European Neurological Society / European
Pediatric Neurology Society: EPNS / European Association of Neurosurgical
Societies / European Stroke Organisation / Stroke Alliance for Europe / European
Stroke Organisation / Epilepsy Alliance Europe Task Force / International League
against Epilepsy / British Epilepsy Association / British Pediatric Neurology
Association / Epilepsy Action / International Bureau for Epilepsy / National
Institute of Neurological Disorders and Stroke / Movement Disorder Society /
European Parkinson's Disease Association / Cure Parkinson's Trust /
Neuroförbundet / Párkinson Albacete / Párkinson Alicante / Deutsche Parkinson
Vereinigung / Jung & Parkinson / Kompetenznetz Parkinson / Verein Parkinson
Nurses und Assistenten / Parkinson Slovácko / Parkinson Selbsthilfe Österreich /
Parkinsonline (PON) Austria / Alzheimer Europe / Alzheimer's Disease
International / Federation of European Neuroscience Societies / European
Association for NeuroOncology / Federazione Alzheimer Italia / Alzheimer Society
of Ireland / Hungarian Alzheimer Society
Asia:
Neurology Asia / Federation of Asian-Oceanian Neuroscience Societies / Asian
Ocean Association of Neurology / Asian Society for Neuro-Oncology / Neurological
Society of India / Indian Academy of Neurology / Indian Society of
Neuro-Oncology / Mongolian Neuroscience Society / Australasian Neuroscience
Society / Asian Australasian Society of Neurological Surgeons / Parkinson's
Disease Society / Parkinson's Disease Foundation / Parkinson's Disease and
Movement Disorder Society / Parkinson's Disease Patients Welfare Society /
Taiwan Parkinson Association / Parkinson’s Support Group / Yayasan Peduli
Parkinson Indonesia / Malaysian Parkinson's Disease Association / Japanese
Society of Psychiatry and Neurology / Japanese Society of Neurology / Japan
Neuroscience Society / Japan Neurosurgical Society / The Neurospinal Society of
Japan / Taiwan Neurosurgical Spine Society / Alzheimer's & Related Disorders
Society of India / Alzheimer's Association Japan / Jordan Alzheimer’s
Association / Alzheimer's Association of Israel / Iran Dementia & Alzheimer's
Association / Alzheimer's Indonesia / Hong Kong Alzheimer's Disease Association
/ Dementia Care Foundation Bangladesh / Qatar Alzheimer’s Society / Korean
Association for Dementia / Foundation Alzrus / Saudi Alzheimer's Disease
Association / Japanese Society of Child Neurology
Middle East and other regions:
Emirates Neurology Society / Society for Arab Neuroscientists / Saudi Neurology
Society / Pan Arab Union of Neurological Societies / Israel Society for
Neuroscience (ISFN) / Iranian Neurological Association / OMAN Neurology Society
/ Bahrain Medical Society / Bahrain Neurological Association / Egyptian Society
of Neurology, Psychiatry and Neurosurgery / African Academy of Neurology /
Neurological Association of South Africa / Society of Neuroscientists of Africa
/ Southern African Neuroscience Society: SANS / Australian and New Zealand
Association of Neurologists / Neurosurgical Society of Australasia /
Australasian Neuroscience Society Inc / Australia and New Zealand Child
Neurology Society (ANZCNS) / Australian Neuroscience Society / Tikvah4Parkinson
/ Africa Parkinson's Disease Foundation / Parki̇nson Hastaliği Derneği̇ /
Parkinson's Disease & Related Movement Disorders Association of South Africa /
Alzheimer's Family Support Group / Corporación Alzheimer Chile / Dementia
Australia / Saudi Alzheimer's Disease Association / Qatar Alzheimer’s Society /
Oman Alzheimer’s Society / Jordan Alzheimer’s Association / Alzheimer's South
Africa
Hospitals:
North America:
Hospital for Sick Children / Providence Health & Services / Hartford Hospital /
Scripps Health System San Diego / Nationwide Children's Hospital / Massachusetts
General Hospital / University of Michigan Health System / Brigham and Women's
Hospital / Children's Hospital Boston / Society of Cardiovascular and
Interventional Radiology / Group Health Cooperative Health Care System Seattle /
National Jewish Medical and Research Center / Baylor Health Care System /
Peacehealth / Intermountain Healthcare / Houston Methodist / University of Utah
Health Care / M D Anderson Cancer Center / Texas Health Resources Inc. / Mayo
Clinic / Scott and White Memorial Hospital / Ochsner Health System / Cleveland
Clinic / Nebraska Medical Center / Memorial Sloan Kettering Cancer Center /
Deer's Head Hospital Center / Navy Medicine / H Lee Moffitt Cancer Center &
Research Institute / St Louis Children's Hospital / Allina Health / Gwinnett
Medical Center Lawrenceville Georgia / Dartmouth Hitchcock Medical Center /
Memorial Hermann Northeast Hospital / University of Chicago Hospitals /
University of Virginia Health System / Cincinnati Children's Hospital Medical
Center / Mercy / Edmond Medical Center / MedStar Health / Sanford Health (Union
Hospital Mayville North Dakota) / University of North Carolina Healthcare /
Northwestern Medicine / Arizona State Hospital / Mount Sinai Medical Center New
York / Lahey Clinic / Children's Mercy Hospitals and Clinics / University of
Kentucky Healthcare Good Samaritan Hospital / Fox Chase Cancer Center / Beth
Israel Deaconess Medical Center / Banner Health / Partners Healthcare System /
Texas Heart Institute at St Luke's Episcopal Hospital / Vancouver Island Health
Authority / Advocate Health Care / Children's Healthcare of Atlanta Pediatric
Hospital / Inova Health System Northern Virginia / Froedtert Hospital and
Medical College of Wisconsin / Tricare Military Health System / Johns Hopkins
Medicine / Henry Ford Hospital / Edward Hospital & Health Services / UCLA
University of California Los Angeles Health System / Indiana University Health /
BayHealth Medical Center / Baptist Health System / Children's Hospital of
Philadelphia / St Jude Children's Research Hospital / Georgia Regents Health
System / London Health Sciences Centre / Munson Healthcare (Mercy Hospital
Cadillac) / Kaiser Permanente / Long Island Jewish Medical Center / Nemours
Healthcare for Children / Aurora Health Care / Carolinas Healthcare System /
Seattle Children's Hospital and Medical Center / University Hospitals of
Cleveland Ohio / New York Presbyterian / Lower Manhattan Hospital / Lifebridge
Health / William Beaumont Hospital / Hospital for Special Surgery / University
of Pittsburgh Medical Center / University of Maryland Medical Center / Santé
Montérégie / Sutter Health Hospitals / University Health Network / University of
Iowa Hospitals and Clinics / Fairview Health Services / Rex Healthcare /
Vancouver Coastal Health / City of Hope Duarte – California / Kennedy Krieger
Institute / Childrens Hospital Los Angeles / University of Wisconsin Health /
Alberta Health Services / Fraser Health / Emory Healthcare / Cedars Sinai
Medical Center / Dana Farber Cancer Institute Boston / Centre for Addiction &
Mental Health
Europe:
HELIOS Kliniken Gruppe / Guy's and St Thomas' Hospital NHS / Rigshospitalet /
Norrbottens Lans Landsting / Hôpitaux de Rouen / Kantonsspital St.Gallen / Oslo
University Hospital / Sahlgrenska University Hospital / Erasmus Medisch Centrum
Universitait Medisch Centrum Rotterdam / Universitätsklinikum Dusseldorf /
Centre Hospitalier Universitaire Vaudois Lausanne / NHS Greater Glasgow and
Clyde / Johanniter Krankenhaus / Universitätsklinikum Carl Gustav Carus Dresden
/ Royal Berkshire NHS Foundation Trust / Universitätsklinikum und Medizinische
Fakultät Tübingen / Universitätsklinikum Freiburg / University Clinic Heidelberg
Universittsklinikum Heidelberg / Inselspital Universitatsspital Bern /
Universitätsklinikum Aachen Aör / L’Institut Curie / Karolinska Institute &
University Hospital / Clalit Health Services / Assistance Publique Hôpitaux de
Paris / Hôpitaux Universitaires de Geneve / Uniklinik Köln - Klinikum der
Universitat Zu Köln / Universitätsklinikum Jena Klinikum der Friedrich Schiller
Universität / Universitair Medisch Centrum Utrecht / Instytut Psychiatrii i
Neurologii / UniverstätsSpitals Zürich / Istituto Oncologico Veneto / Leiden
University Medical Center / Leids Universitair Medisch Centrum / Universitair
Ziekenhuis Leuven / Institute of Cancer Research Royal Cancer Hospital /
Universitätsklinikum Hamburg Eppendorf / Universitair Medisch Centrum Groningen
/ Tel Aviv Sourasky Medical Center / Universitätsklinikum Ulm / Hirslanden
Privatklinikgruppe / NHS Fife / Universitätsklinikum Münster / Rhön-Klinikum AG
/ Klinikum der Johannes Gutenberg Universität Mainz / Asklepios Klinikum Bad
Abbach / Universitätsklinikum Magdeburg / Klinik und Poliklinik für Hals Nasen
Ohrenheilkunde Ludwig Maximilians Universität München / Centre Hospitalier
Universitaire de Lyon hôpitaux de Lyon / Krankenhaus der Stadt Dornbirn /
Universitätsklinikum Erlangen / Vu Medical Center Amsterdam
Asia:
Dokkyo Medical University Hospital / Sun Yat-sen University First Affiliated
Hospital / Cancer Institute & Hospital Chinese Academy of Medical Sciences /
Taipei Veterans General Hospital / Institute of Medical Science University of
Tokyo / National Taiwan University Hospital / Clalit Health Services / Assaf
Harofeh Medical Center Tel Aviv University Sackler Faculty of Medicine / Mahatma
Gandhi Institute of Medical Sciences & The Kasturba Hospital / Tata Memorial
Centre / Chang Gung Memorial Hospital / Sankara Nethralaya Hospital / Fortis
Healthcare / Sri Ramachandra University & Medical Centre / Sri Venkateswara
Institute of Medical Sciences / Jaslok Hospital & Research Centre / Hospital
Authority / Buddhist Tzu Chi General Hospital / King Faisal Specialist Hospital
& Research Centre / Beppu National Rehabilitation Center for Persons with Severe
Disabilities / Schneider Children's Medical Center of Israel / Changhua
Christian Hospital Changhua City / Assuta Medical Centers Assuta Hospital /
National Cancer Center Hospital / Sheba Medical Center / L.R.S Institute of
Tuberculosis & Respiratory Diseases / National Center of Neurology and
Psychiatry / Japan Hospital Association / Kyoto University Hospital / Barzilai
Medical Center / Beijing Hospital / Guangdong Provincial TCM Hospital / Max
Healthcare / Jilin University Bethune Hospital - First Hospital of Jilin
University / Apollo Hospitals / Hadassah Medical Organization / Xinqiao Hospital
Third Military Medical University / National Hospital Organization / Peking
Union Medical College Hospital Beijing / National Center for Child Health and
Development National Children's Medical Center Research Institute / Rambam
Health Care Campus / Tel Aviv Sourasky Medical Center / Beijing Maternity
Hospital / Guangzhou City Twelfth People's Hospital / Anhui Provincial Hospital
/ Amrita Institute of Medical Sciences and Research Centre / M.V Hospital for
Diabetes and Diabetes Research Centre
Middle East and other regions:
National Guard Health Care Service / Royal Children's Hospital / Hadassah
Medical Organization / Assaf Harofeh Medical Center Tel Aviv University Sackler
Faculty of Medicine / Kbb Istanbul / Group Florence Nightingale Hastanesi / Dar
Al Fouad Hospital / Babol University Hospitals / Hospital Clínico de la
Universidad de Chile / Royal Adelaide Hospital / Hospital San José Tec de
Monterrey / Riyadh Military Hospital / Arab Contractors Medical Centre / Diani
Beach Hospital Kenya / As Salam International Hospital / Mater Health Services
Brisbane / ACIBADEM / Neuropsychiatric Hospital Aro Abeokuta / Clalit Health
Services / Auckland District Health Board / Austin Health / Memorial Hospital /
Assuta Medical Centers Assuta Hospital / Ege University Medical School &
Hospital / Instituto do Coração do Hospital das Clinicas / Cancer Institute /
Institut Pasteur de Madagascar / INCA Instituto Nacional de Câncer / Ankara
Saglik Müdürlügü / Baskent Universitesi Adana Hastanesi / Hospital El Cruce /
Vkv Amerikan Hastanesi / Baker Heart Research Institute / Gambro Healthcare /
Netcare Group / Hospital Italiano de Buenos Aires / Haydarpasa Gata Arastirma
Hastanesi / Centre Hospitalier Mohammed VI Marrakech / Sheba Medical Center /
Hunter New England Health / Medical Park / Children's Hospital Trust / Baskent
Universitesi Istanbul Tip Fakültesi / Sydney Adventist Hospital / Grupo Médica
Sur / St John of God Health Care / Hospital Israelita Albert Einstein / Ganzouri
Specialized Hospital / Children's Hospital at Westmead / King Edward Memorial
Hospital for Women / Hamad Medical Corporation / Tel Aviv Sourasky Medical
Center / Department Health & Human Services of Tasmania Royal Hobart Hospital /
Hospital de Clinicas de Porto Alegre / Life Healthcare Hospital Group / Rajaei
Cardiovascular, Medical & Research Center / Clínica Alemana de Santiago de Chile
/ Edna Adan Maternity Hospital / Hospital de Câncer de Barretos Fundaçao Pio XII
/ Clínica las Condes / Rambam Health Care Campus / Melomed Hospital Holdings /
Royan Institute Research and Clinical Center for Infertility and Reproductive
Health / King Faisal Specialist Hospital & Research Centre
Universities and Institutes:
Europe:
University of Trieste / University of Milan / Netherlands Institute for
Neuroscience / University of Birmingham / University of Cambridge / Maastricht
University / Maastricht University / Keele University / University of Bordeaux /
Instituto Internacional de Estudios En Seguridad Global / Sapienza University of
Rome / University of Groningen / UCL (University College London) / University of
Pierre and Marie Curie / Imperial College London / King's College London,
University of London / University of St Andrews / The European Institute for
Theoretical Neuroscience / University of Amsterdam / Nottingham Trent University
/ University of Pavia / University of Bristo / Max Planck Society / Radboud
University / University of Bordeaux / Inserm - French National Institute of
Health and Medical Research / University of Gothenburg / Utrecht University /
Université Laval / University of Oxford / Instituto Superior de Estudios
Psicológicos / University of Sheffield / University of Edinburgh / University of
Bonn / Vrije Universiteit Amsterdam / Oxford Brookes University / VU University
Amsterdam / Plymouth University / Irish Institute of Clinical Neuroscience /
University of Nottingham / Dublin Neurological Institute / European Neuroscience
Institute Göttingen / Leiden University / Brain and Spine Foundation / Umg –
Universität / Neurological Institute Foundation Casimiro Mondino / Charité -
Universitätsmedizin Berlin / Bristol University / University College London /
Bournemouth University / Karolinska Institute / Universitat Pompeu Fabra
Barcelona / Esco E-Universitas / Netherlands Institute for Neuroscience /
University of Groningen / Radboud University / Irish Institute of Clinical
Neuroscience / Dublin Neurological Institute / University of Split / University
of Zagreb / European University Cyprus / Johannes Kepler University Linz /
Juraj Dobrila University of Pula / University of Osijek / University of
Rijeka / Bezmialem Vakif University / Biomedical University of Rome / Bogomoletz
Institute of Physiology, Kiev / Bosnia and Herzegovina / Brighton and Sussex
Medical School / Bristol Medical School / Bukovinian State Medical University /
Bülent Ecevit University / Çanakkale Onsekiz Mart University / Cardiff
University School of Medicine / Celal Bayar University / CEU San Pablo
University / Charles University / Christian-Albrecht University of Kiel / Claude
Bernard University Lyon / Crimea State Medical University / Çukurova
Üniversitesi / Cumhuriyet University / D'Annunzio University of Chieti–Pescara /
Danylo Halytsky Lviv State Medical University / David Tvildiani Medical
University / Dicle University / Dnipropetrovsk State Medical Academy / Dokuz
Eylul University / Donetsk National Medical University / Dumlupınar University /
Dundee Medical School / Durham University School of Medicine and Health / Düzce
University / Eberhard Karl University of Tübingen / Emilia-Romagna / Erasmus
Universiteit Rotterdam / Erciyes University / Ernst Moritz Arndt University of
Greifswald / Eskişehir Osmangazi University / Fatih University / Fırat
University / First Pavlov State Medical University of St. Peterburg / François
Rabelais University / Free and Hanseatic City of Hamburg / Free Hanseatic City
of Bremen / Friedrich Schiller University Jena / Friedrich-Alexander University
of Erlangen and Nürnberg / Friuli-Venezia Giulia / Gazi Üniversitesi /
Gaziosmanpaşa University / Georgia-Augusta University of Göttingen / Giresun
University / Glasgow Medical School / Goce Delčev University of Štip / Gomel
State Medical University / Gothenburg University, Institute of Medicine /
Gülhane Military Medical Academy / Hacettepe University / Harran University /
Heidelberg-Mannheim / Heinrich-Heine University of Düsseldorf / Henri Poincaré
University / Hull York Medical School / Humanitas University/ I.M. Sechenov
First Moscow State Medical University / Imperial College School of Medicine /
İnönü University / International University of Goražde / Istanbul Bilim
University / Istanbul Medipol University / Istanbul University Cerrahpaşa /
Istanbul University Istanbul / Ivane Javakhishvili Tbilisi State University /
Ivano-Frankivsk National Medical University / Izhevsk State Medical Academy /
Jean Monnet University / Johann Wolfgang von Goethe University of Frankfurt am
Main / Johannes Gutenberg University of Mainz / Joseph Fourier University /
Julius Maximilian University of Würzburg / Justus-Liebig-Universität Gießen /
Karadeniz Technical University / Karl Landsteiner University of Health Sciences
/ Karolinska Institutet / Katholieke Universiteit Leuven – Faculty of Medicine /
Keele University School of Medicine / Kharkiv Medical Academy of Post-graduate
Education / Kharkiv National Medical University / King's College London School
of Medicine and Dentistry / Kırıkkale University / Koç University / Kocaeli
University / Kursk State Medical University / Kyiv Medical University /
ithuanian University of Health Sciences / Liverpool Medical School /
Ludwigs-Maximilians University of Munich (LMU) / Lugansk State Medical
University / Maltepe University / Manchester Medical School / Marche Polytechnic
University / Marmara University / Martin-Luther University of Halle and
Wittenberg / Masaryk University / Mecklenburg-Western Pomerania / Medical
University of Białystok / Medical University of Gdańsk / Medical University of
Graz / Medical University of Hannover / Medical University of Innsbruck /
Medical University of Łódź / Medical University of Lübeck / Medical University
of Lublin / Medical University of Plovdiv / Medical University of Silesia in
Katowice / Medical University of Sofia / Medical University of Varna / Medical
University of Vienna / Medical University of Warsaw / Medical University Pleven
/ Mersin University / Mevlana University / Miguel Hernández University of Elche
/ Mustafa Kemal University / National O.O. Bogomoletz Medical University /
National University of Ireland / Near East University Faculty of Medicine /
Necmettin Erbakan University / New Vision University / Newcastle University
Medical School / North Rhine – Westphalia / Northern Ireland / Northern State
Medical University / Norwegian University of Science and Technology / Norwich
Medical School at the University of East Anglia / O.O. Bogomolets National
Medical University / Odessa National Medical University / Ondokuz Mayıs
University / Örebro University / Oryol State University Medical Institute /
Otto-Guericke-University of Magdeburg / Ovidius University / Palacký University
of Olomouc / Pamukkale Üniversitesi / Paracelsus Medical University / Paris 12
Val de Marne University / Paris 13 University / Paris Descartes University /
Paris Diderot University / Paris-Sud 11 University / Paul Sabatier University /
Pavol Jozef Šafárik University – Košice / Peninsula College of Medicine and
Dentistry / People's Friendship University / Petre Shotadze Tbilisi Medical
Academy / Philipps University of Marburg / Pierre and Marie Curie University /
Pomeranian Medical University in Szczecin / Poznań University of Medical
Sciences / Queen's University Belfast Medical School / Radboud University
Nijmegen / Republic of Macedonia / Rhenish Friedrich Wilhelm University of Bonn
/ Rhenish Westphalian Technical University of Aachen / Rhineland-Palatinate /
Riga Stradiņš University / Rostov-on-Don State Medical University / Royal
College of Surgeons in Ireland / Ruprecht Karl University of Heidelberg /
Russian Education Center REC-Russian Education Center / Saba University School
of Medicine / Saint Camillus International University of Health and Medical
Sciences / Saint George's Medical School in Cyprus / Saint Petersburg State
Medical Academy / Schleswig-Holsatia / School of Clinical Medicine, University
of Cambridge / Selçuk University / Semmelweis University of Medical Sciences /
Sheffield Medical School / Slovak Medical University – Bratislava /
Smolensk State Medical Academy / Sofia University – Faculty of Medicine /
Southampton Medical School / St George's, University of London / St. Cyril and
Methodius University / St. Petersburg State University / St. Theresa's Medical
University of Yerevan / State University of Tetovo / Süleyman Demirel
Üniversitesi / Sumy State University / Swansea University Medical School /
Tbilisi State Medical University, Georgia / Technical University of Munich (TU)
/ Ternopil State Medical University / The International Academy of Ecology and
Medicine / The National Hospital / The State Medical and Pharmaceutical
University "Nicolae Testemiţanu" / Titu Maiorescu University / Trakia
University of Stara Zagora / Trakya University / Transylvania University of
Brașov / Turgut Özal University / Tver State Medical University / UCL Medical
School / Ufuk University / Ukrainian Medical and Dental Academy / Uludağ
Üniversitesi / Umeå University, Faculty of Medicine / Universidad Alfonso X El
Sabio / Universidad Autónoma de Madrid / Universidad CEU Cardenal Herrera /
Universidad Complutense de Madrid / Universidad de Alcalá / Universidad de Cádiz
/ Universidad de Cantabria / Universidad de Córdoba / Universidad de
Extremadura/ Universidad de Granada / Universidad de La Laguna / Universidad de
Las Palmas de Gran Canaria / Universidad de Málaga / Universidad de Murcia /
Universidad de Navarra / Universidad de Oviedo / Universidad de Salamanca /
Universidad de Santiago de Compostela / Universidad de Sevilla / Universidad de
Valladolid / Universidad de Zaragoza / Universidad Europea de Madrid /
Universidad Francisco de Vitoria / Universidad Rey Juan Carlos / Universidade
Nova de Lisboa / Universita Cattolica del Sacro Cuore / Universitaires
Notre-Dame de la Paix / Universitat Autònoma de Barcelona/ Universitat de
Barcelona / Universitat de Girona / Universitat de Lleida / Universitat de
València / Universitat des Saarlandes / Universitat Internacional de Catalunya /
Universität Rostock / Universitat Rovira i Virgili / Universitätsklinikum
Benjamin Franklin / Université Catholique de Louvain / Université de Liège /
Université de Mons / Université Libre de Bruxelles / Université Lille Nord de
France / Universiteit Antwerpen / Universiteit Gent / Universiteit Hasselt /
University College Cork / University College Dublin / University Hospital /
University Hospitals of the Ruhr-Universität Bochum / University Medicine
Berlin of Freie Universität Berlin / University of Aberdeen School of Medicine /
University of Algarve / University of Angers / University of Antilles-Guyane /
University of Athens / University of Auvergne / University of Banja Luka /
University of Bari / University of Basel / University of Beira Interior /
University of Belgrade / University of Bergen / University of Berne / University
of Birmingham Medical School / University of Bologna / University of Brescia /
University of Burgundy / University of Caen Lower Normandy / University of
Cagliari / University of Castilla–La Mancha / University of Catania / University
of Catanzaro / University of Coimbra / University of Cologne / University of
Copenhagen / University of Crete / University of Cyprus / University of
Debrecen Medical School / University of Defence / University of Duisburg-Essen /
University of East Sarajevo / University of Eastern Finland / University of
Eastern Piedmont / University of Edinburgh Medical School / University of
Ferrara / University of Florence / University of Foggia / University of
Franche-Comté / University of Fribourg / University of Galați / University of
Gaziantep / University of Geneva / University of Genoa / University of Groningen
/ University of Hamburg / University of Helsinki / University of Iceland /
University of Insubria / University of Ioannina / University of Kragujevac /
University of L'Aquila / University of Latvia / University of Lausanne /
University of Leiden / University of Limerick / University of Limoges /
University of Lisbon / University of Ljubljana / University of Malta /
University of Maribor / University of Medicine and Pharmacy / University of
Medicine and Pharmacy of Craiova / University of Medicine and Pharmacy of Târgu
Mureş / University of Messina / University of Minho / University of Modena and
Reggio Emilia / University of Molise / University of Montenegro / University of
Montpellier / University of Mostar / University of Nantes / University of
Naples / University of New Caledonia / University of Nice Sophia Antipolis /
University of Nicosia Medical School / University of Nis / University of
Nottingham Medical School / University of Novi Sad / University of Oldenburg /
University of Opole / University of Oradea / University of Ostrava / University
of Oulu / University of Parma / University of Patras / University of
Pécs Medical School / University of Perugia / University of Picardy / University
of Pisa / University of Poitiers / University of Porto / University of Pristina
/ University of Regensburg / University of Reims Champagne-Ardenne / University
of Rennes / University of Rome La Sapienza / University of Rome Tor Vergata /
University of Rouen / University of Salerno / University of Sarajevo /
University of Sassari / University of Siena / University of Southern Denmark /
University of St Andrews School of Medicine / University of Strasbourg /
University of Tampere / University of Tartu / University of the Basque Country /
University of Thessaloniki / University of Thessaly / University of Thrace /
University of Traditional Medicine / University of Trieste / University of
Tromsø / University of Turin / University of Turku / University of Tuzla /
University of Udine / University of Ulm / University of Verona / University of
Western Brittany / University of Zurich / Uppsala University Faculty of Medicine
/ Uzhhorod National University / Van Yüzüncü Yıl Üniversitesi / Victor Segalen
Bordeaux 2 University / Vilnius University / Vinnytsia State M.I. Pirogov
Memorial Medical University / Volgograd State Medical University /
Voronezh State Medical Academy / Vrije Universiteit Brussel / VU University
Medical Center Amsterdam, Faculty of Medicine / Warwick Medical School /
Westphalian University of Münster / Witten/Herdecke University / Wrocław Medical
University / Yeditepe University / Yerevan State Medical University / Yıldırım
Beyazit Universitesi / Zaporizhia State Medical University
North America:
John Hopkins School of Medicine / University of Pennsylvania / New York
University / University of Washington / University of Southern California /
Boston University / Yale University / Washington University / University of
California, San Diego / Vanderbilt University / University of Chicago / Duke
University / University of North Carolina Chapel Hill / Emory University / Brock
University / Laurentian University / University of Alberta / University of
Guelph / McMaster University / Dalhousie University / Concordia University /
Carleton University / University of Calgary / Western University / The
University of Winnipeg / Harvard University / Stanford University / University
of California, San Francisco / Massachusetts Institute of Technology (MIT) /
Columbia University / University of California, Los Angeles (UCLA) / Washington
University in St. Louis / University of Toronto / McGill University / University
of Washington / University of California, Berkeley / Duke University /
University of Pittsburgh / University of Rochester / Northwestern University /
University of British Columbia / Princeton University / Baylor College of
Medicine / Icahn School of Medicine at Mount Sinai / University of Michigan /
University of North Carolina Chapel Hill / University of California Irvine (UCI)
/ Cornell University / California Institute of Technology - Caltech / University
of Minnesota Twin Cities / University of California, Davis / University of
Wisconsin Madison / University of Texas Southwestern Medical Center / Brown
University / Rush University / The Ohio State University / University of Miami /
University of Maryland Baltimore / Yeshiva University / University of Colorado
at Boulder / Oregon Health & Science University / University of Iowa / Case
Western Reserve University / University of Florida / The University of Alabama
at Birmingham / University of Cincinnati / Rutgers University / University of
Utah / Carnegie Mellon University / Indiana University Bloomington / Medical
University of South Carolina / University of Arizona / Tufts University /
Virginia Commonwealth University / University of Kentucky / Dartmouth College /
Stony Brook University / Indiana University - Purdue University Indianapolis /
University of Ottawa / Philadelphia University / University of Kansas /
University of Southampton / Augusta University / Georgetown University /
McMaster University / Thomas Jefferson University
Asia:
Chulalongkorn University / Tsinghua University / Kyushu University / Hokkaido
University / Sri Ram Chandra Bhanja Medical College and Hospital / Tohoku
University / National Taiwan University (NTU) / National Yang-Ming University /
Madras Medical College, Chennai / All India Institute of Medical Sciences, New
Delhi / Osaka University / Nagoya University / Fudan University /
National Institute of Mental Health and Neuro Sciences (NIMHANS) / The Hong Kong
University of Science and Technology (HKUST) / Keio University International
Center / Thrissur Govt. Medical College, Thrissur / Government Medical College,
Kozhikode / Peking University / Government Medical College, Thiruvananthapuram /
Institute of Post Graduate Medical Education and Research - [IPGMER], Kolkata /
Taipei Medical University / Kasturba Medical College, Mangalore / Indian
Institute of Technology Bombay (IITB) / Kyoto University / Pohang University of
Science and Technology (POSTECH) / KAIST - Korea Advanced Institute of Science
and Technology / University of Hong Kong (HKU) / Seth GS Medical College, Mumbai
/ Capital University of Medical Sciences / Mahidol University / Nanyang
Technological University (NTU) / University of Delhi / SMS Medical College,
Jaipur / Jawaharlal Institute of Post Graduate Medical Education and Research,
Pondicherry / Christian Medical College, Vellore / King George's Medical
University, Lucknow / National University of Singapore (NUS) / Korea University
/ Beijing Normal University / University Putra Malaysia (UPM) / Kyung Hee
University / Grant Medical College and Sir J. J. Group of Hospitals, Mumbai /
University Sains Malaysia (USM) / Sungkyunkwan University / Sri Ramachandra
Institute of Higher Education and Research, Chennai / University of the
Philippines / Shanghai Jiao Tong University / University of Science and
Technology of China / The Chinese University of Hong Kong (CUHK) / Yonsei
University / The University of Tokyo
Middle East and other countries:
University of Cape Town / Bar Ilan University / University of South Africa /
University of Queensland / King Saud University / Tel Aviv University / Ben
Gurion University of the Negev / University of Johannesburg / University of
Nairobi / University of Adelaide / University of Tehran / University of the
Western Cape / University of Pretoria / Weizmann Institute of Science /
University of Kwazulu Natal / University of New South Wales / University of
Melbourne / Monash University / University of the Witwatersrand / Tehran
University of Medical Sciences / Stellenbosch University / University of
Auckland / Cairo University / Hebrew University of Jerusalem / University of
Haifa / Technion Israel Institute of Technology / King Abdulaziz University /
Australian National University / University of Sydney
Top Neurology Companies:
Europe:
AstraZeneca / Fujirebio Europe / Galen Limited / Bristol-Myers Squibb /
OncoVison / Intento SA / Brainomix / reHaptix GmbH / Mintlabs / Advanced
Accelerator Applications / To – BBB / DIVIDAT GMBH / Santhera Pharmaceuticals /
Avergen / BioCrea / Vasopharm / BTG plc / Neurim Pharmaceuticals / Newron
Pharmaceuticals
USA:
Teva / Biogen / Novartis / Janssen / Pfizer / Sanofi / Allergan / Takeda /
Trevena / Medivation / AceIRx Pharmaceuticals / Selonterra / NeuroGenetic
Pharmaceuticals / Neuropore Therapies / Neurocrine Biosciences / Denali
Therapeutics / Cortexyme / Kezar Life Sciences / CANTA Bio / Aoxing
Pharmaceutical / Cell>Point / NeuroSearch / Karuna Pharmaceuticals / Santhera
Pharmaceuticals / EIP Pharma / Euthymics Biosciences / ADispell
Asia:
Qilu Pharmaceutical / Eisai / Rongchang / China Chemical & Pharmaceutical Co.
Ltd / Sun Pharmaceutical Industries Ltd. / Aurobindo Pharma / Torrent
Pharmaceuticals / Cadila Healthcare / Piramal Enterprises / Glenmark
Pharmaceuticals / Biocon / Harbin Pharmaceutical Group / China National
Pharmaceutical Group / Sinopharm Group / North China Pharmaceutical Group Corp /
China Nepstar / WuXi AppTec / Tong Ren Tang
Jobs Opportunities in Neurology:
Europe:
Locum Consultant Neurologist / Sr CRA II - CNS - (United Kingdom) /
Administration Specialist / Product Manager / Marketing - Student Placements
2018 / Clinical Trial Administrator / International Market Access Director /
Neurology Consultant – Yorkshire Contract Clinical Project Manager / Acute
Paediatric Speech and Language Therapist / Senior Account Executive / Senior
Audiologist / Account Manager / Junior Specialist Doctors – Lower / Neurology
SpR/Consultant – Norfolk / Trust Grade Doctor in Stroke Medicine / Clinical
Sales Application Specialist - Blood Analysis / SMA Senior Medical Manager /
Registered Nurse - Trustwide / Experienced Registered Nurse - Neurosciences /
Sister/ Charge Nurse / Consultant in Diagnostic/Interventional Neuroradiology /
Junior Specialist Doctor (Standard) in Neurology / Staff Nurse / Paediatric
Department - Staff Nurse / Locum Band 6/7 Adults Speech and LanguageTherapist /
Branch Manager/Sales & Marketing - Medical Technology / Consultant in
Diagnostic/Interventional Neuroradiology / Senior Staff Nurse / Medical Manager
/ Medical Sales - Mobile Operating Theatres / Consultant Neurologist / Clinical
Study Physician (Neurology) / Medical Manager – Neurology / Senior Medical
Advisor – Immunology / European Medical Director – Psychiatry / Director of
Clinical Research – Neurology / Senior Medical Manager, EMEA Neurology / Senior
Medical Manager – Neuro
USA:
Physician – Neurologist / Neurology Physician / Neurologist - UnityPoint Clinic
- Multi-Specialty Clinic / Research Assistant / Neonatal Neurology Faculty /
Neurosurgeon / Neurologist – Interventional / Subspecialty Academic Neurologist
/ Outpatient Neurologist / Neurologist - Willowbrook / Child Neurologist
/ NeuroMuscular - Neurologist - St. Anthony Hospital / Stroke Neurologist /
Neurologist - Headache Job / Neurodiagnostic Technician / Neurologist Physician
Elizabeth, NJ Consultant / Research Associate III - Neuroscience & Cell Biology
/ Board Certified Neurologist / Veterinarian- Neurologist / Neurohospitalist
Opportunity in Sunny Central Florida / Neurologist (Sunport) / Physician MD/DO
In~Patient Neurologist / Neurologist- Mercy Hospital Jefferson, MO / Clinical
Academic Movement Disorder Neurologist / Clinical Academic Movement Disorder
Neurologist / Reading Physician – Neurologist / Neurologist Opportunity - Mercy
Hospital Washington / Neurologist for West Palm Beach / Physician - Neurologist
- Escanaba, MI / Neurologist- Allen Memorial Hospital / Medical Research
Specialist / Neurologist-Vascular / Neurology Opportunity Orlando, Florida /
Outpatient Neurologist - Northwest Neurology / Neurologist / Neurologist
Physician San Francisco, CA Consultant / Neuromuscular Neurologist /
Neurologist-Multiple Sclerosis Job / Neurologist – General / Neurologist –
Neurophysiology / Cerebrovascular Neurologist / Instructor or Assistant
Professor / Neurologist Physician Elizabeth, NJ Consultant / Neurologist –
Pearland / Neuroscience Intern / Neurologist - Central WI / Clinical
Neurologist: Multiple Sclerosis and Neuroimmunology / Neurophysiologist -
Jacksonville, FL
Asia:
Associate Consultant/ Consultant- DM Neurology / Consultant Doctor / Neuro
Surgeon / Specialized and Super specialized Doctors / Associate Consultant /
Neuro ICU/NCCU/Neuroscience Critical Care Unit-Nurse Manager / Orthopedic
Neurology RN / Chief of Medical Staff / Pediatric Dentistry Consultant / Cancer
Center Service Manager / Neuropsychiatrist / Stroke Neurologist / Research
Associate / Researcher
Neurology Journals:
Acta Neurochirurgica / Acta Neurochirurgica, Supplement / Acta Neurologica
Belgica / Acta Neurologica Scandinavica / Acta Neurologica Taiwanica / Acta
Neuropathologica / Acta neuropathologica communications / Activitas Nervosa
Superior / Acupuncture in Medicine / Advances in Alzheimer's Disease / Advances
in Autism / Aging and Disease / Aktualnosci Neurologiczne / Aktuelle Neurologie
/ Aktuelle Neurologie, Supplement / Alzheimer's and Dementia / Alzheimer's and
Dementia: Diagnosis, Assessment and Disease Monitoring / Alzheimer's and
Dementia: Translational Research and Clinical Interventions / Alzheimer's
Research and Therapy / American Journal of Neuroradiology / American Journal on
Intellectual and Developmental Disabilities / Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration / Annals of Clinical and Translational Neurology /
Annals of Indian Academy of Neurology / Annals of Neurology / Annual Review of
Vision Science / Aphasiology / Archives of Neuroscience / Archivos de
Neurociencias / Arquivos de Neuro-Psiquiatria / ASN Neuro / Autism Research /
Autonomic Neuroscience: Basic and Clinical / Basal Ganglia / Basic and Clinical
Neuroscience / Behavioral Sleep Medicine / Behavioural Neurology / Biological
Psychiatry: Cognitive Neuroscience and Neuroimaging / BMC Neurology / Brain /
Brain and Development / Brain and nerve = Shinkei kenkyu no shinpo / Brain
Imaging and Behavior / Brain Impairment / Brain Injury / Brain Pathology / Brain
Research / Brain Stimulation / Brain Topography / Brain Tumor Pathology /
British Journal of Neuroscience Nursing / British Journal of Neurosurgery /
Canadian Journal of Neurological Sciences / Cardiovascular Psychiatry and
Neurology / Case Reports in Neurology / Cephalalgia / Cerebellum /
Cerebrovascular Diseases / Cerebrovascular Diseases Extra / Ceska a Slovenska
Neurologie a Neurochirurgie / Child's Nervous System / Chinese Journal of
Cerebrovascular Diseases / Chinese Journal of Contemporary Neurology and
Neurosurgery / Chinese Journal of Neurology / Clinical and Experimental
Neuroimmunology / Clinical Autonomic Research / Clinical EEG and Neuroscience /
Clinical Journal of Pain / Clinical Neurology / Clinical Neurology and
Neurosurgery / Clinical Neuropathology / Clinical Neuropharmacology / Clinical
Neurophysiology / Clinical Neurophysiology Practice / Clinical Neuroradiology /
Clinical neurosurgery / Clinical Spine Surgery / CNS Drugs / CNS Spectrums /
Coluna/ Columna / Confinia Cephalalgica / CONTINUUM Lifelong Learning in
Neurology / Cortex / Current Alzheimer Research / Current Neurology and
Neuroscience Reports / Current Neuropharmacology / Current Opinion in Neurology
/ Current Pain and Headache Reports / Current Treatment Options in Neurology
/ Dementia e Neuropsychologia / Der Nervenarzt / Deutsche Zeitschrift für
Akupunktur / Developmental Medicine and Child Neurology / Diagnostics in
Neuropsychiatry / Douleurs / Dusunen Adam / Egyptian Journal of Neurology,
Psychiatry and Neurosurgery / Epilepsia / Epilepsy and Behavior / Epilepsy and
Behavior Case Reports / Epilepsy and Seizure / Epilepsy Currents / Epilepsy
Research / Epilepsy Research and Treatment / Epileptic Disorders / Epileptology
/ Equilibrium Research / European Journal of Neurology / European Journal of
Paediatric Neurology / European Neurological Review / European Neurology /
European Neuropsychopharmacology / European Stroke Journal / Experimental
Neurobiology / Expert Review of Neurotherapeutics / Focus on Autism and Other
Developmental Disabilities / Focus on Parkinson's Disease / Folia
Neuropathologica / Fortschritte der Neurologie Psychiatrie / Frontiers in
Neurology / Frontiers of Neurology and Neuroscience / Functional Neurology /
Future Neurology / Geriatrie et Psychologie Neuropsychiatrie du Vieillissement /
Global Spine Journal / Handbook of Clinical Neurology / Head and Face Medicine /
Headache / Human Brain Mapping / Human Psychopharmacology / Ideggyogyaszati
Szemle / Innovations in Clinical Neuroscience / Interdisciplinary Neurosurgery:
Advanced Techniques and Case Management / International Journal of Alzheimer's
Disease / International Journal of Epilepsy / International Journal of
Functional Informatics and Personalised Medicine / International Journal of MS
Care / International Journal of Nutrition, Pharmacology, Neurological Diseases
/ International Neurourology Journal / International Review of Neurobiology /
Internet Journal of Neurology / Interventional Neuroradiology / Iranian Journal
of Child Neurology / Iranian Journal of Neurology / JAMA Neurology / Japanese
Journal of Neurosurgery / Journal für Neurologie, Neurochirurgie und Psychiatrie
/ Journal of Brachial Plexus and Peripheral Nerve Injury / Journal of Cerebral
Blood Flow and Metabolism / Journal of Child Neurology / Journal of Clinical and
Experimental Neuropsychology / Journal of Clinical Neurology / Journal of
Clinical Neuromuscular Disease / Journal of Clinical Neurophysiology / Journal
of Clinical Neuroscience / Journal of Clinical Sleep Medicine / Journal of
Craniovertebral Junction and Spine / Journal of Electromyography and Kinesiology
/ Journal of Experimental Stroke and Translational Medicine / Journal of
Geriatric Psychiatry and Neurology / Journal of Head Trauma Rehabilitation /
Journal of Headache and Pain / Journal of Huntington's disease / Journal of
Intellectual Disability - Diagnosis and Treatment / Journal of Intellectual
Disability Research / Journal of Korean Neurosurgical Society / Journal of
Neural Transmission / Journal of Neurodegenerative Diseases / Journal of
Neurodevelopmental Disorders / Journal of Neuroendovascular Therapy / Journal of
Neurogastroenterology and Motility / Journal of Neuroimaging / Journal of
Neuroimmunology / Journal of NeuroInterventional Surgery / Journal of Neurologic
Physical Therapy / Journal of Neurological Sciences / Journal of Neurological
Surgery Reports / Journal of Neurological Surgery, Part B: Skull Base / Journal
of Neurological Surgery. Part A: Central European Neurosurgery / Journal of
Neurology / Journal of Neurology, Neurosurgery and Psychiatry / Journal of
Neuromuscular Diseases / Journal of Neuro-Oncology / Journal of
Neuro-Ophthalmology / Journal of Neuropathology and Experimental Neurology /
Journal of Neuropsychiatry and Clinical Neurosciences / Journal of
Neuroradiology / Journal of Neuroscience Nursing / Journal of Neurosciences in
Rural Practice / Journal of Neurosurgery / Journal of Neurosurgery: Pediatrics /
Journal of Neurosurgery: Spine / Journal of Neurosurgical Anesthesiology /
Journal of Neurosurgical Sciences / Journal of Neurotrauma / Journal of
NeuroVirology / Journal of Oral & Facial Pain and Headache / Journal of Pain /
Journal of Pain and Symptom Management / Journal of Parkinson's Disease /
Journal of Pediatric Epilepsy / Journal of Pediatric Neurology / Journal of
Pediatric Neuroradiology / Journal of Spinal Cord Medicine / Journal of Spinal
Disorders and Techniques / Journal of Stroke / Journal of Stroke and
Cerebrovascular Diseases / Journal of the History of the Neurosciences / Journal
of the International Neuropsychological Society / Journal of the Japan Epilepsy
Society / Journal of the Neurological Sciences / Journal of the Peripheral
Nervous System / Journal of Vestibular Research: Equilibrium and Orientation /
Klinische Neurophysiologie / Kranion / Medecine du Sommeil / Metabolic Brain
Disease / Molecular Neurodegeneration / Motor Control / Motricite Cerebrale
Readaptation Neurologie du Developpement / Movement Disorders / Multiple
Sclerosis / Multiple Sclerosis and Related Disorders / Multiple Sclerosis
International / Muscle and Nerve / Nature Reviews Neurology / Nervenheilkunde /
Neural Plasticity / Neurobiology of Aging / Neurobiology of Sleep and Circadian
Rhythms / Neurocase / Neurochirurgie / Neurocirugia / Neurocritical Care /
Neurodegenerative disease management / Neurodegenerative Diseases /
Neuroendocrinology Letters / Neuroepidemiology / Neuroforum / NeuroImage:
Clinical / Neuroimaging Clinics of North America / Neurologia / Neurologia
Argentina / Neurologia Croatica / Neurologia i Neurochirurgia Polska /
Neurologia Medico-Chirurgica / Neurologic Clinics / Neurological Research /
Neurological Sciences / Neurological Surgery / Neurologie und Rehabilitation /
Neurologist / Neurology / Neurology and Clinical Neuroscience / Neurology and
Therapy / Neurology Asia / Neurology India / Neurology International / Neurology
Psychiatry and Brain Research / Neurology Research International / Neurology:
Clinical Practice / Neurology: Neuroimmunology and NeuroInflammation /
Neuromodulation / Neuromuscular Disorders / Neuro-Oncology / Neuro-Ophthalmology
/ Neuropathology / Neuropathology and Applied Neurobiology / Neuropediatrics /
Neurophysiologie Clinique / Neuropsychiatry / Neuroradiology / Neuroradiology
Journal / NeuroRehabilitation / Neurorehabilitation and Neural Repair /
Neurosciences / Neuroscientist / Neurosurgery / Neurosurgery Clinics of North
America / Neurosurgery Quarterly / Neurosurgical Focus / Neurosurgical Review /
Neurotherapeutics / Neurourology and Urodynamics / Nevrologicheskii Zhurnal /
Nevrologiya, Neiropsikhiatriya, Psikhosomatika / No To Hattatsu / NPG Neurologie
- Psychiatrie – Geriatrie / Open Forum Infectious Diseases / Open Neurology
Journal / Open Neurosurgery Journal / Open Spine Journal / Operative
Neurosurgery / Otology and Neurotology / Pain / Pain Medicine / Pain Research
and Treatment / Parkinsonism and Related Disorders / Parkinson's Disease /
Pediatric Neurology / Pediatric Neurosurgery / Postepy Psychiatrii i Neurologii
/ Practical Neurology / Pratique Neurologique – FMC / Progress in Neurological
Surgery / Progress in Neurology and Psychiatry / Psychiatry and Clinical
Neurosciences / Restorative Neurology and Neuroscience / Revista Brasileira de
Neurologia e Psiquiatria / Revista Chilena de Neuro-Psiquiatria / Revista de
Neurologia / Revista Ecuatoriana de Neurologia / Revista Mexicana de
Neurociencia / Revista Neurociencias / Revue Neurologique / Romanian Journal of
Neurology/ Revista Romana de Neurologie / Scandinavian Journal of Pain /
Schizophrenia Research and Treatment / Schmerz / Schweizer Archiv für Neurologie
und Psychiatrie / Seizure : the journal of the British Epilepsy Association /
Seminars in Neurology / Seminars in Pediatric Neurology / Sleep / Sleep and
Breathing / Sleep Medicine Clinics / Sleep Medicine Reviews / Spinal Cord/ Spine
/ Spine Journal Stereotactic and Functional Neurosurgery / Stroke / Stroke
Research and Treatment / Surgical Neurology International / The Lancet Neurology
/ The Neurodiagnostic journal / Therapeutic Advances in Neurological Disorders /
Topics in Spinal Cord Injury Rehabilitation / Topics in Stroke Rehabilitation /
Translational Neurodegeneration / Translational Stroke Research / Turk Noroloji
Dergisi / Turkish Neurosurgery / US Neurology / World Neurosurgery / Zeitschrift
für Epileptologie / Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova /
Zhurnal Voprosy Neirokhirurgii Imeni N.N. Burdenko
Motives to be at NEURO Conclave 2024:
1. Content to guide in your future research:
Neurology Conferences will help you to give a new way or path to your
studies in the field. You can get a lot of ideas for your current research
to draw a conclusion of your current work or you will get a better idea of
where to invest your time and research. Neurology Conferences will shape
your future with you to get the best out in you.
2. Get to know and learn most recent advancements:
If you wish to know most of the recent research and advancements made in the
field of Neurology, Neuroscience, and Neurosurgery, we suggest you attend
Neurology Conferences 2024. This Neurology Conferences will give you
promising research ideas as well.
3. Discuss the various aspects of research and get intriguing ideas for
research:
Neurology Conferences will give you various facets of research being
delivered at the stage. This will help you to evaluate you’re your own
research with a new perspective. Neurology Conferences will serve those who
seek to research in this field by providing those tons of ideas to ponder
and to invest their valuable time to achieve their lifetime goal.
4. Self-improvement:
Neurology Conferences will help you to improve yourself and your research by
getting various insights from eminent personalities of the field. Neurology
Conferences 2024 will show where you lag in your research, where you should
put efforts and how to maximize your research with accuracy, will guide you
to have a better future as a Researcher.
5. Networking with your peers:
Neurology Conferences will give the best opportunity to interact with your
peers and your superiors to g=exchange some novel ideas and will provide you
a chance to build a strong professional relationship between you and the
attendees. Neurology Conference 2024 will do so through networking sessions.
6. Witness the revelation of recent research:
Neurology Conferences will reveal some of the most recent studies and
researches in Paris. These intriguing and informative studies will affect
young researchers and students and motivate them to study hard. This will
inspire them to invest time in their own research and in the future, they
will reveal their crucial researches through Neurology Conferences 2024.
7. Get every bit what you had paid:
Neurology Conferences is committed and bound to produce a successful
conference. We are trying to accumulate world-class speakers with great
research to reveal at Neurology Conferences 2024. This is possible only when
we will have your support as well. So please do share the words of the
conference with your colleagues and contacts so that we have the most number
of participants.
8. Inspiration and motivation to achieve new heights:
Neurology Conferences is the one that will inspire you to achieve new
milestones in research by giving ideas and fuel to the ideas you have.
Neurology Conferences 2024 will help you to get your dreams to come true by
making you realize that you have the potential to unleash your acumen by
your researches.
* Max Seats
15 SEATS
* Speaker Time
20 MINS
* Workshop Proposal
CLICK HERE
30% OFF ON EARLY BIRD REGISTRATIONS
Contact us now and we will make your event unique & unforgettable
register now
Here are some fascinating facts
ABOUT NEURO CONCLAVE 2025
GEOGRAPHIC REGION
All numbers indicates percentage %
49
Europe
26
North America
7
Middle East
17
Asia Pacific
1
Africa
AUDIENCE DEMOGRAPHICS
All numbers indicates percentage %
16
Neurologists & Neuroscientists
14
Neurosurgeons
26
Researchers, R & D Institutes
12
Academicians
10
Doctors
11
Business & Industry
7
Students
4
Others
KEY FACTS
1 20 INNOVATIVE START-UPS AND TOP ENTERPRISES
2 100+
DISTINGUISHED SPEAKERS
3 15+
KEYNOTE SPEAKERS
4 15+ WORKSHOPS & TRAINING COURSES
5 REPRESENTATION FROM INDUSTRIES
6 REPRESENTATION FROM 100+ WORLD'S PREMIER UNIVERSITIES
7 B2B MEETINGS
EXPERT PICKS-TOP TRENDING ABSTRACTS
STRESS-INDUCED ENDOCRINE AND METABOLIC DISORDERS
HASSAN M. HESHMATI
ENDOCRINOLOGY METABOLISM CONSULTING, LLC, USA
Stress is a universal non-specific response to any pressure or demand. It is a
condition caused by a stressor. In humans, the stressor can be a variety of
factors (e.g., physical activity, extreme temperature, noise, workload,
financial difficulties, violence, disease, and death of a loved one). Stress
disturbs the equilibrium b
Loading...
View More
CIRCUIT FORMATION AND SENSORY PERCEPTION IN THE MOUSE OLFACTORY SYSTEM
HITOSHI SAKANO
UNIVERSITY OF FUKUI, JAPAN
In the mouse olfactory system, odor information is converted to a topographic
map of activated glomeruli in the olfactory bulb. Although the arrangement of
glomeruli is genetically determined, the glomerular structure is plastic and can
be modified by environmental odor stimuli. If the pups are exposed to a
particular odorant,
Loading...
View More
BRAIN MICROVASCULAR ENDOTHELIAL CELLS POSSESS SECOND CILIUM THAT ARISES FROM THE
DAUGHTER CENTRIOLE
RAMANI RAMCHANDRAN
MEDICAL COLLEGE OF WISCONSIN, USA
Primary cilia are microtubule-based structures that are found in most eukaryotic
cells and are specialized organelles that compartmentalize cell signaling
molecules. In brain endothelial cells (ECs), cilia are blood flow sensors, and
respond to flow by increasing intracellular calcium levels. In addition to flow
sensing, endothe
Loading...
View More
UNDERSTANDING EXECUTIVE FUNCTIONING EF DEFICITS INHERENT IN ADHD AND AUTISM ASD
MARY HYNES DANIELAK
THE COUNSELING AND DEVELOPMENT CENTER ALPHARETTA, USA
Executive Functions (EF) are a topic that is often thrown around loosely by both
parents and professionals without a clear understanding of what are the specific
EF’s and how they manifest. Even professionals can´t agree on how many executive
functions exist. These functions are core deficits in ADHD, ASD, and other
disorders
Loading...
View More
BRAIN INJURY AND PRISON OVER-REPRESENTATION, PREVENTION AND REFORM
MOLLY TOWNES O’BRIEN
ANU COLLEGE OF LAW, AUSTRALIA
Background People who have suffered a brain injury are significantly
over-represented in prisons around the world. Compared to the general
population, people in prison are more than five times as likely to have had a
brain injury. Brain injuries may have multiple ongoing symptoms which lead to
the commission of criminal offens
Loading...
View More
A CASE SERIES OF MANIC DELIRIUM LIFE SAVING TREATMENT FOR PATIENTS IN RURAL
AREAS
BENJAMIN KOPEC
GREAT SOUTHERN MENTAL HEALTH SERVICE, AUSTRALIA
Manic delirium is an ill-defined, but serious diagnosis. It is a complex
neuropsychiatric syndrome with considerable morbidity and mortality outlined by
acute mania with features of delirium not otherwise precipitated my medical or
neurological conditions. Presentations of manic delirium typically involve
disturbances in thought
Loading...
View More
SERTRALINE ASSOCIATED WITH GOLD NANOPARTICLES REDUCE CELLULAR TOXICITY AND
INDUCE SEX-SPECIFIC RESPONSES IN BE...
HELENA MENDES ABELAIRA
UNIVERSITY OF SOUTHERN SANTA CATARIN (UNESC), BRAZIL
This study aimed to evaluate the effects of sertraline associated with gold
nanoparticles (AuNPs) in vitro cell viability and in vivo behavior and
inflammatory biomarkers in a mouse model of anxiety. Sertraline associated with
AuNPs were synthesized and characterized. For the in vitro study, NIH3T3 and
HT-22 cells were treated w
Loading...
View More
PRENATAL DIAGNOSIS OF FETAL CORTICAL DEVELOPMENTAL MALFORMATIONS USING 3D-ICRV
RENDERING TECHNOLOGY
YIMEI LIAO
SHENZHEN MATERNITY & CHILD HEALTHCARE HOSPITAL, CHINA
This study aimed to assess the correlation between abnormal SF on intrauterine
neurosonography and MCD, and to explore the value of Whole-Genome Sequencing
(WGS) in prenatal detection. This was a prospective study of fetuses with a
sonographic diagnosis of abnormal SF between 2018 and 2020. Intrauterine and/or
postnatal MRI ex
Loading...
View More
GENETIC ETIOLOGY AND PROGNOSIS OF FETUSES WITH LATERAL FI SSURE ANGLE 0 ON
TRANSTHALAMIC PLANE
QING ZENG
SHENZHEN MATERNITY AND CHILD HEALTHCARE HOSPITAL, CHINA
To explore the etiology and prognosis of fetuses with a lateral fissure angle
<0° on the transthalamic plane. A total of 62 cases of fetuses with a lateral
fissure angle <0° detected by ultrasound examination in Shenzhen Maternity and
Child Healthcare Hospital were collected. Prenatal/postnatal genetic testing was
performed,
Loading...
View More
A huge thanks to all our amazing partners.
We couldn’t have a conference without you!
WE HAVE BEST PARTNERS & CLIENTS
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
×
Your message has been sent. Thank you!
About
About Conference Venue & Hospitality Accommodation
Poster Guidelines
Our Experts
Organizing Committee Academic Speakers Industry Speakers Poster Presentations
Abstract
Abstract Submission Scientific Sessions
Sponsors
Become A Sponsor
Contact Us
Peers Alley Media
827 E 51 Ave East
V5X1E4
Vancouver BC, Canada
BERLIN, GERMANY
NEURCONCLAVE@NEUROLOGISTSMEET.COM
©2019 all right reserved, made with by PeersAlley Conferences
* Terms & Conditions
* Privacy policy
+1 (506) 909-0537